Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,intracellular ligand-gated ion channel activity (GO:0005217),-0.7917101260729631,-2.0148880322195013,0.0,0.08791543634873075,0.073,5/11,9.90%,ITPR1;RYR2;ITPR3;RASA3;MCOLN1
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.8097614964405102,-2.0056507829056236,0.0,0.05084266198480815,0.086,6/11,13.20%,ITPR1;TRPC3;ITPR3;TRPC6;ITPR2;TRPC4
prerank,L-glutamate transmembrane transporter activity (GO:0005313),-0.7265585823555527,-1.9420922163622423,0.0035587188612099642,0.0688494381044277,0.162,6/14,9.02%,SLC7A11;SLC1A3;SLC25A13;SLC1A1;SLC1A2;SLC38A7
prerank,solute:sodium symporter activity (GO:0015370),0.8018706475460815,1.9191174425825246,0.0,0.020690104001894558,0.021,5/27,3.53%,SLC4A10;SLC4A4;SLC5A6;SLC5A2;SLC4A8
prerank,calcium-release channel activity (GO:0015278),-0.6644603499062708,-1.886086057738994,0.007936507936507936,0.09427076909683177,0.284,6/17,10.40%,ITPR1;RYR2;ITPR3;RASA3;MCOLN1;ITPR2
prerank,platelet-derived growth factor binding (GO:0048407),0.8818136299969315,1.8430451655232822,0.0,0.06650390572037536,0.11,4/11,1.32%,COL6A1;COL3A1;COL1A2;COL1A1
prerank,chloride transmembrane transporter activity (GO:0015108),0.8235459271359449,1.8198586441709894,0.0013297872340425532,0.07389322857819484,0.176,4/16,3.53%,SLC26A7;SLC26A2;SLC26A6;SLC4A8
prerank,retinoid binding (GO:0005501),-0.6012053472744516,-1.8145595912144339,0.0091324200913242,0.15422274135391803,0.472,5/22,2.50%,ALDH1A2;NR2F2;PTGDS;RBP4;CYP26B1
prerank,metalloendopeptidase activity (GO:0004222),0.6543605921412432,1.8131379658943187,0.0,0.06034613667219246,0.19,13/76,6.79%,ADAMTSL3;ADAMTS3;ADAMTS17;ADAMTS2;TRABD2B;ADAM9;ADAMTSL1;ECE1;ADAMTS10;MMP28;ADAM10;SPG7;MMP14
prerank,intracellular chloride channel activity (GO:0061778),-0.6261973243601936,-1.788798931004205,0.011320754716981131,0.1348238447275716,0.544,8/16,16.27%,ANO4;ANO1;ANO3;TTYH2;ANO10;ANO6;ANO2;TTYH3
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.6261973243601936,-1.788798931004205,0.011320754716981131,0.1348238447275716,0.544,8/16,16.27%,ANO4;ANO1;ANO3;TTYH2;ANO10;ANO6;ANO2;TTYH3
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.7250961876241644,-1.7638480573249615,0.009404388714733543,0.14882070851803217,0.635,3/10,2.06%,SLC6A13;SLC6A1;SLC6A12
prerank,cAMP binding (GO:0030552),-0.7053140775349124,-1.750193183893893,0.026402640264026403,0.14876186284443865,0.682,5/11,10.27%,RAPGEF4;PDE4D;RAPGEF2;PDE2A;PDE4B
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.6213652221025479,-1.7364859677244535,0.007874015748031496,0.14924439736790557,0.723,6/15,11.01%,ALDH1A2;ALDH1A1;ALDH4A1;ALDH1L1;ALDH2;ALDH9A1
prerank,ligand-gated calcium channel activity (GO:0099604),-0.590082003716216,-1.7320589511477062,0.01680672268907563,0.13991361337864816,0.734,7/19,10.00%,ITPR1;RYR2;ITPR3;GRIN2B;RASA3;MCOLN1;GRIN2A
prerank,bicarbonate transmembrane transporter activity (GO:0015106),0.7887446706966962,1.7309186432949504,0.001358695652173913,0.22463541487771235,0.62,5/15,5.65%,SLC26A7;SLC26A2;SLC26A6;SLC4A8;SLC4A11
prerank,MAP kinase phosphatase activity (GO:0033549),-0.6605587113939643,-1.7245312542218652,0.013651877133105802,0.13672792259456218,0.764,4/12,11.79%,DUSP16;DUSP10;DUSP3;DUSP6
prerank,metallopeptidase activity (GO:0008237),0.6040264113269947,1.7193400398692884,0.0,0.22660590097313088,0.685,17/113,6.79%,ADAMTSL3;ADAMTS3;ADAMTS17;ADAMTS2;TRABD2B;BMP1;ADAM9;ADAMTSL1;ECE1;ADAM30;PAPPA;PSMD7;ADAMTS10;MMP28;ADAM10;SPG7;MMP14
prerank,sulfate transmembrane transporter activity (GO:0015116),0.7962317301494102,1.6996304444324943,0.0,0.2637636387724517,0.791,3/14,2.99%,SLC26A7;SLC26A2;SLC26A6
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.6797869078548319,1.671539152987393,0.006002400960384154,0.34187933755511485,0.902,9/32,9.01%,SLC38A2;SLC38A1;SLC38A6;SLC1A5;SFXN3;SLC7A10;SLC38A3;SLC43A1;SLC6A7
prerank,anion:anion antiporter activity (GO:0015301),0.7599503169878693,1.6666002287332116,0.008108108108108109,0.32633439169125755,0.916,7/17,15.62%,SLC26A7;SLC26A2;SLC26A6;SLC4A2;SLC26A4;SLC4A3;SLC26A11
prerank,carbohydrate:cation symporter activity (GO:0005402),0.7986978643969724,1.6584832607473279,0.005917159763313609,0.3293667508492072,0.938,3/11,2.03%,SLC23A1;SLC23A2;SLC5A2
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.7359122523926852,1.636426498690407,0.012195121951219513,0.39373894888453886,0.976,4/15,14.43%,PLA2G4F;PLA2G4A;PLA2G5;PLA2G12A
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.6251999752064192,-1.6361584646371237,0.031496062992125984,0.25437626717399203,0.935,6/13,11.01%,ALDH1A2;ALDH1A1;ALDH4A1;ALDH1L1;ALDH2;ALDH9A1
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",-0.630324926878663,-1.6328931470002186,0.027586206896551724,0.24097303336549694,0.939,8/12,14.78%,PDE8B;PDE7B;PDE4D;PDE2A;PDE4B;PDE8A;PDE1B;PDE4C
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",-0.5588866468574257,-1.6238788134045703,0.04201680672268908,0.2398078890283451,0.952,7/18,11.01%,ALDH1A2;ALDH1A1;FAR2;ALDH6A1;HSD17B12;ALDH2;ALDH9A1
prerank,chemorepellent activity (GO:0045499),-0.5075972981927775,-1.6080208977244859,0.005025125628140704,0.24759317164476885,0.965,7/25,3.42%,SEMA6A;DPP4;EPHA7;SEMA3D;SEMA7A;NRG3;SEMA5A
prerank,chemoattractant activity (GO:0042056),0.651713095057693,1.5978658138183834,0.021303258145363407,0.579651326402284,0.998,6/26,9.70%,PGF;VEGFA;FGF2;CCL15;HMGB1;BMP4
prerank,symporter activity (GO:0015293),0.7979634802901369,1.5937105283794828,0.01488095238095238,0.5609064458535591,0.998,3/10,7.53%,SLC4A4;SLC5A6;SLC28A2
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.6032660476839526,1.579911522113634,0.0056947608200455585,0.6050096057968963,0.998,10/55,7.04%,SLC38A2;SLC38A1;SLC23A1;SLC23A2;SLC16A9;SLC16A1;SLC38A6;ABCC1;SLC25A32;SLC38A3
prerank,ankyrin binding (GO:0030506),-0.5198583984622412,-1.5690412329880814,0.0211864406779661,0.2917222345745977,0.987,5/19,9.30%,SLC8A1;CACNA1D;CDH1;KCNQ2;FLNC
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.673883630315094,1.5639322801987752,0.026246719160104987,0.6701623210518418,0.999,9/20,18.25%,DLG2;MAGI3;AK3;AK6;DLG1;DTYMK;AK1;LRGUK;MPP1
prerank,diacylglycerol kinase activity (GO:0004143),-0.6147477536723016,-1.5628743220744739,0.06375838926174497,0.2855780539493911,0.988,7/11,14.58%,DGKB;DGKD;DGKG;DGKH;DGKE;DGKZ;DGKA
prerank,organic anion transmembrane transporter activity (GO:0008514),0.5430873995167762,1.5621243450967774,0.0020408163265306124,0.6397922041062037,0.999,18/134,5.93%,SLC38A2;SLC38A1;SLC26A7;SLC26A2;SLC23A1;SLC23A2;SLC5A6;SLCO3A1;SLCO2A1;SLC16A1;SLC26A6;SLC38A6;SLC4A8;SLC1A5;ABCC1;SFXN3;SLC4A11;SLC25A32
prerank,R-SMAD binding (GO:0070412),0.6974497496777647,1.5568828387669629,0.02857142857142857,0.6352499438788971,0.999,5/18,6.33%,PMEPA1;DDX5;SMAD6;LDLRAD4;SMAD4
prerank,amino acid transmembrane transporter activity (GO:0015171),0.5985251970350045,1.5554763627335917,0.006795016987542469,0.6077854889868708,0.999,8/47,7.48%,SLC47A1;SLC38A2;SLC38A1;SLC38A6;SLC1A5;SLC7A10;SLC38A3;SLC43A1
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.6365999752757323,1.5536918952095549,0.022388059701492536,0.586375178078756,0.999,4/29,3.81%,SLC26A7;SLC26A2;SLC26A6;SLC1A5
prerank,gated channel activity (GO:0022836),0.7219210747508858,1.55292196800656,0.027888446215139442,0.561391488584739,0.999,3/14,7.38%,PIEZO2;TMEM266;TMC8
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.569307549088359,1.5274713929524215,0.012304250559284116,0.6804276152822603,1.0,9/53,9.01%,SLC47A1;SLC38A2;SLC38A1;SLC38A6;SLC1A5;SLC7A10;SLC38A3;SLC43A1;SLC6A7
prerank,BMP binding (GO:0036122),-0.6024222718981285,-1.5198217245841112,0.039603960396039604,0.3490415643496533,0.996,3/11,9.15%,ENG;GREM2;BMPR2
prerank,mechanosensitive ion channel activity (GO:0008381),0.7280580250528556,1.5154251742120783,0.04330175913396482,0.7249597480144353,1.0,2/12,7.38%,PIEZO2;TMC8
prerank,aspartic-type peptidase activity (GO:0070001),0.7510931913969656,1.5130337056523748,0.043478260869565216,0.7098461975474011,1.0,4/10,17.79%,BACE2;DDI2;BACE1;NAPSA
prerank,inorganic anion transmembrane transporter activity (GO:0015103),0.6270756379606087,1.511436948396464,0.025031289111389236,0.6915995676982493,1.0,5/27,5.65%,SLC26A7;SLC26A2;SLC39A14;SLC26A6;SLC4A11
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.7084755136199136,1.5063942442445581,0.02442528735632184,0.693256418090147,1.0,5/12,12.68%,CRYZ;AKR1C1;CBR4;DHRS4;NDUFS7
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.6182335022981229,1.5037451814414697,0.027479091995221028,0.6812955674909565,1.0,3/31,1.21%,KCNK5;SLC12A7;SLC12A2
prerank,endopeptidase activity (GO:0004175),0.5031376448391107,1.496003613289524,0.001001001001001001,0.7024418025334572,1.0,76/257,24.22%,ADAMTSL3;ADAMTS3;ADAMTS17;HTRA3;ADAMTS2;TRABD2B;PCSK5;F3;HTRA4;ADAM9;ADAMTSL1;ECE1;PRSS38;PRSS12;FAP;USP24;ADAMTS10;USP2;PSMA8;PRSS53;MMP28;ADAM10;SPG7;MMP14;BACE2;TASP1;CLPP;MBTPS1;DDI2;BACE1;PSMA4;USP40;PDIA3;RHBDL3;ADAMTS6;USP48;ADAMTS20;USP34;USP11;PSMA6;MMP16;USP7;CASP1;USP33;USP36;NLN;USP13;PSEN2;HGF;USP35;IDE;PRSS36;PCSK7;NAPSA;TPP2;USP10;USP46;USP1;RHBDD3;CTSZ;PSMA3;UCHL1;USP5;CTSB;PSMB1;SENP1;USP47;CTSK;CTSO;MMP2;PSMA5;AFG3L2;PSMA7;USP49;PHEX;USP14
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),-0.6116010213324785,-1.4890040389259467,0.07371794871794872,0.37496463213796005,0.998,3/10,11.79%,DUSP16;DUSP10;DUSP6
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),-0.6116010213324785,-1.4890040389259467,0.07371794871794872,0.37496463213796005,0.998,3/10,11.79%,DUSP16;DUSP10;DUSP6
prerank,solute:anion antiporter activity (GO:0140323),0.6856877499447114,1.479528668511117,0.058663028649386086,0.7801365575272181,1.0,7/14,15.62%,SLC26A7;SLC26A2;SLC26A6;SLC4A2;SLC26A4;SLC4A3;SLC26A11
prerank,outward rectifier potassium channel activity (GO:0015271),-0.5898201257810392,-1.4791729897603367,0.06761565836298933,0.37713122284753997,0.999,4/11,5.34%,KCNK2;KCND3;KCND2;KCNT1
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.5768592573605661,1.4785737781148318,0.03263403263403263,0.7589768857181025,1.0,19/40,24.79%,PRMT8;PEMT;TPMT;LRTOMT;TARBP1;NNMT;LCMT1;HNMT;CARNMT1;THUMPD3;GNMT;PCMT1;ARMT1;SUV39H1;FBL;ASMT;METTL8;METTL9;DNMT1
prerank,histone methyltransferase activity (GO:0042054),0.5823661091094523,1.4696362384270032,0.041820418204182044,0.7898693513485174,1.0,19/32,30.72%,PRMT8;KMT5A;KMT2C;EHMT1;CARM1;SETDB1;MEN1;NTMT1;SUV39H1;FBL;SETD2;PRMT1;SMYD2;EHMT2;SETD7;PRMT5;NSD3;TTLL12;SUZ12
prerank,lysine-acetylated histone binding (GO:0070577),0.6239435743192142,1.4653823221821272,0.06430446194225722,0.7663343580463624,1.0,15/20,25.53%,BAZ2A;BRD4;BRD3;CARM1;PHIP;BRD2;BRD9;MLLT3;THAP7;ATAD2B;BRDT;KMT2A;TAF1;SMARCA4;ZMYND8
prerank,acetylation-dependent protein binding (GO:0140033),0.6239435743192142,1.4653823221821272,0.06430446194225722,0.7663343580463624,1.0,15/20,25.53%,BAZ2A;BRD4;BRD3;CARM1;PHIP;BRD2;BRD9;MLLT3;THAP7;ATAD2B;BRDT;KMT2A;TAF1;SMARCA4;ZMYND8
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.5542101358218804,1.4628560951249592,0.04452054794520548,0.7595328222340514,1.0,12/48,13.39%,PIEZO2;SLC12A7;SLC12A2;SLC4A11;CALHM6;CALHM5;SLC12A4;TRPM7;TRPM4;TMEM165;TRPM6;ATP6V1B2
prerank,glutamate receptor activity (GO:0008066),-0.5063129272025423,-1.4626731762258904,0.07172995780590717,0.39499774623523504,0.999,9/19,7.75%,GRM7;GRM5;GRM3;GRIA1;GRM8;GRID2;GRM1;GRIK2;GRIA4
prerank,SUMO transferase activity (GO:0019789),0.6523140273543719,1.4618493875408622,0.0534045393858478,0.7434528127067322,1.0,5/16,14.16%,HDAC4;TOPORS;TRIM28;RANBP2;PIAS4
prerank,O-acyltransferase activity (GO:0008374),0.5978779429053623,1.4611335986636846,0.0594059405940594,0.7264900735794486,1.0,8/30,10.45%,PLA2G4A;SOAT1;PIGW;LPCAT1;MBOAT2;LPCAT4;GPAT4;LPCAT3
prerank,RNA polymerase II complex binding (GO:0000993),0.5765333635686484,1.454613139472916,0.05194805194805195,0.7424353721738036,1.0,18/32,25.45%,ELOF1;BRD4;CCAR2;ERCC5;SCAF1;ESRRB;URI1;AGO1;AGO2;PCF11;RPRD1A;ELP4;RTRAF;PAF1;HNRNPU;SMYD2;RECQL5;UVSSA
prerank,sulfuric ester hydrolase activity (GO:0008484),0.6788087136040406,1.4506607128878055,0.06876790830945559,0.7437519882585802,1.0,9/12,27.08%,ARSJ;ARSB;SULF1;ARSA;ARSI;SULF2;GNS;ARSG;SGSH
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.6673283765016322,1.4505105307173585,0.06878306878306878,0.7253203752543863,1.0,3/14,6.99%,KCNJ2;KCNE5;KCNIP2
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.7120840414260562,1.4446577794671023,0.07254623044096728,0.738603871432712,1.0,4/10,7.56%,DSE;GALE;FUOM;GFUS
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.6909560414587934,1.4402052468655615,0.0625,0.7465186572493098,1.0,2/12,0.78%,PGF;VEGFA
prerank,cation transmembrane transporter activity (GO:0008324),0.5488017442994353,1.4279756677743352,0.0481651376146789,0.7950430788649029,1.0,7/48,9.01%,SLC38A2;SLC38A1;SLC38A6;SLC1A5;SFXN3;SLC38A3;SLC6A7
prerank,ion gated channel activity (GO:0022839),-0.4539956765357494,-1.4261675729788759,0.0660377358490566,0.4626593972107151,1.0,7/24,8.49%,ANO4;ANO1;KCNT1;ANO3;TTYH2;ANO10;ANO6
prerank,ATPase binding (GO:0051117),0.512526528113204,1.4259823124498496,0.02691065662002153,0.7874203186299259,1.0,17/71,14.53%,ESR1;EGFR;ATP1B1;SLC2A13;PTPN3;RDX;TCIRG1;ATP6V0A1;ANK2;CLPP;SNTA1;SYVN1;TMEM106B;EZR;S100A1;ABCA1;ATP6V1E1
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.6628416474733251,1.4183222820699002,0.08005427408412483,0.8149793014876939,1.0,6/14,22.75%,CAPN5;CAPN10;CAPN2;CAPN15;CAPNS1;CAPN6
prerank,tropomyosin binding (GO:0005523),-0.5026749102195127,-1.413275322604851,0.08196721311475409,0.4734722897335259,1.0,5/16,10.02%,NEBL;TMOD3;TMOD1;LMOD1;S100A6
prerank,Wnt-activated receptor activity (GO:0042813),0.6422919310033677,1.4129590790457118,0.08254397834912043,0.8273130655389591,1.0,5/15,9.47%,PKD1;LRP5;FZD7;FZD5;ROR1
prerank,semaphorin receptor binding (GO:0030215),-0.4577312186785271,-1.4103617801761215,0.06666666666666667,0.46235045742434905,1.0,13/23,21.24%,SEMA6A;SEMA3D;SEMA7A;SEMA5A;SEMA4D;SEMA3G;RIT2;SEMA4A;PLXNB1;SEMA4G;SEMA5B;SEMA6D;SEMA3B
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.5419857693946409,-1.4062856940312187,0.08940397350993377,0.45475936553078394,1.0,3/11,6.85%,LEF1;MBD2;GATA2
prerank,MAP kinase kinase kinase activity (GO:0004709),0.6760156315685375,1.4036730494155178,0.10142857142857142,0.8616059923667265,1.0,2/11,3.78%,EGFR;MAP3K5
prerank,I-SMAD binding (GO:0070411),0.651375775113108,1.4016564532780336,0.10694444444444444,0.8550196187946487,1.0,7/13,12.61%,SMAD9;SMAD6;SMAD4;AXIN1;SMAD7;TGFB1I1;TGFBR1
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),-0.5640549799370174,-1.3965555342349627,0.12539184952978055,0.4606481361525363,1.0,4/10,7.50%,PRKAG2;PRKAR2B;PRKAR1B;PKIG
prerank,hyaluronic acid binding (GO:0005540),-0.5830997372358928,-1.3947281418086115,0.11326860841423948,0.4490006061632518,1.0,4/10,16.30%,CEMIP;LAYN;HYAL2;CD44
prerank,ubiquitin-specific protease binding (GO:1990381),0.6103571406890043,1.3916785061916457,0.09311224489795919,0.8950199396807397,1.0,12/19,32.06%,VCP;SYVN1;CHMP3;CLTC;SUMO1;LCOR;DERL1;AMFR;SELENOS;PRKN;SPATA2;SART3
prerank,serine-type peptidase activity (GO:0008236),0.48903837842609127,1.391283854001986,0.03477344573234984,0.8787341690725277,1.0,10/96,7.86%,HTRA3;PCSK5;F3;HTRA1;PRSS38;PRSS12;FAP;PRSS53;CLPP;MBTPS1
prerank,pre-mRNA binding (GO:0036002),0.567923530584666,1.3898973077302286,0.07833537331701346,0.8693462940970973,1.0,15/28,24.32%,SRSF6;DDX5;CELF4;CELF3;HNRNPL;U2AF1;ZRSR2;PTBP1;RBM4;U2AF2;RBM22;TRA2B;HNRNPA1;HNRNPU;RBM24
prerank,RNA polymerase core enzyme binding (GO:0043175),0.5435979536942478,1.3870351988656984,0.08558030480656506,0.868728204887167,1.0,18/33,25.45%,ELOF1;CCAR2;ERCC5;ESRRB;URI1;AGO1;SPTY2D1;AGO2;PCF11;ERBB2;RPRD1A;ELP4;RTRAF;PAF1;HNRNPU;SMYD2;RECQL5;UVSSA
prerank,RNA cap binding (GO:0000339),0.6372256096453798,1.3870060559763902,0.09329829172141918,0.8518681849370144,1.0,12/16,28.60%,CYFIP1;EIF4E3;EIF4A1;SNUPN;AGO2;NCBP3;EIF3D;NCBP1;NCBP2;CYFIP2;EIF4E;LARP1
prerank,protein phosphorylated amino acid binding (GO:0045309),0.540041289567168,1.3868190660881812,0.07710011507479862,0.8367366052487797,1.0,5/42,3.29%,IRS1;NEDD4;PTPN3;VAV2;SHC1
prerank,protein tyrosine kinase activator activity (GO:0030296),0.6078160452635241,1.3867483102299312,0.09184993531694696,0.8211536065370065,1.0,6/19,9.53%,EFNA5;GAS6;ABI1;DGKQ;ANGPT4;PAK2
prerank,inward rectifier potassium channel activity (GO:0005242),0.5860086475689829,1.3850588865988707,0.0903387703889586,0.815106169563174,1.0,3/24,4.12%,KCNJ2;KCNJ15;KCNN1
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.581565885738871,1.3781592467708577,0.09259259259259259,0.837098320353708,1.0,7/27,6.94%,SLC23A1;SLC9B2;SLC4A8;SLC9A8;SLC4A11;SLC9A4;SLC9A1
prerank,manganese ion binding (GO:0030145),0.5266803121389768,1.3773341543450115,0.07062780269058296,0.8267068851573328,1.0,17/48,23.64%,ME1;ADCY2;B4GALT1;XPNPEP1;PPM1M;WRN;HMGCL;ABL1;GALNT1;GALNT3;MPPED2;XYLT2;NEK4;GALNT2;B4GALT7;PRIMPOL;ARG2
prerank,cation:chloride symporter activity (GO:0015377),0.6939303081645375,1.37705726639042,0.11063218390804598,0.8137070476133569,1.0,3/10,7.65%,SLC12A7;SLC12A2;SLC12A4
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.5370154125088175,1.374846166633254,0.0869047619047619,0.8115345062286623,1.0,16/37,25.81%,VARS1;VARS2;WARS2;HARS2;YARS1;DARS2;YARS2;NARS2;EPRS1;SARS1;SARS2;DARS1;CARS2;TARS2;QARS1;CARS1
prerank,store-operated calcium channel activity (GO:0015279),-0.5645368428535679,-1.373286834803355,0.1111111111111111,0.48173422230605717,1.0,5/10,13.20%,TRPC3;TRPC6;ORAI1;ORAI2;TRPC4
prerank,frizzled binding (GO:0005109),0.555480805128319,1.371855364175962,0.09341317365269461,0.8130593008460404,1.0,5/34,6.70%,MYOC;LRP6;WNT9A;DVL1;FZD7
prerank,aspartic-type endopeptidase activity (GO:0004190),0.6491535088017094,1.371143715895945,0.09985935302390998,0.8030716081878216,1.0,6/12,23.62%,HM13;BACE2;DDI2;BACE1;NAPSA;SPPL2A
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.5521844385278529,1.3675719320670208,0.0883054892601432,0.8083676933573932,1.0,14/30,25.13%,GAS6;NOL3;CARD16;CST3;CD27;SERPINB9;PRDX3;BIRC6;BIRC5;CAST;BIRC3;DPEP1;UBE2Z;XIAP
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),-0.5052600324780336,-1.3645246448331378,0.10038610038610038,0.48683215588679196,1.0,3/13,2.28%,CDH5;BMP6;BMP7
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),-0.4417155932520401,-1.3638782013231947,0.10576923076923077,0.4728764772883914,1.0,7/22,12.05%,CPEB2;RBMS3;ELAVL4;ELAVL1;EXOSC8;ZC3H12A;ZFP36
prerank,insulin-like growth factor receptor binding (GO:0005159),0.6506837158258291,1.3606875401694312,0.13285714285714287,0.8302261778640408,1.0,4/12,8.51%,GNAS;IRS1;SHC1;SOCS2
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.5416426959318648,1.359952350063023,0.0880952380952381,0.8205823485135368,1.0,24/33,35.34%,ELOF1;CCAR2;ERCC5;ESRRB;URI1;AGO1;AGO2;PCF11;RPRD1A;ELP4;RTRAF;PAF1;TBP;HNRNPU;SMYD2;RECQL5;UVSSA;ZNF326;ELP2;RPRD2;WAC;LLPH;DHX9;SUPT4H1
prerank,cysteine-type endopeptidase activity (GO:0004197),0.4953618046066585,1.358938504205019,0.054838709677419356,0.8134412912649617,1.0,32/78,24.22%,CAPN5;USP24;USP2;GPAA1;CAPN10;CAPN2;USP40;PDIA3;USP48;USP34;USP11;USP7;CASP1;USP33;USP36;USP13;USP35;CAPN15;USP10;USP46;USP1;CTSZ;UCHL1;USP5;CTSB;CAPNS1;USP47;CTSK;CTSO;CAPN6;USP49;USP14
prerank,transcription coactivator binding (GO:0001223),0.5837911516502582,1.3564545407993625,0.10800508259212198,0.8136440239690095,1.0,7/20,11.85%,ESR1;CIT;SMAD4;RORA;CCNT2;TERT;MED25
prerank,protease binding (GO:0002020),0.4780249458411761,1.356437015239265,0.03630705394190872,0.8014205796866604,1.0,22/99,14.08%,F3;COL3A1;SLC2A13;COL1A2;COL1A1;TIMP2;TIMP3;COMP;NOL3;FAP;ANXA2;CRADD;CARD16;VCP;SYVN1;CST3;STIM1;ITGAV;ATP9A;SERPINB9;CHMP3;CLTC
prerank,histone acetyltransferase activity (GO:0004402),0.543639235501364,1.3559055223788345,0.10378510378510379,0.792414807640435,1.0,17/30,29.39%,NAA60;NAA40;TADA2A;KAT14;KAT6B;KAT2A;ARRB1;CREBBP;ATF2;KAT7;KAT8;KAT2B;TAF1;SRCAP;TAF10;USP22;TADA3
prerank,wide pore channel activity (GO:0022829),-0.4351654344321158,-1.3549866639650032,0.09210526315789473,0.47745239711112447,1.0,4/23,4.91%,GJB6;GJB2;GJC1;GJD3
prerank,insulin-like growth factor I binding (GO:0031994),-0.5307235438053377,-1.3499497275567738,0.15593220338983052,0.47559073398289287,1.0,6/13,4.96%,IGF1R;INSR;IGFBP2;ITGA6;IGFBP3;ITGB4
prerank,transcription corepressor binding (GO:0001222),0.5582937571761329,1.348035054662198,0.11300121506682867,0.8199395487193382,1.0,10/27,17.71%,ESR1;PHF1;PER3;EHMT1;RORA;USP11;PER1;HDAC6;LCOR;THAP7
prerank,nuclear import signal receptor activity (GO:0061608),0.6151628409882359,1.3451906007225816,0.1390728476821192,0.8226351081829878,1.0,9/15,19.36%,IPO5;IPO4;HIKESHI;KPNA2;TNPO2;KPNA3;IPO9;TNPO1;KPNA4
prerank,myosin binding (GO:0017022),0.5041107138828046,1.3441097208540496,0.06853932584269663,0.8160486666162208,1.0,13/55,15.84%,MYOC;GSN;DMD;RAB8A;LLGL1;GIPC1;RHOA;RAB3D;STXBP5;KIRREL1;RAB11B;RAB3B;CXCR4
prerank,metal ion:proton antiporter activity (GO:0051139),0.6352592795184706,1.3422328516719921,0.13636363636363635,0.813380580865895,1.0,10/13,29.53%,SLC9B2;SLC9A8;SLC9A4;SLC9A1;LETM1;SLC11A1;SLC9A5;SLC9A7;SLC9A6;SLC9A9
prerank,3'-5' DNA helicase activity (GO:0043138),0.5916694159108873,1.3403651898366078,0.13765182186234817,0.8112655462012703,1.0,4/16,12.11%,NAV2;MCM2;WRN;ERCC3
prerank,ionotropic glutamate receptor binding (GO:0035255),0.6714107393442397,1.3368077254142534,0.13314447592067988,0.8169689337525645,1.0,5/10,14.33%,GNAS;DLG4;NSF;SHANK1;SQSTM1
prerank,gap junction channel activity (GO:0005243),-0.44008671239954206,-1.3362483696724798,0.10714285714285714,0.49368830057034246,1.0,4/22,4.91%,GJB6;GJB2;GJC1;GJD3
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.510856379814989,-1.3336997048787853,0.09090909090909091,0.48556507565699586,1.0,3/12,1.02%,TGFBR3;ENG;LTBP1
prerank,LRR domain binding (GO:0030275),-0.5002562737530065,-1.3319317521636083,0.1509433962264151,0.4768789771075079,1.0,3/14,2.99%,ROBO1;PAWR;LRRFIP2
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.608630084532833,1.3311462551001656,0.1268357810413885,0.8342345795049608,1.0,8/15,22.61%,KMT2C;WDR5;KMT2D;SETD4;KMT2B;WDR82;SETD1A;KMT2A
prerank,transferrin receptor binding (GO:1990459),0.6553889430944168,1.3303597780582381,0.1464088397790055,0.8268816485074622,1.0,4/10,12.49%,SNX2;SNX1;CHUK;RGMA
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.4882875334135882,-1.329811250460375,0.10408921933085502,0.4569049693218095,1.0,5/16,6.90%,PTPRG;PTPRB;PTPRD;PTPRO;PTPRK
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.4882875334135882,-1.329811250460375,0.10408921933085502,0.4569049693218095,1.0,5/16,6.90%,PTPRG;PTPRB;PTPRD;PTPRO;PTPRK
prerank,poly(A) binding (GO:0008143),-0.4288236637673045,-1.3293856722003092,0.107981220657277,0.4464091644478623,1.0,5/21,5.11%,RBPMS;RBMS1;RBMS3;ELAVL4;DDX3X
prerank,sodium:proton antiporter activity (GO:0015385),0.6558529670826925,1.328583825229344,0.14102564102564102,0.8243761927221033,1.0,4/11,6.94%,SLC9B2;SLC9A8;SLC9A4;SLC9A1
prerank,histone demethylase activity (GO:0032452),0.5534582312867847,1.328407667393073,0.12561576354679804,0.8146168653559783,1.0,10/27,16.74%,JMJD1C;RIOX2;KDM2A;PHF8;KDM5B;KDM4A;FBXL19;HR;KDM5C;KDM6B
prerank,ribonuclease activity (GO:0004540),0.48851735793306406,1.3265184677115476,0.09281767955801105,0.8128634083235168,1.0,20/56,19.54%,RNASE7;ERN2;PPP1R8;RNASE3;SMG6;ZC3H12D;RNASE6;AGO1;DIS3L2;ZC3H12C;AGO2;YBEY;LACTB2;SND1;EXOSC4;RPP40;N4BP1;ELAC2;KHNYN;NOB1
prerank,BMP receptor binding (GO:0070700),-0.5052614470844875,-1.3248842684921749,0.13333333333333333,0.4438399049283556,1.0,3/12,2.28%,CDH5;BMP6;BMP7
prerank,endonuclease activity (GO:0004519),0.5018663812793169,1.322708715636251,0.096045197740113,0.8215804589106738,1.0,16/49,19.54%,N4BP2;ERN2;SMG6;ERCC5;ZC3H12D;ERCC4;OGG1;AGO1;ZC3H12C;AGO2;YBEY;LACTB2;SND1;DIS3;KHNYN;NOB1
prerank,amino acid:sodium symporter activity (GO:0005283),0.6419599790601419,1.3197828732634949,0.15417256011315417,0.8254489409089183,1.0,2/11,0.11%,SLC38A2;SLC38A1
prerank,methyltransferase activity (GO:0008168),0.5014414212816977,1.319159961787869,0.08455467869222097,0.8182382693753363,1.0,21/46,29.58%,PRMT8;LRTOMT;EEF1AKMT3;EHMT1;NNMT;LCMT1;EEF1AKMT2;CARNMT1;GCSH;ARMT1;NTMT1;SUV39H1;ASMT;PRMT1;BUD23;DNMT1;NSUN3;METTL27;MEPCE;PRMT5;PRMT3
prerank,nuclear export signal receptor activity (GO:0005049),0.6393300737057978,1.3172981763683118,0.15620641562064155,0.8158773647762184,1.0,3/11,11.20%,XPO1;XPO6;XPO4
prerank,NAD binding (GO:0051287),0.5461377348528909,1.3171942848985445,0.13341493268053856,0.8065579441289326,1.0,9/26,17.47%,ME1;SORD;SIRT5;CRYZ;NNT;BDH2;SIRT2;CRYL1;HSD17B8
prerank,monovalent cation:proton antiporter activity (GO:0005451),0.6313045928387911,1.3164875699100258,0.1490857946554149,0.8004630599281723,1.0,9/12,29.53%,SLC9B2;SLC9A8;SLC9A4;SLC9A1;LETM1;SLC9A5;SLC9A7;SLC9A6;SLC9A9
prerank,phosphotyrosine residue binding (GO:0001784),0.5222523570844628,1.314021580193648,0.12796208530805686,0.8021617072555255,1.0,4/37,3.29%,IRS1;PTPN3;VAV2;SHC1
prerank,fibroblast growth factor binding (GO:0017134),0.5620577775584827,1.31325284664847,0.12781954887218044,0.7962253146376932,1.0,5/21,13.27%,THBS1;FGFR1;FGFR2;ITGAV;GLG1
prerank,ligand-gated cation channel activity (GO:0099094),0.47820212296034365,1.3111840614430692,0.08467309753483387,0.7963821476328576,1.0,9/75,9.14%,KCNJ2;KCNJ15;GRIK4;GRIN3A;KCNN1;CHRNB2;CHRNA5;TRPM4;KCNK6
prerank,GTPase inhibitor activity (GO:0005095),0.6129722986224871,1.3106668864984379,0.1627260083449235,0.789560343301736,1.0,8/13,20.89%,SLIT2;IPO5;GPS1;PDE6D;ARL2;IQGAP1;RTKN;GPS2
prerank,alkali metal ion binding (GO:0031420),-0.4922665822836034,-1.3097858111868577,0.13059701492537312,0.4653768063520162,1.0,1/13,0.01%,ATP1A2
prerank,mannose binding (GO:0005537),0.6202872727564714,1.3094586993483144,0.16208393632416787,0.7864896355904766,1.0,4/12,21.83%,COLEC11;LMAN2L;LMAN2;LMAN1
prerank,small GTPase binding (GO:0031267),0.44691942948606994,1.305219819502014,0.03838383838383838,0.797017837016897,1.0,81/169,28.55%,SGSM2;PLCE1;SRGAP2;YBX3;DOCK4;EXOC4;EHD1;ANKRD27;UNC13B;DOCK7;FGD6;GOLGA5;RAB34;ERC1;RABGEF1;RILP;RAB3GAP1;CDC42EP2;RIC1;GGA2;RAB8A;IFT20;PEX5;RAF1;GOLGA4;NDRG1;PDE6D;CYFIP1;PPP6R1;LZTR1;PAK2;RGP1;ARFIP2;RCC1;SOD1;RCC2;EVI5L;TRIP11;CDC42EP5;OCRL;LSM2;ABCA1;USP33;RANBP2;CCDC186;HPS4;TMEM127;AKAP13;IQGAP1;GGA1;DAPK3;BIRC5;MYCBP2;RAB3GAP2;EVI5;MAPKAP1;RTKN;OPTN;ABI2;LRRK2;KCTD13;MLPH;TSC2;RAPGEF6;RABGAP1;RAB11FIP4;AFDN;NUTF2;TBC1D20;ARHGDIB;CYRIB;RABGGTB;WAS;GCC2;XPO5;MYO5A;GGA3;NOX1;SPHK2;ULK1;MTSS2
prerank,RNA 7-methylguanosine cap binding (GO:0000340),0.6249030637751525,1.3025237083049677,0.18488529014844804,0.7999848741998885,1.0,10/12,31.78%,CYFIP1;EIF4E3;AGO2;NCBP3;NCBP1;NCBP2;CYFIP2;EIF4E;LARP1;DCPS
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.6325077814744078,1.2981226609721386,0.16224188790560473,0.8117545980039376,1.0,7/11,29.58%,PRMT8;CARM1;PRMT1;FBXO11;PRMT9;PRMT5;PRMT3
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.5453500793418983,1.2974797551403263,0.14603960396039603,0.8060559411613667,1.0,4/25,8.81%,FMO1;MICAL2;MTRR;AKR1C1
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.49245601412723633,1.2964308788928416,0.14482758620689656,0.8020926539255233,1.0,23/44,26.51%,KMT5A;KMT2C;KMT5C;EHMT1;NSD1;ASH1L;SETD5;WDR5;KMT2D;SETDB1;SETD4;KMT2B;MEN1;WDR82;SUV39H2;SETD1A;SUV39H1;SETD2;KMT2A;SETDB2;SMYD2;EHMT2;SETD7
prerank,cation channel activity (GO:0005261),0.4579670205912918,1.2958605982326272,0.09725158562367865,0.7959415598162415,1.0,13/94,8.87%,PIEZO2;KCNK5;PKD1;SLC24A3;SEC61A1;TRPV3;ANXA2;SLC4A11;MCU;CALHM6;CALHM5;TRPM7;TRPM4
prerank,clathrin adaptor activity (GO:0035615),0.5893347235868835,1.2950959481560602,0.16395663956639567,0.7909243824454395,1.0,6/15,16.45%,STON2;AP2A1;STON1;AP2A2;DAB2;HIP1
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.575796309064863,1.2944233492799704,0.15528781793842034,0.7856653091067973,1.0,5/17,14.34%,AK5;AK3;DTYMK;CLP1;AK1
prerank,acylglycerol lipase activity (GO:0047372),0.6253901849158666,1.2936207911937567,0.16833095577746077,0.7812876833329601,1.0,1/11,0.40%,MGLL
prerank,UDP-glycosyltransferase activity (GO:0008194),0.4711460663992701,1.2898946174004164,0.11546840958605664,0.7901052125629691,1.0,17/70,19.98%,EXT1;GXYLT2;CHPF2;POGLUT3;B3GNT7;POGLUT1;B4GALT1;OGT;MGAT4B;HEXA;B3GNT9;B4GAT1;B3GNT6;GXYLT1;EXT2;GCNT7;B4GALNT3
prerank,miRNA binding (GO:0035198),0.5246012951325344,1.2877800251891862,0.1440886699507389,0.7911600197410167,1.0,13/30,23.78%,ZC3H7A;PUM1;MATR3;HNRNPA2B1;RBM10;AGO1;AGO2;RBM4;ZC3H10;TUT7;ZNF346;HNRNPA1;YBX1
prerank,sodium channel activity (GO:0005272),0.5100372389762398,1.2847774280844182,0.14840989399293286,0.7957544714542898,1.0,5/37,6.62%,CACNA1G;GRIK4;HCN4;SLC4A11;SCN11A
prerank,histone deacetylase binding (GO:0042826),0.45418011086207416,1.2844334133995028,0.08718487394957983,0.7892569551796472,1.0,36/88,25.75%,NCOR2;HDAC9;HDAC4;DACT1;ANKRA2;MEF2B;IKZF3;BEX4;PKN2;MAPK8;MIER2;KPNA2;SFPQ;KAT2A;HDAC1;MEF2D;MEF2A;YWHAE;NACC1;SIRT2;HDAC6;NIPBL;MTA3;LCOR;THAP7;AKAP8;MIER1;KAT2B;GLI3;TP53;CHD4;PHF6;YWHAB;NCOR1;HDAC2;SUDS3
prerank,E-box binding (GO:0070888),-0.36369922342375754,-1.2826462545193786,0.09248554913294797,0.5128113067828177,1.0,4/34,4.52%,TCF4;ZEB1;AHR;MITF
prerank,ferrous iron binding (GO:0008198),0.5532331142587439,1.2817158264870818,0.18546365914786966,0.7932258735372668,1.0,9/21,23.68%,FTO;FXN;ALKBH1;FECH;DNAJC24;TET2;PHYH;ISCU;ALKBH3
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.4578116147220697,1.2797868370188155,0.10767590618336886,0.7940016880543903,1.0,19/75,18.75%,ME1;EHHADH;LDHC;SORD;KDSR;GFUS;AKR1C1;NSDHL;CBR4;DHRS4;DHRS9;BDH2;MDH1B;CRYL1;PHGDH;PGD;AKR1A1;HSD17B8;DHRS3
prerank,enoyl-CoA hydratase activity (GO:0004300),0.6323931999446595,1.2787651181801818,0.18785310734463276,0.791000035036603,1.0,5/10,22.45%,EHHADH;ECHDC2;AUH;ECHDC1;HADHA
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.6065667689743544,1.2751643013483165,0.18627450980392157,0.7994039015215378,1.0,3/12,3.29%,IRS1;GAB2;SHC1
prerank,calcium channel regulator activity (GO:0005246),-0.3722244374919502,-1.2747966102170416,0.11538461538461539,0.5185614497228941,1.0,11/37,15.11%,ITPR1;PRKG1;NRXN1;CACNG7;CACNG8;REM1;PACSIN3;CACNG4;SLC30A1;MCUB;INAFM1
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.5994538055381181,1.2744788275672259,0.17832647462277093,0.7946399534327994,1.0,1/13,1.05%,EHHADH
prerank,protein kinase inhibitor activity (GO:0004860),0.5042740740895152,1.274266639169904,0.15005861664712777,0.7879572500262965,1.0,19/42,27.06%,CIT;SPRED2;GMFB;PARVA;HEXIM1;CAMK2N1;GSKIP;CDKN1C;DUSP19;RPTOR;TAOK3;SMCR8;YWHAB;IBTK;MAPK8IP1;QARS1;SOCS1;NCK1;SH3BP5
prerank,GTPase binding (GO:0051020),0.43351206407361004,1.2742167883384188,0.047379032258064516,0.7809361797517187,1.0,89/194,28.55%,SGSM2;PLCE1;SRGAP2;YBX3;DOCK4;EXOC4;EHD1;ANKRD27;UNC13B;DOCK7;FGD6;GOLGA5;RAB34;ERC1;RABGEF1;RILP;RAB3GAP1;CDC42EP2;LAMTOR1;RIC1;GGA2;RAB8A;IFT20;PEX5;RAF1;GOLGA4;NDRG1;PDE6D;CYFIP1;PPP6R1;LZTR1;PAK2;RGP1;ARFIP2;RCC1;SOD1;RCC2;EVI5L;TRIP11;CDC42EP5;OCRL;LSM2;ABCA1;USP33;RANBP2;CCDC186;HPS4;TMEM127;AKAP13;IQGAP1;GGA1;SPTBN1;EPRS1;DAPK3;BIRC5;MYCBP2;RAB3GAP2;EVI5;MAPKAP1;RTKN;GNB1;OPTN;ATG16L1;ABI2;LRRK2;KCTD13;MLPH;TSC2;RAPGEF6;STOML2;RABGAP1;YBX1;RAB11FIP4;AFDN;NUTF2;TBC1D20;ARHGDIB;CYRIB;RABGGTB;WAS;GCC2;AMBRA1;XPO5;MYO5A;GGA3;NOX1;SPHK2;ULK1;MTSS2
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.6078788420982273,1.2740361671372422,0.1721194879089616,0.7745712138440864,1.0,8/11,30.04%,UBR5;STUB1;UBE4A;UBOX5;AMFR;UBE4B;RBX1;ANAPC11
prerank,methylation-dependent protein binding (GO:0140034),0.4751047455248644,1.273803622073752,0.13823857302118173,0.7684185687052835,1.0,24/57,25.68%,MORC3;PHF1;ING3;SGF29;MBTD1;PYGO1;ING5;PHF8;CBX2;KDM4A;WDR5;L3MBTL2;ING4;CBX5;THAP7;ZMYND11;CHD8;CDYL;BPTF;MPHOSPH8;KAT8;ZCWPW2;ZMYND8;CHD1
prerank,signal sequence binding (GO:0005048),0.5097944181736018,1.2731657866906432,0.15938606847697756,0.7642671070087582,1.0,17/35,19.73%,KDELR3;SEC61A1;IPO5;IPO4;KCNIP2;PEX5;KDELR1;KDELR2;KPNA2;TNPO2;CAT;TOMM70;KPNA3;POM121;TNPO1;KPNA4;NFKBIA
prerank,phosphoric ester hydrolase activity (GO:0042578),-0.341147209611499,-1.2694780389991058,0.11206896551724138,0.5188540732088546,1.0,10/49,7.56%,ATP1A2;PPP1CB;DUSP16;PTPRO;DUSP10;PXYLP1;SAMHD1;PLCXD3;DUSP3;ACP2
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),-0.40292473947789037,-1.269055510774747,0.1712707182320442,0.5087259652311442,1.0,13/24,28.06%,ZDHHC14;GLUL;ZDHHC18;ZDHHC3;ZDHHC2;ZDHHC23;ZDHHC12;ZDHHC21;ZDHHC7;ZDHHC6;GOLGA7B;ZDHHC24;ZDHHC22
prerank,lysophospholipase activity (GO:0004622),0.5463248479593245,1.2652712523415026,0.1767741935483871,0.788822203649138,1.0,2/20,1.79%,MGLL;PLA2G4A
prerank,protein kinase C binding (GO:0005080),0.48652908022618746,1.2636266147111617,0.14874141876430205,0.7887302721056396,1.0,11/43,14.33%,IRS1;ADAM9;HDAC9;DACT1;PRKCSH;DACT3;ITGAV;ABL1;NELL1;PICK1;SQSTM1
prerank,androgen receptor binding (GO:0050681),0.5238101788938144,1.2608769652359313,0.19578686493184635,0.7925723442315807,1.0,5/25,12.50%,FOXP1;DDX5;NSD1;RNF14;TGFB1I1
prerank,phospholipid transfer activity (GO:0120014),0.5301370800873869,1.258652077403014,0.20205920205920205,0.7955497871270344,1.0,5/21,4.74%,TNFAIP8L3;PITPNC1;PRELID3B;PITPNA;PITPNM1
prerank,transforming growth factor beta binding (GO:0050431),0.5330890264446859,1.2585221318819426,0.20075757575757575,0.78920494385737,1.0,7/23,9.72%,THBS1;LTBP3;TGFB3;ACVR1;TGFBR2;TSKU;ITGAV
prerank,kinase inhibitor activity (GO:0019210),0.5068856127515368,1.257703731229528,0.18149882903981265,0.7856227868225435,1.0,16/33,28.77%,LRP6;GMFB;PARVA;HEXIM1;GSKIP;CDKN1C;DUSP19;TAOK3;SMCR8;YWHAB;MAPK8IP1;QARS1;SOCS1;NCK1;SH3BP5;WARS1
prerank,ubiquitin binding (GO:0043130),0.4530606381156238,1.2562896733008935,0.12958963282937366,0.7849986077773632,1.0,28/73,21.03%,NEDD4;MVB12B;RAE1;TOM1L1;OTUB1;NBR1;FAF2;DDI2;SHARPIN;UCHL3;WDR48;OTUB2;USP33;MARK4;SQSTM1;UBAP1;USP13;UBE2L6;SIRT2;CXCR4;N4BP1;USPL1;NPLOC4;CKS1B;UCHL1;UBAP1L;NUP62;USP5
prerank,receptor antagonist activity (GO:0048019),0.5646910201780855,1.25114167613632,0.2077028885832187,0.79927021209541,1.0,2/17,3.95%,DKK3;LRPAP1
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.5729685904650836,1.2507401868408023,0.20273972602739726,0.7941873214989326,1.0,2/15,8.47%,CMKLR1;ACKR4
prerank,damaged DNA binding (GO:0003684),0.48513947704762117,1.2502496978135533,0.1701388888888889,0.7895915451121142,1.0,25/44,33.38%,MPG;HMGB1;ERCC5;RBBP8;ERCC4;RAD1;OGG1;TDG;SDE2;ERCC3;ERCC2;DCLRE1B;CREBBP;FANCG;CRY2;POLD1;SMC6;XPA;PNKP;DDB1;XRCC1;ERCC1;POLQ;RPA3;CUL4B
prerank,glucuronosyltransferase activity (GO:0015020),0.5453908359133071,1.246794801140351,0.20234986945169714,0.7971817771879791,1.0,4/19,18.85%,EXT1;B4GAT1;B3GAT2;EXT2
prerank,metal ion transmembrane transporter activity (GO:0046873),0.504094633533681,1.2458469692131597,0.18401937046004843,0.794836883231,1.0,5/27,4.09%,SLC23A1;SLC12A2;SLC9B2;SLC4A8;CNNM2
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),0.5100245401435678,1.2445358094617625,0.20300751879699247,0.7937196811789653,1.0,4/28,8.43%,GRIK4;GABRA3;CHRNB2;CHRNA5
prerank,flavin adenine dinucleotide binding (GO:0050660),0.4608478853769822,1.2440295330160378,0.17809734513274336,0.7894689986180198,1.0,11/53,11.53%,MICAL2;ACOXL;AOX1;XDH;ACOX3;NOX4;QSOX1;MTRR;ETFA;ETFDH;AIFM1
prerank,thiol-dependent deubiquitinase (GO:0004843),0.4525344884279612,1.2417913147205726,0.14423076923076922,0.7923603871171745,1.0,48/83,30.65%,USP24;USP2;OTUB1;USP50;USP40;UCHL3;USP48;USP45;OTUB2;USP34;USP11;TANK;USP7;USP33;USP36;USP13;USP19;USP35;PSMD14;OTUD5;OTULIN;YOD1;USP32;USP10;USP46;USP1;UCHL5;ZRANB1;MPND;OTUD6B;UCHL1;BRCC3;USP5;USP47;DESI2;CYLD;USP4;USP49;USP14;MYSM1;USP21;USP16;USP22;USP37;USP30;OTUD3;USP26;COPS5
prerank,RNA polymerase binding (GO:0070063),0.5380293684687882,1.2410777229682306,0.2198952879581152,0.7887178485365073,1.0,7/18,20.52%,NEDD4;PKN2;ANP32B;CCNT2;PABPN1;STOM;PHRF1
prerank,tRNA binding (GO:0000049),0.4712278525899979,1.2407706225668949,0.1847953216374269,0.7837035628801787,1.0,17/43,22.94%,SSB;ELP5;TRNAU1AP;TERT;DALRD3;DARS2;ALKBH1;ELP1;YARS2;XPOT;ALKBH8;SARS1;SARS2;EIF2AK4;EIF2A;NSUN6;PUS1
prerank,cyclic nucleotide binding (GO:0030551),-0.421618324328617,-1.2404990763626194,0.17370892018779344,0.5625370947707429,1.0,6/21,10.27%,RAPGEF4;PDE4D;RAPGEF2;KCNH1;PDE2A;PDE4B
prerank,potassium ion antiporter activity (GO:0022821),0.5678033191406051,1.2398594174803064,0.20596205962059622,0.7814038399308925,1.0,4/15,6.94%,SLC24A3;SLC9A8;SLC9A4;SLC9A1
prerank,deubiquitinase activity (GO:0101005),0.44551507871718754,1.2375560824968104,0.1350210970464135,0.7846219920020537,1.0,49/88,30.65%,USP24;USP2;OTUB1;USP50;MINDY4;USP40;UCHL3;USP48;USP45;OTUB2;USP34;USP11;TANK;USP7;USP33;USP36;USP13;USP19;USP35;PSMD14;OTUD5;OTULIN;YOD1;USP32;USP10;USP46;USP1;UCHL5;ZRANB1;MPND;OTUD6B;UCHL1;BRCC3;USP5;USP47;DESI2;CYLD;USP4;USP49;USP14;MYSM1;USP21;USP16;USP22;USP37;USP30;OTUD3;USP26;COPS5
prerank,insulin-like growth factor binding (GO:0005520),-0.45364613825383115,-1.234898486082654,0.19148936170212766,0.5638151101179897,1.0,6/15,4.96%,IGF1R;INSR;IGFBP2;ITGA6;IGFBP3;ITGB4
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.545961672163853,1.2322570309215195,0.23715415019762845,0.7940910807687394,1.0,8/16,25.08%,ATP6V1C2;TCIRG1;ATP6V0A1;ATP6V0D1;ATP6V1B2;ATP6V1C1;ATP6V0E1;ATP6V0B
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.545961672163853,1.2322570309215195,0.23715415019762845,0.7940910807687394,1.0,8/16,25.08%,ATP6V1C2;TCIRG1;ATP6V0A1;ATP6V0D1;ATP6V1B2;ATP6V1C1;ATP6V0E1;ATP6V0B
prerank,sequence-specific DNA binding (GO:0043565),0.4118743157842052,1.2311796822827608,0.012,0.7924001025203199,1.0,114/590,15.99%,TBX15;FOXP2;ESR1;SIX1;FOXP1;KLF12;HOXA5;NFIX;ZNF423;FOXD1;NFIB;TCF7L2;RARB;ELF4;VSX1;HOXB6;PRRX2;JDP2;GLI2;PRDM5;GLIS2;LHX9;CUX1;NFAT5;HDAC4;ELF1;RXRA;ONECUT2;MEOX2;HES5;KLF5;SIX4;TCF7L1;ZNF250;ATF4;NR2F1;TCFL5;GMEB1;FOXC2;RXRB;LBX2;SAFB;SMAD4;NFE2L2;BHLHE40;PKNOX2;MEF2B;RFX7;E2F3;PBX1;MEIS3;TBX21;SOX9;HOXA9;HOXA6;SMG6;MAEL;IKZF3;RARA;FOXJ3;ESRRB;TFE3;FOXK1;ZNF76;NFATC1;FOXL1;RFX2;SLTM;ZIC1;MBNL2;RORA;FOXA1;SMG1;ZBTB2;UBP1;CSRNP1;PRDM4;SREBF1;RUNX2;KDM2A;ABL1;ZIC4;RFX5;POU6F1;CHTOP;TERT;HSF4;TELO2;NEUROD2;KDM5B;SRF;NR1D2;HEY1;GLIS1;TEN1;LONP1;FBXL19;MEF2D;HOXB4;ZNF740;MEF2A;NFATC3;HOXA4;ERF;ZNF148;CPSF4;EN2;MAFG;MBD1;GRHL1;FOXO3;NKX6-2;NFE2;CREB1
prerank,methylated histone binding (GO:0035064),0.45718931089292053,1.230625038574784,0.17275747508305647,0.7886688144496421,1.0,25/62,25.68%,MORC3;PHF1;ING3;SGF29;MBTD1;PYGO1;ING5;PHF8;CBX2;KDM4A;WDR5;L3MBTL2;ING4;CBX5;THAP7;ZMYND11;CHD8;CDYL;BPTF;MPHOSPH8;KAT8;TAF1;ZCWPW2;ZMYND8;CHD1
prerank,cell-cell adhesion mediator activity (GO:0098632),-0.3373231612500733,-1.2305730979353253,0.12307692307692308,0.5612364086358732,1.0,14/42,10.11%,STXBP6;BSG;ESAM;LRRC4C;NTNG1;TMOD3;CNTN6;DSCAML1;CNTN4;BAIAP2;ROBO4;CD200;PDLIM5;NEXN
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",0.5971394072210493,1.2302704413550256,0.22939560439560439,0.784238977108226,1.0,4/12,13.30%,AOX1;XDH;FXN;ISCA2
prerank,histone methyltransferase binding (GO:1990226),0.5898884961799289,1.2299870796314099,0.22786647314949202,0.779679636937574,1.0,5/11,20.94%,CBX1;PHF1;PRDM4;LCOR;NOP56
prerank,serine-type endopeptidase activity (GO:0004252),0.43807457701280916,1.2296236702358057,0.16630901287553648,0.775322023565819,1.0,8/80,7.86%,PCSK5;F3;PRSS38;PRSS12;FAP;PRSS53;CLPP;MBTPS1
prerank,cell adhesion mediator activity (GO:0098631),-0.39785519115678386,-1.2294644349569475,0.15025906735751296,0.5526597357748645,1.0,10/24,10.11%,BSG;ESAM;LRRC4C;BCAM;NTNG1;CNTN6;DSCAML1;CNTN4;ROBO4;NEXN
prerank,phospholipase A2 activity (GO:0004623),0.5038494030267235,1.2292750224403057,0.19951040391676866,0.7711476070181974,1.0,6/26,16.48%,PLA2G4F;PLA2G4A;PLA2G5;PLA2G12A;PNPLA3;PLA2G15
prerank,double-stranded DNA binding (GO:0003690),0.41103061226732196,1.2288449688649747,0.02,0.7672369110525675,1.0,119/531,20.21%,TBX15;ESR1;EGFR;SIX1;FOXP1;KLF12;HOXA5;NFIX;NFIB;RARB;ELF4;VSX1;HOXB6;PRRX2;JDP2;GLI2;GLIS2;LHX9;CUX1;NFAT5;ELF1;RXRA;ONECUT2;MEOX2;HES5;KLF5;SIX4;TCF7L1;ZNF250;ATF4;NR2F1;TCFL5;GMEB1;FOXC2;RXRB;PRKDC;LBX2;SAFB;BHLHE40;HMGB1;PKNOX2;MEF2B;RFX7;E2F3;PBX1;MEIS3;TBX21;SOX9;HOXA9;HOXA6;RARA;FOXJ3;ERCC5;ESRRB;TFE3;FOXK1;ZNF76;NFATC1;RFX2;PSIP1;RBBP8;ZIC1;MBNL2;FOXA1;ZBTB2;UBP1;PRDM4;SREBF1;RUNX2;ABL1;ZIC4;RFX5;POU6F1;WDR48;TDG;HSF4;NEUROD2;KDM5B;SRF;TDP1;NR1D2;HEY1;GLIS1;RAD50;MEF2D;HOXB4;ZNF740;NFATC3;HOXA4;CPSF4;EN2;MAFG;MBD1;GRHL1;FOXO3;NKX6-2;NFE2;CREB1;HOXA2;POLG2;NFKB2;KLF3;NR3C1;MEN1;HDGFL2;E2F1;ZMYND11;ZBTB32;ATF2;RAD51;KLF10;HOXB2;TEAD2;XRCC6;IRF3;NR3C2;NFATC4;ATF6;MAX
prerank,cytokine activity (GO:0005125),0.4213801421047892,1.2287332688957255,0.12976313079299692,0.7621379039482071,1.0,21/131,15.25%,GDF10;WNT9A;VEGFA;FGF2;IL33;INHBC;TGFB3;CCL13;SLURP1;CCL15;TGFB2;HMGB1;CXCL16;FAM3C;BMP4;CTF1;INHBA;NDP;BMP5;CLCF1;IL6
prerank,CARD domain binding (GO:0050700),0.5799122603384508,1.228727331143167,0.23374827109266944,0.7567915506045094,1.0,4/14,13.71%,CARD14;CARD16;MAVS;CASP1
prerank,poly-pyrimidine tract binding (GO:0008187),0.5223504142002175,1.228275977415909,0.23929471032745592,0.7530150605338207,1.0,10/23,14.12%,HNRNPH1;PABPC1;SSB;DAZAP1;DIS3L2;PATL1;KHDRBS1;PTBP1;HNRNPC;U2AF2
prerank,translation initiation factor activity (GO:0003743),0.48025195917531843,1.2281069855002322,0.2046783625730994,0.748476827806632,1.0,22/36,36.53%,EIF4A2;EIF4G2;EIF4G3;EIF4E3;EIF4A1;AGO2;EIF4G1;EIF2S2;EIF3D;EIF3A;EIF2A;EIF2S1;EIF4E;EIF3M;EIF3I;EIF3K;COPS5;EIF2D;EIF5B;EIF2B5;EIF1B;EIF3E
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.5482913134943491,1.2243999152360316,0.2337317397078353,0.7570675526394383,1.0,9/18,25.13%,GAS6;NOL3;CD27;SERPINB9;PRDX3;BIRC5;BIRC3;DPEP1;XIAP
prerank,calcium channel inhibitor activity (GO:0019855),-0.5031435307580838,-1.2237622373610744,0.23509933774834438,0.5545754739862528,1.0,4/11,14.45%,ITPR1;PACSIN3;SLC30A1;MCUB
prerank,mRNA methyltransferase activity (GO:0008174),0.5871546077892755,1.2209057014585902,0.21783625730994152,0.7645688497425478,1.0,6/12,25.90%,TRMT61B;METTL16;TRMT61A;METTL8;METTL14;RNMT
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.4038132063418854,1.217563423688901,0.006,0.7721088373884849,1.0,138/732,15.99%,TBX15;FOXP2;PLAGL1;ESR1;SIX1;FOXP1;KLF12;ZBTB7C;PRRX1;ZFHX3;HOXA5;HIVEP3;PBX3;NFIX;HOXA3;ZNF423;FOXD1;NFIB;SKIL;TCF7L2;RARB;ELF4;HOXB6;MKX;SMAD9;NFIA;ZIM3;MUC1;ZFHX4;PRRX2;JDP2;GLI2;PRDM5;DMTF1;GLIS2;HOXC6;NFAT5;HDAC4;STAT5A;SIX5;ELF1;HOXB3;RXRA;ONECUT2;MEOX2;HES5;KLF5;SIX4;STAT3;ZBTB25;TCF7L1;ZNF250;ATF4;ZFP14;NR2F1;TCFL5;GMEB1;FOXC2;RXRB;SAFB;SMAD4;NFE2L2;BHLHE40;PKNOX2;MEF2B;ZNF471;RFX7;E2F3;PBX1;MEIS3;SKI;ZNF691;HEYL;TBX21;THRAP3;SOX9;HOXA9;HOXA6;IKZF3;NRIP1;RARA;NSD1;FOXJ3;ESRRB;TFE3;FOXK1;ZNF76;NFATC1;FOXL1;RFX2;ZIC1;RORA;FOXA1;ZBTB2;UBP1;PRDM4;SREBF1;EHF;RUNX2;ZNF260;ZIC4;RFX5;POU6F1;NFE2L1;NRF1;HSF4;MAZ;NEUROD2;FOXO6;FOXP4;SRF;NR1D2;HEY1;GLIS1;ZNF112;HDAC1;MEF2D;HOXB4;ZNF740;MYPOP;MEF2A;NACC1;RUNX1;NFATC3;HOXA4;ZNF148;EN2;VDR;ZKSCAN1;MAFG;PER1;GRHL1;FOXO3;HDAC6;FOXN3;NKX6-2;NFE2;CREB1
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.40406739390703883,1.2171637447150803,0.008,0.7684296637846495,1.0,126/731,13.92%,TBX15;FOXP2;PLAGL1;ESR1;SIX1;FOXP1;KLF12;ZBTB7C;PRRX1;ZFHX3;HOXA5;HIVEP3;PBX3;NFIX;HOXA3;ZNF423;FOXD1;NFIB;SKIL;TCF7L2;RARB;ELF4;HOXB6;MKX;SMAD9;NFIA;ZIM3;MUC1;ZFHX4;PRRX2;JDP2;GLI2;PRDM5;DMTF1;GLIS2;TWIST1;HOXC6;NFAT5;HDAC4;STAT5A;SIX5;ELF1;HOXB3;RXRA;ONECUT2;MEOX2;HES5;KLF5;SIX4;STAT3;ZBTB25;TCF7L1;ZNF250;ATF4;ZFP14;NR2F1;TCFL5;GMEB1;FOXC2;RXRB;SAFB;SMAD4;NFE2L2;BHLHE40;PKNOX2;MEF2B;ZNF471;RFX7;E2F3;PBX1;MEIS3;SKI;ZNF691;HEYL;TBX21;THRAP3;SOX9;HOXA9;HOXA6;IKZF3;NRIP1;RARA;NSD1;FOXJ3;ESRRB;TFE3;FOXK1;ZNF76;NFATC1;FOXL1;RFX2;ZIC1;RORA;FOXA1;ZBTB2;UBP1;PRDM4;SREBF1;EHF;RUNX2;ZNF260;ZIC4;RFX5;POU6F1;NFE2L1;NRF1;HSF4;MAZ;NEUROD2;FOXO6;FOXP4;SRF;NR1D2;HEY1;GLIS1;ZNF112;HDAC1;MEF2D;HOXB4;ZNF740;MYPOP;MEF2A;NACC1;RUNX1;NFATC3;HOXA4
prerank,MHC class II protein complex binding (GO:0023026),0.5942792816911591,1.2171079934716333,0.2658959537572254,0.7634707888024121,1.0,2/11,13.55%,ATP1B1;YWHAE
prerank,adrenergic receptor binding (GO:0031690),0.5503919806053196,1.2156649898155187,0.2345679012345679,0.7637012960013595,1.0,3/16,7.83%,GNAS;NEDD4;DLG4
prerank,low-density lipoprotein particle binding (GO:0030169),0.5413095005399927,1.2149430543029358,0.23412698412698413,0.7613971322273988,1.0,1/16,0.08%,THBS1
prerank,lipoprotein particle receptor binding (GO:0070325),0.49456999105761495,1.210470971228719,0.24341279799247176,0.7726833420281468,1.0,9/27,20.48%,LRP1;APBB3;LRPAP1;AP2A1;ANKRA2;CLTC;APBB1;DNAJA1;CLU
prerank,potassium:proton antiporter activity (GO:0015386),0.599286952757471,1.210267738354842,0.24820659971305595,0.7683221502900863,1.0,7/10,29.53%,SLC9A8;SLC9A4;SLC9A1;SLC9A5;SLC9A7;SLC9A6;SLC9A9
prerank,regulatory RNA binding (GO:0061980),0.4747158319359863,1.2077925793004491,0.21830985915492956,0.7723793679470397,1.0,13/38,23.78%,ZC3H7A;PUM1;MATR3;HNRNPA2B1;RBM10;AGO1;AGO2;RBM4;ZC3H10;TUT7;ZNF346;HNRNPA1;YBX1
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.4014311596322011,1.2055678885786527,0.021,0.7754752682418231,1.0,103/597,13.92%,TBX15;BNC2;ESR1;SIX1;FOXP1;KLF12;HOXA5;NFIX;NFIB;TCF7L2;RARB;ELF4;VSX1;HOXB6;SMAD6;PRRX2;JDP2;GLI2;PRDM5;DMTF1;GLIS2;LHX9;CUX1;NFAT5;HDAC4;ELF1;RXRA;ONECUT2;MEOX2;HES5;KLF5;SIX4;STAT3;TCF7L1;ZNF250;ATF4;MCMDC2;NR2F1;CHD3;TCFL5;GMEB1;FOXC2;RXRB;LBX2;PER3;SMAD4;NFE2L2;BHLHE40;HMGB1;PKNOX2;MEF2B;RFX7;E2F3;PBX1;MEIS3;TBX21;SOX9;HOXA9;HOXA6;MCM2;CENPC;RARA;FOXJ3;ESRRB;TFE3;FOXK1;ZNF76;CDC6;CARM1;NFATC1;RFX2;HNRNPL;ZIC1;MBNL2;FOXA1;ZBTB2;UBP1;PRDM4;SREBF1;RUNX2;ABL1;ZIC4;RFX5;POU6F1;HSF4;NEUROD2;KDM5B;SFPQ;SRF;NR1D2;HEY1;GLIS1;ZW10;MEF2D;CDC45;HSPD1;HOXB4;ZNF740;ARID4B;KMT2D;RUNX1;NFATC3;HOXA4
prerank,N-acyltransferase activity (GO:0016410),-0.3603013847291398,-1.205450956719324,0.16447368421052633,0.5870738626058316,1.0,4/32,3.31%,CERS4;NMT2;TGM2;PLAAT3
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.41012750782685453,1.204947449359766,0.13691683569979715,0.7724116024223767,1.0,30/173,14.56%,FOXP2;PLAGL1;FOXP1;KLF12;ZFHX3;SKIL;JDP2;PRDM5;DEAF1;HES5;ZBTB25;NR2F1;TCFL5;ZNF25;NFX1;BHLHE40;SKI;HEYL;TBX21;FOXK1;ZBTB2;ZFP90;POU6F1;FOXP4;HEY1;MYPOP;NACC1;NFATC3;ERF;ZNF148
prerank,histone deacetylase activity (GO:0004407),0.5231375964504309,1.2045335580060874,0.25605095541401274,0.76889120495242,1.0,9/19,25.75%,HDAC9;HDAC4;MIER2;HDAC1;SIRT2;HDAC6;MIER1;HDAC2;SUDS3
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),0.5890634404211551,1.2044581343905494,0.2769010043041607,0.7642867049717325,1.0,4/10,12.08%,RIOX2;KDM2A;PHF8;KDM4A
prerank,SH3 domain binding (GO:0017124),0.443728260811359,1.203451121456437,0.20372398685651696,0.7630118737278492,1.0,16/62,12.56%,ADAM9;DPYSL3;MAPK15;AFAP1L1;CD3E;SOCS7;DNM2;ABI1;CBL;ZNF106;SYNJ1;WIPF1;ABL1;SHANK1;REPS1;KHDRBS1
prerank,tRNA methyltransferase activity (GO:0008175),0.5375477710377549,1.2033926657542349,0.2480106100795756,0.7583908359742064,1.0,5/16,17.88%,TARBP1;TYW3;THUMPD3;TRMT44;ALKBH8
prerank,ion channel activity (GO:0005216),0.4304654279114341,1.2000055326269246,0.18823529411764706,0.7655277285480632,1.0,11/80,8.87%,PIEZO2;GRIK4;GRIN3A;TRPV3;CHRNB2;CALHM6;TMC8;CALHM5;TRPM7;CHRNA5;TRPM4
prerank,myosin II binding (GO:0045159),0.5915704844665205,1.1979321267367973,0.30303030303030304,0.7680638549086607,1.0,3/10,12.59%,GSN;LLGL1;STXBP5
prerank,nuclease activity (GO:0004518),0.4479391975866487,1.195472907576266,0.2223463687150838,0.7717173059707525,1.0,15/52,18.12%,N4BP2;RNASE7;ERN2;RNASE3;ERCC5;RNASE6;OGG1;WRN;DIS3L2;REXO1;SND1;N4BP1;AEN;DIS3;DFFB
prerank,retinoic acid binding (GO:0001972),-0.4623727558387303,-1.1947484850124477,0.26101694915254237,0.600898709865262,1.0,2/12,2.50%,NR2F2;CYP26B1
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),0.5949900121748756,1.1944892590768477,0.26025459688826025,0.7705621921611514,1.0,2/10,1.19%,SLCO3A1;SLCO2A1
prerank,RNA binding (GO:0003723),0.3951372612263192,1.1937224846242478,0.001,0.7686030294429627,1.0,492/1321,27.93%,SRSF6;STRBP;C1D;LRP1;RRBP1;RPSA;COL14A1;DDX5;P4HB;HOXB6;HELB;SERPINH1;FNDC3B;YBX3;DDX17;HNRNPH1;RCC1L;PPP1CC;ERI3;TCF20;RDX;GNL3;AHNAK;PNISR;KHDC4;LUC7L2;ANXA7;SRSF1;PABPC1;NOL3;ARC;SAMD4A;SRSF5;SIDT2;CLK3;ARCN1;TSR1;HDLBP;RBFOX2;MBNL1;EIF4A2;IPO5;GCN1;RBM39;ZRANB2;BAZ2A;ANXA2;DUSP11;STAT3;KCTD12;ZC3H7A;ZCCHC24;TRIM28;RAE1;CELF4;RBM42;SPATS2L;RRS1;DYNC1H1;VCP;CHD3;SRSF2;CASC3;EIF4G2;SREK1;ATXN2L;TENT4B;KMT2C;GOLGB1;SNRNP70;RTCA;CCAR2;NFX1;PRKDC;RRP7A;SAFB;SSB;FAM98A;PUM1;MRPS35;MRPS28;HMGB1;DAP3;GNL2;PRKRA;TENT5A;MTHFSD;MATR3;PRPF40B;ABCF1;FUS;PPP1R8;CKAP4;HNRNPA2B1;CS;HNRNPDL;LAS1L;EIF4G3;ELP5;THRAP3;FBRSL1;TES;EWSR1;RBM47;HUWE1;SMG6;PURG;SRSF11;GDI2;PA2G4;ACO1;CHERP;RBBP6;TRNAU1AP;HARS2;CELF3;LUC7L;GSPT1;EMG1;RBM45;NOA1;LUC7L3;ZC3H12D;SLTM;UBAP2L;HNRNPL;RAVER2;HNRNPH2;PSIP1;SRFBP1;MBNL2;RBM28;ALG13;R3HDM2;SF3B2;SF3B1;PRRC2C;RBM25;PKN2;ZNF106;ILF3;ZCCHC9;PCBP4;MYEF2;SF3A1;PNN;TBRG4;NXF1;PDIA3;ZC3H11A;SMG1;RBM10;LARP1B;WDR3;BZW1;FAM98B;DAZAP1;RBM26;GTF2F1;SRRM1;U2AF1;AGO1;RBM6;NVL;ZC3H15;MRPL39;KPNA2;YARS1;CHTOP;RBM5;TERT;TRMT1;NUFIP2;ARF1;MAZ;PABPN1;TAF15;MSI2;FAM120A;SFPQ;ZC3H12C;DGCR8;FUBP1;METTL16;DALRD3;PRRC2A;USO1;DARS2;SRF;RCC2;ESF1;DDX50;CRNKL1;PATL1;EIF4A1;NOSIP;EZR;LONP1;MRPS14;RRP12;SNUPN;KHDRBS1;CSNK1E;AGO2;PSMA6;EIF4G1;CCDC59;HSPD1;DHX29;HNRNPM;ADD1;PCBP2;DIDO1;LSM2;ALKBH1;PTBP1;YWHAE;RALY;HMGN2;MANF;RBM4;NOLC1;SUGP2;HNRNPC;SUPV3L1;ETF1;TIAL1;UTP14A;CLTC;FAM133B;USP36;U2AF2;DCAF13;SRPK1;ZCCHC7;HEXIM1;ARHGEF1;G3BP2;ELP1;FNDC3A;PRR3;LACTB2;SND1;EIF2S2;CPSF4;HNRNPK;HEATR6;FLNB;YTHDC1;RTCB;XRN1;CMSS1;NCBP3;SARNP;DDX19A;LRRC59;NOC4L;IREB2;MRTO4;THOC2;DDX56;SRSF3;RPP40;FYTTD1;ISY1;UBAP2;PPAN;N4BP1;PCF11;BYSL;ZC3H10;PARP1;EIF3D;AATF;RPS27A;UBC;TUT7;ELAC2;TSN;YARS2;EIF3A;SUMO1;RC3H2;NCBP1;MRPL45;SSRP1;ADAT1;XPOT;SLC4A1AP;SPTBN1;RPP14;SNRPA;BOP1;TUFM;SECISBP2;ACIN1;EPRS1;SRSF7;SRSF10;KHNYN;TRMT6;ALKBH8;COA6;CPSF7;TFB2M;AQR;CPSF6;U2SURP;RBM22;TOP3B;NCBP2;USP10;SPATS2;TNPO1;SARS1;SARS2;FASTKD3;ZCCHC17;POLR1G;CAST;SEC23IP;PEBP1;DRG2;SAFB2;SYNCRIP;PTCD3;UCHL5;CAVIN1;CLUH;CCT4;XRCC6;LARP7;GANAB;ZNF346;CSTF2;AKAP8;TRA2B;CCT6A;RPL7A;RAMAC;TRIP6;EIF2AK4;NOC2L;MTREX;HNRNPH3;DNAJC21;UNK;DARS1;PARP12;RTRAF;CALR;MRPL12;PYM1;CIRBP;EIF2A;EIF2S1;TRA2A;RCAN3;AFF2;ZCCHC8;NOP56;ABT1;CSTF2T;DHX8;PPP1R10;ENDOV;DDX49;FBL;SBDS;CHD2;SAP18;WDR36;PSMD4;ATXN2;SCAF4;HNRNPA3;SNRPB;MRPS24;HNRNPA1;FXR2;UPF1;SRSF4;POLR2B;SHFL;DNAJC2;MRPS21;TASOR;DHX16;NGDN;MCAT;MRPS26;FAM50A;SUMO2;NSUN6;UNC50;TOP1;SLC3A2;RSRC2;PRDX1;DHX32;EIF4B;SRP72;PUS1;DCP1A;TCP1;NIFK;PRMT1;RBM19;FKBP4;BCLAF1;PPIG;WDR46;SF3B6;R3HDM1;WDR75;ZC3H14;HNRNPU;YBX1;RPP21;DUS3L;SMC1A;RPS9;SF1;TBL3;BUD23;MRPL37;KRI1;STAU1;METAP2;ZFR;GTPBP4;PABPC4;PHF6;RPS27L;CDK13;SUGP1;UPF3B;MTO1;RBM3;HDAC2;C1QBP;SNRNP35;DDX39B;UTP11;SLC25A11;TUBB4B;RTF1;FAM120C;NOP58;METTL14;PUS10;PSMC1;CARS1;DDX20;RNMT;MRPL13;TOE1;ANKHD1;NAA15;TPR;YY1;EIF1AX;SEC61B;DDX41;DKC1;SRBD1;RIDA;MAK16;EIF4E;POP5;UBTF;FCF1;SLC25A5;PSMA1;XPO5;NOP53;MEX3B;SRRT;TNRC6A;TRMT1L;RPL41;MRPL4;GPATCH1;SON;FXR1;CCDC47;GPATCH8;LSM5;YTHDF1;RBM27;ZC3H18;RPL30
prerank,endoribonuclease activity (GO:0004521),0.4798754034468631,1.1915949562217987,0.24,0.7714453063563542,1.0,12/32,21.19%,ERN2;SMG6;ZC3H12D;AGO1;ZC3H12C;AGO2;YBEY;LACTB2;SND1;KHNYN;NOB1;ENDOV
prerank,iron ion binding (GO:0005506),0.45770235359109485,1.1915714487819682,0.20958751393534003,0.766890769632812,1.0,16/48,23.68%,AOX1;FTO;FXN;SCD5;PHF8;ABCE1;AGMO;ISCA2;ALKBH1;FECH;ALKBH8;DNAJC24;TET2;PHYH;ISCU;ALKBH3
prerank,heparan sulfate sulfotransferase activity (GO:0034483),-0.42819399709389316,-1.1890200577345411,0.2633587786259542,0.602893541190225,1.0,5/15,9.31%,HS3ST3A1;NDST3;NDST4;NDST1;HS6ST3
prerank,GTP binding (GO:0005525),0.40733604009679897,1.1887987366763522,0.12563323201621074,0.7719672505899622,1.0,28/172,11.34%,RHOJ;RHOBTB1;RHOQ;MRAS;TUBG2;RND3;GNL3;ATL2;TSR1;RAB2A;DNM2;GNL1;RAB21;ATL3;GNL2;RABL6;RAB8A;RHOT2;ARF4;GBP6;NOA1;RHOA;RHOT1;RRAD;PIP4K2B;ARFIP2;RAB38;ARF1
prerank,NADP binding (GO:0050661),0.4718711757321402,1.188306657389476,0.25355450236966826,0.7687985587607329,1.0,8/32,16.24%,ME1;GMDS;CRYZ;MTRR;CBR4;NNT;CAT;PGD
prerank,vitamin D receptor binding (GO:0042809),0.5511375173241855,1.1873006590706217,0.27132867132867133,0.7677361560590958,1.0,5/14,17.98%,RXRA;THRAP3;MED13;MED14;MED12
prerank,nuclear localization sequence binding (GO:0008139),0.5313481507033108,1.1859683714259133,0.2581913499344692,0.7675907589942637,1.0,9/18,19.73%,IPO5;IPO4;KPNA2;TNPO2;KPNA3;POM121;TNPO1;KPNA4;NFKBIA
prerank,voltage-gated sodium channel activity (GO:0005248),0.5137627364207025,1.183976416747045,0.2723735408560311,0.77013355834516,1.0,3/22,6.62%,CACNA1G;HCN4;SCN11A
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.3993956474182819,-1.1837607495932825,0.20297029702970298,0.6046425059375138,1.0,3/18,1.02%,TGFBR3;ENG;LTBP1
prerank,GTPase activity (GO:0003924),0.4021262524486809,1.183159732656856,0.13737373737373737,0.7683699812363368,1.0,47/192,21.88%,GNAS;RHOJ;RHOBTB1;RHOQ;MRAS;RND3;ATL2;GNG8;TSR1;RAB2A;RAB43;RAB24;DNM2;GNL1;RAB21;ATL3;GNL2;RAB8A;RHOT2;TBC1D24;GBP6;GSPT1;RHOA;RHOT1;RAB38;RAB11B;ARL2;GNAO1;RAB23;RHOB;GNA11;RAB3B;RASL12;GPN3;NKIRAS1;EFL1;RAB5B;DRG2;RHEB;ENTPD7;GNB1;RAB4A;ATL1;LRRK2;RAB1A;RAB18;MFN1
prerank,transcription coregulator binding (GO:0001221),0.44973149763528175,1.1823507213408744,0.23755656108597284,0.7668871416816073,1.0,17/50,20.18%,ESR1;CIT;PHF1;PER3;SMAD4;EHMT1;RORA;CCNT2;TERT;MED25;USP11;PER1;HDAC6;LCOR;THAP7;TEAD2;CHD6
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.4003476132084611,1.1818004041528312,0.12424849699398798,0.764283996889576,1.0,58/254,20.04%,PLAGL1;ESR1;SIX1;PRRX1;HOXA5;NFIB;ELF4;NFIA;GLIS2;NFAT5;ELF1;HOXB3;ONECUT2;MEOX2;KLF5;STAT3;ATF4;GMEB1;FOXC2;RXRB;SMAD4;MEF2B;E2F3;MEIS3;MDM4;SOX9;FOXJ3;ESRRB;ZNF76;NFATC1;FOXA1;UBP1;PRDM4;EHF;RFX5;NRF1;SRF;ZNF112;MEF2A;RUNX1;NFATC3;TFDP1;GRHL1;FOXO3;CREB1;PRDM2;NFKB2;NR3C1;RFXANK;E4F1;ATF2;KLF10;HOXB2;FOSL2;IRF3;VEZF1;TCF3;ATF6
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.510786762609955,1.1792444070410992,0.2782051282051282,0.7684727832976406,1.0,15/20,34.79%,OTUB1;USP50;SENP5;USP7;OTUD5;YOD1;SENP1;USP47;DESI2;SENP3;USP21;COPS5;USP9X;COPS2;USP25
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.49075285809597136,1.179194403495124,0.271356783919598,0.7643537829508085,1.0,9/22,25.08%,ATP6V1C2;TCIRG1;ATP6V0A1;ATP6V0D1;ATP6V1B2;ATP6V1E1;ATP6V1C1;ATP6V0E1;ATP6V0B
prerank,sodium channel regulator activity (GO:0017080),0.4565529706968771,1.1790294747245407,0.2511904761904762,0.7605910276116471,1.0,6/37,7.38%,FGF13;FXYD5;NEDD4;PTPN3;CAMK2D;SNTA1
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.39128914470061177,1.1786964072920343,0.012,0.7574207293420346,1.0,138/831,13.92%,TBX15;FOXP2;PLAGL1;ESR1;SIX1;FOXP1;KLF12;ZBTB7C;PRRX1;ZFHX3;HOXA5;HIVEP3;PBX3;NFIX;HOXA3;ZNF423;FOXD1;NFIB;SKIL;TCF7L2;RARB;TWIST2;ELF4;HOXB6;MKX;SMAD9;NFIA;ZIM3;MUC1;ZFHX4;PRRX2;JDP2;GLI2;PRDM5;DMTF1;GLIS2;TWIST1;HOXC6;DEAF1;LHX9;CUX1;NFAT5;HDAC4;STAT5A;SIX5;ELF1;HOXB3;RXRA;ONECUT2;MEOX2;HES5;KLF5;SIX4;STAT3;ZBTB25;TCF7L1;ZNF250;ATF4;ZFP14;NR2F1;TCFL5;GMEB1;FOXC2;ZNF25;RXRB;NFX1;NFXL1;SAFB;SMAD4;NFE2L2;BHLHE40;PKNOX2;MEF2B;ZNF471;RFX7;E2F3;PBX1;MEIS3;SKI;ZNF691;HEYL;TBX21;THRAP3;SOX9;HOXA9;HOXA6;PURG;IKZF3;NRIP1;RARA;NSD1;FOXJ3;ESRRB;TFE3;FOXK1;ZNF76;NFATC1;FOXL1;RFX2;ZIC1;RORA;FOXA1;ZBTB2;UBP1;ZFP90;PRDM4;SREBF1;EHF;RUNX2;ZNF260;FOXM1;ZIC4;RFX5;POU6F1;NFE2L1;NRF1;HSF4;MAZ;NEUROD2;FOXO6;FOXP4;SRF;NR1D2;HEY1;GLIS1;ZNF112;HDAC1;MEF2D;HOXB4;ZNF740;MYPOP;NPAS1;MEF2A;NACC1;RUNX1;NFATC3;ZBTB9;HOXA4
prerank,secondary active transmembrane transporter activity (GO:0015291),0.44444265589426635,1.1782524713558589,0.22905027932960895,0.7546578595378858,1.0,9/51,12.46%,SLC4A4;SLC5A6;SLCO3A1;SLCO2A1;MCU;SLC28A2;CLCN4;SLC25A3;SLC35E1
prerank,poly(U) RNA binding (GO:0008266),0.5106363368281499,1.1781436138792512,0.2846251588310038,0.7508803989848315,1.0,8/20,13.80%,HNRNPH1;PABPC1;SSB;DAZAP1;DIS3L2;PATL1;KHDRBS1;HNRNPC
prerank,kinase binding (GO:0019900),0.3937353216190118,1.1772228653114691,0.063,0.7498619875035144,1.0,110/434,20.23%,ESR1;EGFR;PKD1;PRKCD;SLC12A7;RHOBTB1;CIT;SLC12A2;TCF7L2;TTC28;GSN;SRCIN1;CNTLN;TIAM1;DLG2;GHR;RND3;PPP1CC;SHC1;SPRED2;STRADA;CARD16;STAT3;CD3E;CSPG4;NISCH;ATF4;TAX1BP1;NBEA;AP2A1;CALM2;MAVS;DVL1;TOM1L1;ILK;PRAM1;ADAM10;ANKRA2;ANK2;IRAK3;SKI;LLGL1;SLC12A4;DLG4;TRIM27;FZD5;LAPTM4B;RBBP6;CDC6;CDK5RAP3;DGKQ;DLG1;TSKS;RHOA;DCTN2;NSF;PAK2;CDC25B;FOXM1;IRAK1;MAP3K12;TELO2;AXIN1;CHEK2;RCC2;CHP1;PTPN2;AP2A2;MAPRE3;SNAP91;CASP1;WNK1;UBQLN1;CLTC;SQSTM1;ACSL3;PRDX3;RHOB;CAMK2N1;PER1;STX1A;STUB1;IQGAP1;FOXO3;GSKIP;PIP5K1A;PARP1;TPRKB;CDC25A;CALM3;UFL1;NR3C1;PRKAG1;TRIM6;VRK2;CNOT9;SUFU;RB1CC1;LRRC14;ATF2;CRK;CKS1B;PEBP1;PTPN23;WWC2;PRKAB1;TRIP6;MAP2K3;MAPKAP1;DCTN1
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),-0.4352805098367226,-1.1764008589715405,0.275,0.6111711659423813,1.0,5/15,9.02%,SLC1A3;SLC25A13;SLC1A1;SLC1A2;SLC38A7
prerank,voltage-gated potassium channel activity (GO:0005249),0.42810431775753766,1.1753588445893466,0.21855010660980811,0.7517996676618673,1.0,9/80,9.14%,KCNJ2;KCNJ15;KCNB1;HCN4;KCNN1;KCNE5;KCNIP2;KCND1;KCNK6
prerank,N-methyltransferase activity (GO:0008170),0.5029552300002053,1.1741560182035178,0.2625994694960212,0.7518850191102567,1.0,10/20,29.91%,PEMT;NNMT;TRMT1;HNMT;GNMT;TFB2M;PRMT1;RNMT;TRMT1L;METTL15
prerank,protein serine/threonine kinase activity (GO:0004674),0.3944285917174525,1.173518826734099,0.08708708708708708,0.7498391926019949,1.0,124/334,24.83%,EGFR;PRKCD;CIT;ULK2;CLK1;MARK1;PRKCE;ACVR1B;MAPK15;CAMKK1;CLK3;CSNK1D;CAMK2D;MAP3K5;CSNK2A2;CSNK2A1;LIMK2;FASTK;PRKCA;DYRK4;NRBP2;ACVR1;BRD4;ILK;NEK7;PRKDC;ERN2;TGFBR2;TLK1;STK39;BCR;IRAK3;CDK10;RAF1;RPS6KA4;PAK4;AKT2;KALRN;CDK12;PKN2;PAK2;MAPK8;SMG1;CSNK1G1;CHUK;RIOK1;RIPK3;ALPK1;IRAK1;MAP4K5;MAP3K12;ATM;BMPR1A;CHEK2;MAPK12;PDPK1;GRK6;NRBP1;UHMK1;CSNK1E;TGFBR1;CLK4;MAP3K10;DMPK;MARK4;WNK1;SRPK1;SQSTM1;BRD2;LATS2;CAMK4;CDC42BPB;TLK2;TRIO;TP53RK;STK16;MKNK2;SIK2;DAPK3;ARAF;BCKDK;VRK2;CLK2;CDK20;MAST2;CDKL2;AKT1;HIPK2;CDK2;IKBKE;STK35;CDK5;EIF2AK4;SGK3;MAPK9;PRKACA;VRK3;MOK;NEK4;LRRK2;CSNK1G3;MAST4;CAMK1;CDKL3;STK38;EIF2AK3;MAP3K14;PRKCI;TOP1;FAM20A;PDIK1L;NEK8;HIPK4;PLK4;TAOK3;RPS6KA2;RPS6KB1;TAF1;TBK1;ROCK1;PINK1;LMTK2;CDK13;TAOK2
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.39990397978219433,1.1731638795523185,0.16683621566632756,0.7469678433269752,1.0,35/181,14.16%,ID2;PRRX1;ZFPM2;TCF7L2;LDB2;LDB1;MDFIC;NCOR2;HDAC4;RXRA;BAZ2A;STAT3;ANXA4;ATF4;BCAS3;TACC2;DACT1;NFE2L2;BHLHE40;JUP;NRIP1;CDK5RAP3;NFATC1;WWP2;RBBP8;MIER2;ATN1;RNF25;COMMD7;TAF6;HDAC1;PSMA6;BBS5;MEF2A;PIAS4
prerank,G protein-coupled amine receptor activity (GO:0008227),-0.38516094683825963,-1.1709428328655747,0.20297029702970298,0.5927335198059412,1.0,12/22,33.10%,HTR2C;HTR4;CHRM3;HTR2B;CHRM2;CHRM1;HRH1;HTR1B;HTR1F;HTR1A;HRH3;HTR1D
prerank,serotonin receptor activity (GO:0099589),-0.38516094683825963,-1.1709428328655747,0.20297029702970298,0.5927335198059412,1.0,12/22,33.10%,HTR2C;HTR4;CHRM3;HTR2B;CHRM2;CHRM1;HRH1;HTR1B;HTR1F;HTR1A;HRH3;HTR1D
prerank,G protein-coupled serotonin receptor activity (GO:0004993),-0.38516094683825963,-1.1709428328655747,0.20297029702970298,0.5927335198059412,1.0,12/22,33.10%,HTR2C;HTR4;CHRM3;HTR2B;CHRM2;CHRM1;HRH1;HTR1B;HTR1F;HTR1A;HRH3;HTR1D
prerank,calcium ion binding (GO:0005509),0.3941492896944731,1.1699303400988685,0.0940940940940941,0.7537003941387884,1.0,58/323,16.03%,THBS1;SLIT3;SLIT2;SMOC2;SLIT1;CDH11;LRP1;GSN;PLA2G4F;ACER3;PLA2G4A;COLEC11;SYT8;DMP1;COMP;CALML4;CRACR2A;ANXA7;NOL3;SPARC;ANXA2;ANXA4;C2CD5;PITPNM1;DSG3;CALM2;THBS3;S100A10;TKT;ARSA;KCNIP2;S100B;TRPM4;STIM1;PGS1;CALU;ANXA1;PLA2G5;RCN1;HSPA5;AOC3;CHP1;MICU2;LETM1;LRP2;S100A1;DCHS1;NUCB1;SRR;MICU1;SCIN;CALB2;NCS1;PKD2L1;IQGAP1;TCHH;PLSCR3;GALNT3
prerank,glutamate receptor binding (GO:0035254),0.5368939840746969,1.1683166176243496,0.27430093209054596,0.7551573521420968,1.0,7/17,19.83%,GNAS;DLG4;NSF;SHANK1;SQSTM1;HIP1;HOMER2
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),0.5043671853071761,1.1653104608119536,0.29442970822281167,0.7615198949127645,1.0,2/19,5.17%,GRIK4;GABRA3
prerank,cGMP binding (GO:0030553),0.5728366397924202,1.1618964296088208,0.3018867924528302,0.7684429078057033,1.0,1/11,0.88%,PDE11A
prerank,lipoprotein particle binding (GO:0071813),0.5000551687022189,1.16117565794861,0.2833333333333333,0.7669008083195382,1.0,1/20,0.08%,THBS1
prerank,omega peptidase activity (GO:0008242),0.4183449224399143,1.160512685302153,0.23003194888178913,0.7651797763498281,1.0,49/89,30.65%,USP24;USP2;OTUB1;USP50;USP40;UCHL3;USP48;USP45;OTUB2;USP34;USP11;TANK;USP7;USP33;USP36;USP13;USP19;USP35;PSMD14;OTUD5;OTULIN;YOD1;USP32;USP10;USP46;USP1;UCHL5;ZRANB1;MPND;OTUD6B;UCHL1;BRCC3;USP5;USP47;DESI2;CYLD;USP4;USP49;USP14;MYSM1;USP21;USP16;USP22;USP37;USP30;OTUD3;ASRGL1;USP26;COPS5
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),0.4777984390761546,1.1600784804366508,0.29207920792079206,0.7625628042681981,1.0,4/26,2.99%,SLC5A6;SLC16A9;SLC16A1;SLC26A6
prerank,phospholipase activity (GO:0004620),0.42508895389888884,1.1593521955777584,0.24890350877192982,0.7611256472174613,1.0,15/67,20.26%,MGLL;PLCE1;PLA2G4F;PLA2G4A;SMPD4;SMPDL3A;PDIA3;ABHD6;PLA2G12A;PNPLA3;GDPD3;PLA2G15;PNPLA7;SEC23IP;PLCB2
prerank,phospholipase inhibitor activity (GO:0004859),0.5726680622774991,1.1586789779575066,0.3124087591240876,0.7595112341579477,1.0,3/10,9.70%,ANXA2;ANXA4;ANXA1
prerank,carboxylic acid binding (GO:0031406),0.44646139407208574,1.1571474214946247,0.28823529411764703,0.7612007893602752,1.0,15/38,20.40%,GCLC;GRIN3A;SESN3;EPDR1;CASTOR2;AKR1C1;SESN2;SRR;SHMT2;GNMT;CAD;SHMT1;UBR2;PHYH;GLRB
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.4574386420020574,1.1563837644826038,0.2784958871915394,0.7597674255624398,1.0,15/35,27.07%,FOXP1;BAZ2A;AGO1;HDAC1;AGO2;NR3C1;KLF10;TAF1C;TBP;FOS;TAF1;TP53;SMARCA4;H3-3A;UBTF
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.5329152395717925,1.1558659488125231,0.29346314325452016,0.7576270238134823,1.0,4/14,21.78%,AK5;DTYMK;AK1;NME3
prerank,nuclear receptor binding (GO:0016922),0.4023419966717857,1.1545621945891458,0.2150313152400835,0.7580281774151878,1.0,29/111,20.37%,ESR1;FOXP1;TCF7L2;DDX5;NCOR2;JMJD1C;RXRA;BAZ2A;BCAS3;TACC2;THRAP3;JUP;NRIP1;NSD1;MED13;RNF14;MED25;TGFB1I1;DCAF13;MMS19;DNAAF4;MED14;LCOR;HMGA1;MED12;CCDC62;BRD8;TRIP6;CALR
prerank,solute:proton symporter activity (GO:0015295),0.5126337291813292,1.1528772826037346,0.292,0.7593218906542917,1.0,5/16,17.10%,SLC2A13;SLC2A9;SLC25A3;SLC17A5;SLC2A10
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),-0.3746512309502554,-1.1523538852734303,0.25116279069767444,0.627747992193678,1.0,8/22,21.99%,DUSP16;DUSP10;DUSP3;MTMR3;DUSP6;DUSP15;DUSP4;CDKN3
prerank,cysteine-type peptidase activity (GO:0008234),0.42075962973860137,1.150070793974075,0.2727272727272727,0.7645780152626195,1.0,37/73,30.41%,USP24;USP2;USP50;CAPN2;USP40;PDIA3;USP48;USP34;USP11;USP7;CASP1;USP33;USP36;USP13;USP35;OTULIN;USP10;USP46;USP1;CTSZ;UCHL1;USP5;CTSB;USP47;CTSK;CTSO;USP49;USP14;USP21;USP16;USP37;USP30;ATG4A;CASP2;BLMH;CASP6;USP26
prerank,mRNA binding (GO:0003729),0.390947118451332,1.149558699571641,0.16032064128256512,0.7625586091636499,1.0,94/249,25.09%,SRSF6;DDX5;YBX3;GNL3;LUC7L2;SRSF1;PABPC1;ARC;SAMD4A;SRSF5;HDLBP;RBFOX2;CELF4;EIF4G2;SNRNP70;SSB;PUM1;CRYZ;PPP1R8;HNRNPA2B1;EIF4G3;RBM47;ACO1;CELF3;LUC7L;LUC7L3;ZC3H12D;HNRNPL;SF3B1;RBM25;PCBP4;MYEF2;ZC3H11A;DAZAP1;AUH;RBM5;ZC3H12C;FUBP1;EIF4A1;MARF1;KHDRBS1;AGO2;EIF4G1;HNRNPM;PCBP2;PTBP1;RBM4;HNRNPC;ETF1;G3BP2;EIF2S2;HNRNPK;YTHDC1;NCBP3;IREB2;THOC2;FYTTD1;N4BP1;PCF11;EIF3D;EIF3A;RC3H2;NCBP1;SLC4A1AP;SHMT2;SECISBP2;KHNYN;AQR;CPSF6;NCBP2;SHMT1;SYNCRIP;CLUH;CSTF2;TRA2B;UNK;CALR;CIRBP;EIF2A;CSTF2T;FXR2;SRSF4;SHFL;RNF20;DCP1A;SF3B6;HNRNPU;SF1;TP53;RBM24;PABPC4;UPF3B;C1QBP;SNRNP35
prerank,Toll-like receptor binding (GO:0035325),-0.4618575953035201,-1.1493119806508347,0.3006535947712418,0.6246284962149995,1.0,6/11,29.66%,TOLLIP;UNC93B1;MYD88;CD36;TLR6;TLR2
prerank,DNA-binding transcription factor binding (GO:0140297),0.3895548945077278,1.1482781680749254,0.20505050505050504,0.7629178579089395,1.0,58/189,25.08%,ID2;PRRX1;ZFPM2;TCF7L2;LDB2;LDB1;PRDM5;TWIST1;TLE2;HDAC9;HDAC4;STAT3;ATF4;TLE6;DACT1;NFE2L2;BHLHE40;HMGB1;SKI;DGKQ;NFATC1;WWP2;TLE3;RBBP8;MIER2;ATN1;SRF;HDAC1;MEF2D;BBS5;MEF2A;MAP3K10;PIAS4;PSMC5;CRTC2;CREB1;CREBBP;RBL2;MTA3;CBX5;DAPK3;HCFC1;ATF2;HIPK2;TCF3;NOC2L;MAD2L2;MIER1;TBP;TXLNG;FOS;TAF1;TP53;CHD4;CRTC1;NCOR1;HDAC2;BBS7
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.5303099559788503,1.1480800581212005,0.29551820728291317,0.759883189414119,1.0,6/14,21.74%,RSAD1;ACO1;ETFDH;ISCA2;IREB2;ISCU
prerank,poly-purine tract binding (GO:0070717),-0.3488275630458218,-1.146104430051341,0.24456521739130435,0.6222417455681056,1.0,9/27,14.43%,RBPMS;RBMS1;RBMS3;ELAVL4;DDX3X;ATXN1;MCRS1;PABPC4L;KHDRBS2
prerank,alpha-actinin binding (GO:0051393),0.47509284164618937,1.1457199903269775,0.311495673671199,0.7637507984569273,1.0,4/24,8.22%,CACNA1C;PDLIM7;RARA;PALLD
prerank,growth factor activity (GO:0008083),0.4172690356885952,1.142582692151978,0.2617230098146129,0.7700487482498926,1.0,5/74,2.08%,PGF;VEGFA;FGF2;OSGIN2;FGF17
prerank,ionotropic glutamate receptor activity (GO:0004970),0.5177983740311047,1.141568946002828,0.33155792276964047,0.7695842917106811,1.0,2/17,2.50%,GRIK4;GRIN3A
prerank,zinc ion transmembrane transporter activity (GO:0005385),0.4996508986062097,1.140275922340776,0.3350582147477361,0.7700432297115373,1.0,5/20,9.85%,SLC39A14;SLC39A11;SLC39A7;SLC30A5;SLC39A13
prerank,protein kinase C activity (GO:0004697),0.5297234867205778,1.1381021953027695,0.3255172413793103,0.7735336444909725,1.0,4/14,9.99%,PRKCD;PRKCE;PRKCA;SMG1
prerank,cytochrome-c oxidase activity (GO:0004129),-0.3952878759469414,-1.1377685868005591,0.272,0.6314308907081531,1.0,6/15,24.19%,COX8A;COX4I1;COX10;COX5B;NDUFA4L2;NDUFA4
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.5289938155120218,1.1370598671744594,0.33661971830985915,0.7734580171538175,1.0,6/14,22.24%,MINDY4;USP7;USP13;OTUD5;YOD1;DESI2
prerank,neurexin family protein binding (GO:0042043),0.5584963136884287,1.1348506005328802,0.3484626647144949,0.7768384614279381,1.0,4/10,17.30%,CEL;SYTL5;NLGN1;SYTL4
prerank,acid-thiol ligase activity (GO:0016878),-0.42646296607139295,-1.1341273921493344,0.28185328185328185,0.6301709628038915,1.0,3/13,5.77%,ACSS3;ACSL1;ACSS2
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),-0.4020402368099316,-1.1330128294548738,0.31153846153846154,0.6228389050388948,1.0,7/16,16.41%,SLC13A3;SLC25A13;SLC1A1;SLC38A7;SLC25A14;SLC13A5;SLC25A30
prerank,FAD binding (GO:0071949),0.4721572981839276,1.1311441586920596,0.31546134663341646,0.785289830125816,1.0,8/24,21.86%,MICAL2;QSOX1;MTRR;AIFM1;AGPS;DAO;MTHFR;CRY2
prerank,calcium-dependent phospholipid binding (GO:0005544),0.42338094919506347,1.130630015632921,0.2948571428571429,0.78327284848308,1.0,6/49,4.38%,PLA2G4F;PLA2G4A;SYT8;ANXA2;ANXA4;C2CD5
prerank,guanyl ribonucleotide binding (GO:0032561),0.38403922878712937,1.1296157360744188,0.2247983870967742,0.7829045117103186,1.0,29/196,11.34%,RHOJ;RHOBTB1;PDE11A;RHOQ;MRAS;TUBG2;RND3;GNL3;ATL2;TSR1;RAB2A;DNM2;GNL1;RAB21;ATL3;GNL2;RABL6;RAB8A;RHOT2;ARF4;GBP6;NOA1;RHOA;RHOT1;RRAD;PIP4K2B;ARFIP2;RAB38;ARF1
prerank,copper ion binding (GO:0005507),-0.31705544211978764,-1.1276329656589665,0.2765957446808511,0.6268829607918532,1.0,11/42,18.03%,PAM;MOXD1;SOD3;LACC1;LOXL3;SUMF1;CUTA;SNCA;S100A13;ATP13A2;MT3
prerank,phosphatidate phosphatase activity (GO:0008195),0.5346967518924128,1.1275704635128478,0.3418079096045198,0.7856786315014006,1.0,3/13,6.19%,PLPP3;PLPP5;PLPP1
prerank,carbohydrate kinase activity (GO:0019200),-0.4471602822843913,-1.1268732315376218,0.29225352112676056,0.619123236520229,1.0,5/11,21.65%,HK2;GALK2;FGGY;XYLB;KHK
prerank,hydro-lyase activity (GO:0016836),0.42997193223689173,1.1249961270420463,0.3150684931506849,0.7903336927478545,1.0,14/41,24.87%,EHHADH;ECHDC2;GMDS;ACO1;AUH;IREB2;ENO2;L3HYPDH;CDYL;UROS;ECHDC1;HADHA;PCBD2;ENO4
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.40489702443871967,1.1218848062346665,0.2989247311827957,0.7966393785763483,1.0,11/72,7.66%,KCNJ2;GSN;PLEKHA4;MARK1;VILL;ANXA2;SNX18;PFN2;FZD7;SLC9A1;FCHO2
prerank,lipase activator activity (GO:0060229),-0.4584114393154354,-1.1207621195256454,0.3227848101265823,0.6240375993980957,1.0,1/10,0.73%,ARHGAP6
prerank,DNA replication origin binding (GO:0003688),0.4771764572555462,1.1199944268468787,0.3371501272264631,0.7990818257909512,1.0,8/23,20.42%,MCMDC2;MCM2;CDC6;CDC45;HSPD1;MCM4;ORC2;KAT7
prerank,potassium channel regulator activity (GO:0015459),-0.2918156717347133,-1.1196619988674419,0.25225225225225223,0.6175572007810528,1.0,9/49,8.91%,NEDD4L;DPP10;KCNIP3;KCNIP4;KCNIP1;ABCC9;WNK2;SLC5A3;DPP6
prerank,filamin binding (GO:0031005),-0.44445679912494485,-1.115589462869399,0.35587188612099646,0.6191304636221459,1.0,6/11,13.26%,NEBL;SYNPO2;RFLNA;CEACAM1;FBLIM1;RFLNB
prerank,lysine N-methyltransferase activity (GO:0016278),0.48207189546288176,1.1145469371975463,0.3402061855670103,0.812663556598876,1.0,9/20,26.51%,EEF1AKMT3;KMT5A;EHMT1;EEF1AKMT2;SETD4;SETD2;SMYD2;EHMT2;SETD7
prerank,NF-kappaB binding (GO:0051059),0.4636263356844361,1.1136155040517526,0.351010101010101,0.8120059712795488,1.0,6/24,12.75%,ANXA4;CDK5RAP3;RNF25;COMMD7;HDAC1;PSMA6
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.5089743966946221,1.1119695356522403,0.3532684283727399,0.8135388124942315,1.0,3/14,2.67%,TIMP2;TIMP3;RARRES1
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.5370389139718134,1.104429786720179,0.3546099290780142,0.8339239172827102,1.0,2/11,8.43%,CHRNB2;CHRNA5
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.41961776806196915,1.1039964884749365,0.3516609392898053,0.8315495503968782,1.0,14/46,26.08%,EXT1;B3GNT7;OGT;MGAT4B;HEXA;B3GNT9;B4GAT1;B3GNT6;EXT2;GCNT7;B3GNT2;PIGQ;MGAT5;RFNG
prerank,transforming growth factor beta receptor binding (GO:0005160),0.4862099757620226,1.1023963104047265,0.35019455252918286,0.8329966063994053,1.0,7/18,12.61%,INHBC;SMAD6;TGFB3;TGFB2;TGFBR2;SMAD7;TGFBR1
prerank,NADPH binding (GO:0070402),0.5076239347261975,1.0993436807837231,0.3629139072847682,0.8391161777310163,1.0,3/13,10.36%,CRYZ;MTRR;CBR4
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.3897634168509892,1.0958492868106038,0.33718487394957986,0.8470387331142244,1.0,15/91,9.26%,KCNJ2;GSN;PLEKHA4;MARK1;VILL;ANXA2;SNX18;PFN2;FZD7;SLC9A1;GBF1;WIPI2;FCHO2;LAPTM4B;SH3PXD2B
prerank,disordered domain specific binding (GO:0097718),0.45941291862279543,1.0938371283376718,0.3793969849246231,0.849461798790601,1.0,7/23,19.35%,HSPA2;CALM2;BCL2L2;CLTC;CALM3;DFFB;TEAD2
prerank,hexose transmembrane transporter activity (GO:0015149),-0.43573097075853773,-1.0886491250599386,0.3447098976109215,0.6756345293333308,1.0,5/12,25.55%,SLC2A1;SLC5A3;SLC2A4;SLC2A3;MFSD4A
prerank,protein homodimerization activity (GO:0042803),0.36091546820406,1.0870654086604217,0.191,0.8672947626775788,1.0,158/589,22.79%,PRPS2;SLIT2;FOXP2;LRP6;EXT1;MGLL;PRMT8;VEGFA;ABCD3;SRGAP2;NPR3;ECE1;NTRK1;GHR;LDB1;PEX7;AOX1;PSMD7;GALE;CAMK2D;GOLGA5;FAP;MAP3K5;SNX2;TGFB2;STAT3;XDH;MID1;NECTIN3;PEX11A;HM13;TMEM266;STARD3NL;ADCY8;ACVR1;CPQ;S100A10;SMAD4;NAA60;ADAM10;KLHL7;BHLHE40;TKT;PRKRA;FGFR1;IRAK3;JUP;MUC13;TRIM27;XPNPEP1;IKZF3;S100B;NFS1;ERCC5;NOG;TIMM9;EEA1;ST3GAL2;SNX1;FGFR2;WRN;SLC39A13;PIP4K2B;MYOM3;ATIC;CHUK;CCDC66;IRAK1;MAP3K12;TDG;TERT;BCL2L2;NRF1;BMPR1A;AXIN1;CHEK2;SNX9;SFPQ;DGCR8;DARS2;SRF;MID2;NRBP1;TENM1;CIDEA;STK25;S100A1;ADD1;PAFAH1B2;ERP29;ALDH3A2;SRM;MAP3K10;UBA5;NDP;SUPV3L1;GUCY2D;SRR;CARNMT1;DCLRE1B;HPS4;CAT;GRHL1;STUB1;CRYL1;WDR54;GSTZ1;NECTIN1;IDE;FECH;HIP1;YARS2;ACP3;SHMT2;DNTTIP1;HMOX1;EPRS1;DAPK3;COQ9;GLB1;TRIM6;KIF20B;CNOT9;SHMT1;AOC1;AKT1;GDNF;ACSL6;EXT2;PAFAH1B3;PHETA2;SARS1;MLXIPL;IRF3;TCF3;DPY30;APPL2;APPL1;MTMR1;CHMP4A;CHMP4B;KYAT1;TPD52;PDCD6IP;FBLN5;LRRK2;PANK3;FXR2;SMIM1;STARD3;ABCD1;TRIM8;ASMT;ABCG2;KMT2A;SLC11A1;TSC2;TMEM192
prerank,protein phosphatase binding (GO:0019903),0.3819943444164092,1.086358438127805,0.3285123966942149,0.8659856152225698,1.0,41/117,24.98%,EGFR;GRIN3A;PPP1R3C;ANAPC5;PPP1R9B;MAP3K5;STAT3;VCP;ADCY8;SLC9A1;STRN4;JUP;DLG4;PPP6R1;PPP6R3;PPP1R3F;GTF2F1;SHOC2;SOD1;ANAPC4;TRAF3;ARPP19;IQGAP1;ERBB2;KCNN4;CDC27;IKBKE;ATP2B4;AKAP11;VRK3;MAP2K7;JAK1;EIF2AK3;PPP1R3B;BOD1L1;PXN;TP53;SNX3;BAD;TBK1;AP3B1
prerank,telomeric DNA binding (GO:0042162),0.432882381896706,1.0841460471223652,0.36449704142011835,0.8695198262576743,1.0,11/32,22.91%,HNRNPA2B1;SMG6;WRN;SMG1;TERT;TELO2;TEN1;RAD50;XRCC6;UPF1;UPF3A
prerank,metal ion binding (GO:0046872),0.3632317648908672,1.083437235705681,0.235,0.8681313437958404,1.0,82/477,16.03%,THBS1;SLIT3;SLIT2;SMOC2;SLIT1;CDH11;LRP1;EYA2;GSN;PLA2G4F;GCLC;ACER3;PLA2G4A;COLEC11;SYT8;MARK1;DMP1;COMP;CALML4;CRACR2A;ANXA7;NOL3;SPARC;MAP3K5;ANXA2;ANXA4;C2CD5;PITPNM1;DSG3;ADCY2;CALM2;THBS3;S100A10;ERN2;TKT;ARSA;KCNIP2;IRAK3;TRIM27;S100B;DCTPP1;TRPM4;STIM1;PGS1;CALU;ANXA1;WRN;HMGCL;PLA2G5;PPA2;SNN;RCN1;ABL1;DIS3L2;TDG;MAPK12;HSPA5;CLYBL;AOC3;MTHFD2;CHP1;MICU2;LETM1;LRP2;S100A1;DCHS1;PI4K2A;NUCB1;TRIM26;SRR;SRPK1;MICU1;SCIN;CALB2;NCS1;PKD2L1;IQGAP1;TCHH;HACL1;CDC42BPB;PLSCR3;GALNT3
prerank,"DNA binding, bending (GO:0008301)",0.49920511972674253,1.0827779931528525,0.38513513513513514,0.8664448191893552,1.0,3/14,8.86%,FOXD1;HMGB1;FOXL1
prerank,Hsp70 protein binding (GO:0030544),0.44118284480116154,1.082228290317667,0.37073170731707317,0.8643118634970877,1.0,15/31,30.99%,SPN;DNAJB14;HIKESHI;PPEF2;STUB1;DNAJC18;DNAJA1;DNAJC2;RNF207;DNAJB12;PPID;ERN1;DNAJB1;PRKN;GPR37
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.5052211584590511,1.0818108253258671,0.38227146814404434,0.8620245101399843,1.0,5/12,27.17%,OPN1MW;OPN1MW3;OPN3;RRH;GPR52
prerank,tumor necrosis factor receptor binding (GO:0005164),-0.41318168069408023,-1.0801570655752348,0.37748344370860926,0.6877735215427563,1.0,5/12,22.57%,STAT1;BABAM2;TRAP1;TRAF2;TRAF1
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.5212630163996284,1.0788965805891273,0.3758765778401122,0.8675631025767058,1.0,4/12,13.22%,JMJD1C;PHF8;KDM4A;HR
prerank,CoA-ligase activity (GO:0016405),-0.3919596725221704,-1.0782438872220494,0.3665338645418327,0.6830967011760267,1.0,3/14,5.77%,ACSS3;ACSL1;ACSS2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.4037447539085802,1.0772105919021457,0.38148984198645597,0.8692056302894384,1.0,21/54,26.34%,ACER3;HDAC9;HDAC4;SIRT5;PM20D2;NTAN1;MIER2;HDAC1;PIGL;NGLY1;SIRT2;HDAC6;NTAQ1;ASAH1;DARS1;HINT3;MIER1;VNN1;HDAC2;SUDS3;FAAH
prerank,acetyltransferase activity (GO:0016407),0.43924334571464857,1.0757299087882166,0.3985594237695078,0.8701483683047132,1.0,12/31,26.59%,SAT2;KAT6B;NAA16;ACAT1;PAFAH1B2;CREBBP;PAFAH1B3;ELP3;KAT8;KAT2B;NAA15;ESCO1
prerank,myosin V binding (GO:0031489),0.4885678762484596,1.0746866087608022,0.40456989247311825,0.8698288621204652,1.0,4/15,15.40%,RAB8A;RAB3D;RAB11B;RAB3B
prerank,voltage-gated calcium channel activity (GO:0005245),0.42129286873057586,1.074138560337617,0.3786635404454865,0.8679166779148991,1.0,6/37,11.23%,CACNA1G;CACNA1C;CACHD1;CATSPER3;ITGAV;CACNA2D2
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.4267850679281222,1.0741012179970804,0.37438423645320196,0.8644194086251852,1.0,15/34,31.19%,EEF1AKMT3;KMT5A;EHMT1;EEF1AKMT2;SETDB1;SETD4;MEN1;SUV39H1;SETD2;SMYD2;EHMT2;SETD7;NSD3;TTLL12;EEF2KMT
prerank,organic cation transmembrane transporter activity (GO:0015101),-0.3767586054195159,-1.0717531001509495,0.34065934065934067,0.6898112517938834,1.0,5/16,26.49%,SLC44A1;SLC22A2;SLC22A4;SLC44A2;SLC29A4
prerank,3'-5' exonuclease activity (GO:0008408),0.4113805298786026,1.0713356963472844,0.3741339491916859,0.8693850063313371,1.0,10/45,17.07%,REV3L;ERI3;REXO2;RAD1;WRN;DIS3L2;RAD50;EXOSC4;CNOT8;DIS3
prerank,syntaxin binding (GO:0019905),0.39143698856195,1.0710029684251579,0.367032967032967,0.8668103193709897,1.0,16/61,17.80%,SYT8;UNC13B;PRRT2;VPS52;NSF;SCFD1;ABL1;TMED9;STXBP5;PTPN2;ABCA1;SNAP23;SCFD2;STX16;VPS11;NAPA
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.43168068791658787,1.0706560429644214,0.36885245901639346,0.8643257497181807,1.0,10/32,23.68%,FTO;RIOX2;KDM2A;PHF8;KDM4A;ALKBH1;HSPBAP1;TET2;PHYH;ALKBH3
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.5321562135183773,1.0704955443220898,0.39598278335724535,0.861308355646394,1.0,3/10,12.37%,PIK3C2B;ATM;PIK3CB
prerank,H4 histone acetyltransferase activity (GO:0010485),0.519427402676924,1.0699552133065826,0.39589442815249265,0.8595380990221466,1.0,5/10,27.84%,NAA60;NAA40;ATF2;KAT8;USP22
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.3612240957573984,1.0654547831533394,0.35858585858585856,0.8694209188608736,1.0,25/188,9.84%,BNC2;SIX1;TCF7L2;VSX1;SMAD6;PRDM5;DMTF1;GLIS2;HDAC4;RXRA;STAT3;ATF4;CHD3;FOXC2;PER3;SMAD4;NFE2L2;HMGB1;PBX1;TBX21;TFE3;FOXK1;CARM1;HNRNPL;FOXA1
prerank,phosphatase binding (GO:0019902),0.37633980697809033,1.064327460077825,0.38105263157894737,0.8692077430215622,1.0,39/105,24.98%,EGFR;PPP1R3C;ANAPC5;MAP3K5;STAT3;SFI1;VCP;JUP;DLG4;TRPC4AP;PPP6R1;DLG1;PPP6R3;PPP1R3F;GTF2F1;SHOC2;ANAPC4;TRAF3;WNK1;IQGAP1;ERBB2;KCNN4;CNST;MAST2;CDC27;IKBKE;RCAN3;VRK3;MAP2K7;CRY2;JAK1;EIF2AK3;TSC2;PXN;TP53;SNX3;BAD;TBK1;AP3B1
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.4178320137265198,-1.0635056371597922,0.37666666666666665,0.701332153195441,1.0,6/11,24.15%,PPP1R1A;PPP1R2;PPP1R14C;PPP1R11;PPP1R14A;PPP1R14B
prerank,gamma-tubulin binding (GO:0043015),0.45264107725486513,1.0634740898661703,0.4094387755102041,0.8682176265142171,1.0,6/21,13.88%,TUBGCP3;BLOC1S2;NDRG1;GIT1;RAB11FIP5;MARK4
prerank,magnesium ion binding (GO:0000287),0.3690070801161423,1.0631541234140145,0.39227642276422764,0.865688354189042,1.0,41/135,27.62%,EYA2;GCLC;MARK1;MAP3K5;ADCY2;ERN2;TKT;IRAK3;DCTPP1;WRN;HMGCL;PPA2;ABL1;DIS3L2;TDG;MAPK12;CLYBL;MTHFD2;PI4K2A;SRR;SRPK1;HACL1;CDC42BPB;PLSCR3;XYLT2;SIK2;PPA1;MAST2;RHEB;ENDOV;MAP2K7;LRRK2;STK38;PINK1;NUDT18;STK3;NIM1K;ERN1;NEK6;ADPRS;ABL2
prerank,cholesterol transfer activity (GO:0120020),-0.38415516233154734,-1.0608536130760435,0.3674911660777385,0.698738173960624,1.0,4/16,6.96%,PLTP;ABCG1;GRAMD1B;STARD4
prerank,sialyltransferase activity (GO:0008373),0.45706014858147914,1.0606754240895007,0.4055766793409379,0.8696740382129678,1.0,4/20,8.59%,ST3GAL4;ST8SIA2;ST6GALNAC5;ST3GAL2
prerank,lipid phosphatase activity (GO:0042577),0.48421526646552615,1.0600636273220043,0.3862433862433862,0.8681522106050122,1.0,2/14,6.19%,PLPP3;PLPP1
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.448938371315493,1.059957036927719,0.3992297817715019,0.8650942219189733,1.0,8/22,20.48%,APBB3;LRPAP1;AP2A1;ANKRA2;CLTC;APBB1;DNAJA1;CLU
prerank,ADP binding (GO:0043531),0.4408024351203448,1.058425663707111,0.3910891089108911,0.8664647939615165,1.0,2/25,1.56%,ME1;GCLC
prerank,chemokine receptor activity (GO:0004950),0.44365996163212973,1.0558210224160514,0.4097938144329897,0.8709083072593501,1.0,2/24,8.47%,CMKLR1;ACKR4
prerank,chloride channel activity (GO:0005254),0.38737461751681185,1.05492315397204,0.40460526315789475,0.8701087042634279,1.0,4/59,5.17%,SLC26A7;CLIC3;CLIC4;GABRA3
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.35525655470636125,1.0537461688283254,0.36072144288577157,0.8701427983817609,1.0,95/269,27.28%,EGFR;SMAD6;PRR7;ACVR1B;FHIT;GLMN;UBE2B;SNCAIP;TRIM28;MID1;HM13;VCP;USP2;CASC3;TNFRSF1B;ANKRA2;OTUB1;SKI;FAF2;SLF2;FZD5;PA2G4;LAPTM4B;CDK5RAP3;ITCH;CUL4A;LTBR;UBE2C;AXIN1;CHEK2;SNX9;SMAD7;HSPA5;KDM4A;TRAF3;CUL1;HSPD1;TANK;MC4R;PCBP2;YWHAE;USP7;SLC22A18;PIAS4;SQSTM1;PSMD1;USP13;UBE2L6;PER1;ARRB1;STUB1;CKB;HDAC6;CXCR4;RPS27A;UBC;APBB1;SUMO1;YOD1;NPLOC4;BLZF1;DNAJA1;IKBKE;NFKBIA;SCAMP3;PSMA3;UCHL1;CALR;CLU;PRKACA;PRKAR2A;UBOX5;MUL1;SLF1;SMAD5;ABI2;JAK1;SUMO2;DERL1;RNF20;TCP1;DET1;CAMLG;TP53;PINK1;UBE2W;DAXX;SMC6;SHPRH;JKAMP;RIPK1;AMBRA1;SLC25A5;RALA;NEK6
prerank,chemokine activity (GO:0008009),0.41892661039552187,1.0531477356197643,0.4019975031210986,0.8686431749618821,1.0,3/31,7.22%,CCL13;CCL15;CXCL16
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),0.49783015158298827,1.052372182631824,0.4311797752808989,0.8676745294541285,1.0,5/13,27.51%,TARBP1;TRMT1;THUMPD3;METTL1;TRMT1L
prerank,ribosome binding (GO:0043022),0.4005456857635801,1.0523214049975849,0.4034285714285714,0.8644689877798382,1.0,20/46,29.73%,RPSA;SEC61A1;NAA16;NCLN;ETF1;EIF6;EFL1;PYM1;EIF2A;EIF2S1;SBDS;SHFL;SRP72;C1QBP;NAA15;SEC61B;CCDC47;YTHDF1;IGHMBP2;ERI1
prerank,nucleotidase activity (GO:0008252),0.48078755218401853,1.0518146838927311,0.4274300932090546,0.8626977595559188,1.0,6/15,22.70%,NT5DC3;NT5C3B;BPNT1;ACP3;NT5C;NT5DC1
prerank,pyrophosphatase activity (GO:0016462),0.3959452500385832,1.0512347131422835,0.4067796610169492,0.8612496439234171,1.0,8/50,10.11%,ALPL;ENTPD2;PLPP5;ENTPD6;PLPP1;DCTPP1;DOLPP1;PPA2
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.515538442929367,1.0508375370119802,0.446064139941691,0.8592259493436725,1.0,5/10,24.16%,NSD1;ASH1L;SETD5;SETD2;SMYD2
prerank,DNA polymerase binding (GO:0070182),0.4579333580641514,1.0502056355567528,0.4190231362467866,0.857712138685818,1.0,9/18,30.44%,HMGB1;SMG6;LONP1;POLG2;CDT1;RAD51;SMARCA4;RTEL1;HSP90AA1
prerank,ubiquitin protein ligase binding (GO:0031625),0.35468663099308506,1.049240535861021,0.38052208835341367,0.8572472870756107,1.0,91/254,27.28%,EGFR;SMAD6;ACVR1B;FHIT;GLMN;UBE2B;SNCAIP;TRIM28;MID1;HM13;VCP;USP2;CASC3;TNFRSF1B;ANKRA2;OTUB1;SKI;FAF2;SLF2;FZD5;PA2G4;LAPTM4B;CUL4A;LTBR;AXIN1;CHEK2;SNX9;SMAD7;HSPA5;KDM4A;TRAF3;CUL1;HSPD1;TANK;MC4R;PCBP2;YWHAE;USP7;SLC22A18;PIAS4;SQSTM1;PSMD1;USP13;UBE2L6;PER1;ARRB1;STUB1;CKB;HDAC6;CXCR4;RPS27A;UBC;APBB1;SUMO1;YOD1;NPLOC4;BLZF1;DNAJA1;IKBKE;NFKBIA;SCAMP3;PSMA3;UCHL1;CALR;CLU;PRKACA;PRKAR2A;UBOX5;MUL1;SLF1;SMAD5;ABI2;JAK1;SUMO2;DERL1;RNF20;TCP1;DET1;CAMLG;TP53;PINK1;UBE2W;DAXX;SMC6;SHPRH;JKAMP;RIPK1;AMBRA1;SLC25A5;RALA;NEK6
prerank,heme binding (GO:0020037),0.38712737171072364,1.0480212079389999,0.41612200435729846,0.8574663191671061,1.0,14/65,14.93%,PTGIS;CYP19A1;CYP1B1;FLVCR1;HMOX2;NOX4;HEBP1;PTGES2;RSAD1;DGCR8;SUOX;CYP2U1;ABCB6;CAT
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.40769522497831107,1.04688586138707,0.4295774647887324,0.8575503632364192,1.0,15/38,29.19%,PLEKHA4;PLA2G4A;WIPI2;SH3PXD2B;ZFYVE19;BBS5;HIP1;SNX13;RUFY4;DENND1A;SNX3;PARD3;ATG2B;PLEKHF1;ZFYVE1
prerank,calcium channel activity (GO:0005262),0.37411152784682616,1.0468139268101049,0.41675503711558853,0.8545894874461863,1.0,13/84,11.23%,PKD1;CACNA1C;SLC24A3;SEC61A1;TRPV3;ANXA2;CACHD1;MCU;TRPM7;TRPM4;CATSPER3;ITGAV;CACNA2D2
prerank,transition metal ion binding (GO:0046914),0.35300339326314134,1.0466009639514173,0.339,0.8519852492265578,1.0,113/397,24.39%,ADAMTS3;ME1;ZFPM2;TIMP2;ACER3;ECE1;SEC24D;GLI2;ADAM30;PAPPA;AOX1;SEC23A;HDAC4;RXRA;SORD;TRIM28;ADCY2;CHD3;ADA;GLO1;SIRT5;SCD5;SKI;MDM4;B4GALT1;TES;XPNPEP1;NSD1;S100B;TIMM9;EEA1;PPM1M;SMPDL3A;SLC30A5;WRN;HMGCL;KDM2A;ABL1;PHF8;TAB2;ABCE1;KDM5B;AGMO;RNF2;SOD1;AOC3;KDM4A;CHORDC1;FBXL19;SEC24C;SEC24B;QPCTL;ISCA2;MMP16;USP33;UBA5;PIAS4;RNF11;LACTB2;LNPEP;MBD1;SIRT2;GALNT1;PLSCR3;IDE;GALNT3;ZFPL1;MPPED2;KDM5C;PLA2G15;KMT2B;XYLT2;DPF3;PRDM2;SHMT2;SEC24A;EPRS1;ALKBH8;COA6;SUV39H2;CAD;SHMT1;ZMYND11;RNF7;AOC1;ZBTB32;NPEPPS;MYCBP2;TK1;LVRN;DNAJC24;TET2;CALR;IKZF4;ZDHHC20;ZKSCAN5;NEK4;ISCU;TRIM8;LOXL2;KMT2A;GPC1;GALNT2;CYLD;B4GALT7;DPEP1;CZIB;PRIMPOL;ARG2;PHEX;TP53;RASSF1;CHD4
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.5079916279296055,1.0464157497992825,0.43380281690140843,0.8493674098508323,1.0,1/11,2.89%,HCN4
prerank,nucleoside-triphosphatase activity (GO:0017111),0.35151788573771564,1.0450787479743382,0.40320962888665995,0.8500640525152287,1.0,58/248,22.00%,GNAS;RHOJ;RHOBTB1;RHOQ;MRAS;RND3;ATL2;GNG8;TSR1;RAB2A;RAB43;CHD1L;RAB24;VCP;CHD3;MYO1E;DNM2;GNL1;RAB21;ATL3;GNL2;RAB8A;RHOT2;TBC1D24;GBP6;GSPT1;RHOA;RHOT1;RAB38;DHX29;RAB11B;ARL2;ABCB6;VWA8;GNAO1;RAB23;RHOB;GNA11;RAB3B;RASL12;GPN3;KLC1;NKIRAS1;EFL1;RAB5B;KIF20B;DRG2;RHEB;ENTPD7;CLU;GNB1;RAB4A;ATL1;LRRK2;RAB1A;RAB18;MFN1;ABCD1
prerank,signaling receptor complex adaptor activity (GO:0030159),0.4122961035155611,1.0437392573127537,0.4164705882352941,0.8507446471557435,1.0,18/38,26.23%,IRS1;GAB2;SHC1;CD3E;SH2B1;AXIN1;SHANK1;G3BP2;MMS19;SPAG9;TRAT1;NUP62;MAPK8IP3;LRRK2;DLG5;TRADD;PTPN11;NCK1
prerank,actin monomer binding (GO:0003785),0.44310991562200186,1.0426423818106383,0.43088418430884184,0.8507247717431655,1.0,6/22,13.38%,PRKCE;LIMA1;COBL;PFN2;ABL1;PFN4
prerank,single-stranded RNA binding (GO:0003727),0.4025020000416369,1.041114431420728,0.4304093567251462,0.8519176487659558,1.0,19/43,29.21%,STRBP;SRA1;ILF3;AGO1;LONP1;AGO2;PTBP1;U2AF2;LACTB2;AQR;ENDOV;HNRNPA1;EIF4B;PUS1;HNRNPU;ZFR;FXR1;EIF4H;DDX11
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.42524614012512413,1.0399783244925687,0.423500611995104,0.8520158938381844,1.0,6/30,11.18%,SLC39A14;SLC39A11;SLC39A7;SLC30A5;SLC39A13;TMEM165
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.3850493690212454,1.0378890839516242,0.42410714285714285,0.8548076162985331,1.0,15/60,11.74%,EGFR;DDR2;NTRK3;NTRK1;ACVR1B;EPHB2;ACVR1;EPHB3;EPHB6;TGFBR2;FGFR1;ROR1;FGFR2;MUSK;DDR1
prerank,Hsp90 protein binding (GO:0051879),0.4150597643470073,1.0372430653411073,0.4412811387900356,0.8534560809145885,1.0,15/33,27.84%,SLC12A2;CSNK2A1;TELO2;CHORDC1;PPEF2;PTGES3L;STUB1;USP19;HDAC6;NR3C1;TSC2;UNC45A;PPID;ERN1;HSF1
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.4719200133044533,1.0369695230064588,0.4291390728476821,0.8511824133727669,1.0,4/15,8.51%,SOCS4;SOCS7;SOCS6;SOCS2
prerank,dynactin binding (GO:0034452),-0.403149782625315,-1.0363580936956358,0.40893470790378006,0.7509472180061354,1.0,2/12,10.14%,BICDL1;SNX6
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.5035761061283711,1.0352668264705884,0.4528301886792453,0.8528164587858675,1.0,3/11,11.62%,NAA60;NAA40;NAA16
prerank,phosphatidylinositol kinase activity (GO:0052742),0.4743710362318211,1.0341412542967936,0.4613368283093054,0.8528814709557212,1.0,5/15,16.06%,PIK3C2B;ATM;PIK3CB;PI4K2A;PI4KB
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.38038443330304617,1.0338055575344853,0.42244224422442245,0.8506869971935422,1.0,15/60,12.40%,EGFR;DDR2;CRIM1;NTRK3;NTRK1;IGF2R;EPHB2;EPHB3;EPHB6;FGFR1;ROR1;FGFR2;MUSK;DDR1;NRP1
prerank,metalloaminopeptidase activity (GO:0070006),0.464075656562268,1.032893444022749,0.45322793148880103,0.850461097542034,1.0,7/16,21.26%,MMP14;XPNPEP1;MMP16;LNPEP;NPEPPS;LVRN;RNPEPL1
prerank,receptor tyrosine kinase binding (GO:0030971),0.3884522174580426,1.0320890261796545,0.45414364640883975,0.8496638217893863,1.0,11/56,14.33%,IRS1;GAS6;DOCK4;GAB2;SHC1;PITPNM1;CBL;ANGPT4;SH2B1;PTPN2;SQSTM1
prerank,cholesterol binding (GO:0015485),-0.2896735621911478,-1.031289444703592,0.4017094017094017,0.7540439348371906,1.0,10/47,6.96%,OSBPL8;APOD;SIDT1;PTCH1;PROM1;ABCG1;GRAMD1B;NR1H3;OSBPL10;STARD4
prerank,ligand-gated ion channel activity (GO:0015276),0.41473442595496546,1.0303947958867876,0.4390832328106152,0.8511420690707023,1.0,4/30,8.43%,GRIK4;GRIN3A;CHRNB2;CHRNA5
prerank,protein kinase binding (GO:0019901),0.3444281261685022,1.0303872958295808,0.412,0.8481728432795438,1.0,116/479,21.31%,ESR1;IRS1;PKD1;PRKCD;SLC12A7;RHOBTB1;CIT;SLC12A2;ADAM9;TCF7L2;SRCIN1;CNTLN;GHR;PRR7;RND3;PPP1CC;SHC1;HDAC9;SPRED2;STAT3;CD3E;CSPG4;NISCH;ATF4;NBEA;AP2A1;CALM2;MAVS;DACT1;ACVR1;DVL1;PRKCSH;TOM1L1;ILK;NOX4;PRAM1;ADAM10;ANKRA2;ANK2;NBR1;IRAK3;SKI;LLGL1;SLC12A4;SOX9;TRIM27;RARA;FZD5;DACT3;RBBP6;CDK5RAP3;DLG1;TSKS;RHOA;DCTN2;NSF;PAK2;ITGAV;CDC25B;FOXM1;ABL1;IRAK1;MAP3K12;TELO2;AXIN1;CHEK2;RCC2;EZR;NELL1;KHDRBS1;PPEF2;PTPN2;AP2A2;MAPRE3;SNAP91;PICK1;WNK1;CLTC;SQSTM1;ACSL3;PRDX3;RHOB;CAMK2N1;IQGAP1;FOXO3;GSKIP;SPAG9;PARP1;TPRKB;CDC25A;CALM3;UFL1;NR3C1;PRKAG1;TRIM6;VRK2;SUFU;RB1CC1;ATF2;CRK;CKS1B;PEBP1;PTPN23;DUSP19;TCF3;PRKAB1;MAP2K3;APPL1;MAPKAP1;DCTN1;MAD2L2;PRKACA;PRKAR2A;BANK1;MAP2K7;MAPK8IP3
prerank,TBP-class protein binding (GO:0017025),0.44015760270167953,1.0296081557846493,0.43333333333333335,0.8473124780231176,1.0,1/21,0.26%,ESR1
prerank,zinc ion binding (GO:0008270),0.3488792883781945,1.0280021740102565,0.42842842842842843,0.8488109999418602,1.0,74/293,20.50%,ADAMTS3;ZFPM2;TIMP2;ACER3;ECE1;SEC24D;GLI2;ADAM30;PAPPA;SEC23A;HDAC4;RXRA;SORD;TRIM28;CHD3;ADA;GLO1;SIRT5;SKI;MDM4;TES;NSD1;S100B;TIMM9;EEA1;SMPDL3A;SLC30A5;KDM2A;PHF8;TAB2;KDM5B;RNF2;SOD1;KDM4A;CHORDC1;FBXL19;SEC24C;SEC24B;QPCTL;MMP16;USP33;UBA5;PIAS4;RNF11;LACTB2;LNPEP;MBD1;SIRT2;IDE;ZFPL1;KDM5C;PLA2G15;KMT2B;DPF3;PRDM2;SHMT2;SEC24A;EPRS1;ALKBH8;SUV39H2;CAD;SHMT1;ZMYND11;AOC1;ZBTB32;NPEPPS;MYCBP2;TK1;LVRN;DNAJC24;TET2;CALR;IKZF4;ZDHHC20
prerank,receptor ligand activity (GO:0048018),0.3458252262510633,1.0265699773487134,0.4305835010060362,0.8498287715422276,1.0,21/245,7.26%,PGF;GDF10;WNT9A;VEGFA;GAS6;FGF2;OSGIN2;IL33;FGF17;INHBC;INSL6;TGFB3;SLURP1;LRPAP1;CCL15;TGFB2;SEMA3E;HMGB1;JAG1;SEMA4B;FAM3C
prerank,ligand-gated channel activity (GO:0022834),0.4166704638287461,1.026086648851265,0.4579780755176614,0.848195055576345,1.0,4/29,8.43%,GRIK4;GRIN3A;CHRNB2;CHRNA5
prerank,DNA secondary structure binding (GO:0000217),0.4131399928707694,1.0257005277864697,0.437726723095526,0.8462249127629381,1.0,9/31,22.61%,HMGB1;ERCC5;RBBP8;WRN;ABL1;MEN1;HMGA1;XRCC3;KMT2A
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.34290764727710854,1.0237345005586036,0.412,0.8489125890248599,1.0,119/431,23.82%,PRPS2;RHOJ;RHOBTB1;ABCD3;N4BP2;RHOQ;MARK1;MRAS;TUBG2;RND3;GNL3;ACVR1B;ATL2;HSPA2;TSR1;SMC4;RAB2A;MAP3K5;TNK1;DNM2;ACVR1;GNL1;RAB21;ATL3;ERN2;GNL2;TLK1;RABL6;RAB8A;ABCF1;IRAK3;RHOT2;ARF4;RPS6KA4;AK6;GBP6;AKT2;NOA1;RHOA;RHOT1;RRAD;HSPA14;PIP4K2B;PEX1;ARFIP2;RAB38;ABL1;NVL;MAP4K5;TDG;ABCE1;ABCB8;BMPR1A;ARF1;HSPA5;DARS2;LONP1;UHMK1;TGFBR1;PSMA6;EIF4G1;LIG4;RAB11B;ARL2;ABCA1;PI4K2A;DMPK;MARK4;WNK1;SRR;ABCB6;SRPK1;CLP1;TBCK;RHOB;RASL12;LATS2;HACL1;CDC42BPB;TLK2;IDE;HASPIN;YARS2;PGK1;MKNK2;SIK2;PRKAG1;DAPK3;BCKDK;CAD;PEX6;MAST2;AKT1;CHD8;RAD51;SARS2;DRG2;ABCF3;RHEB;MTREX;RAB4A;ATL1;LRRK2;PANK3;ANXA6;ABCD1;STK38;TUBB6;PRKCI;TOP1;PPIP5K1;CARS2;RAB1B;PYGL;ARF5;HNRNPU;SYN3;NRAS;KRAS
prerank,G protein-coupled receptor binding (GO:0001664),0.3541570137339982,1.023589013746686,0.45623069001029865,0.8463305494121396,1.0,5/132,1.92%,MYOC;GNAS;LRP6;WNT9A;PROK2
prerank,anion channel activity (GO:0005253),0.37732122898362036,1.0230243235184622,0.4414019715224535,0.8449167699312489,1.0,5/61,5.41%,SLC26A7;CLIC3;CLIC4;GABRA3;LRRC8D
prerank,DNA binding (GO:0003677),0.3389332566238528,1.0221906939049856,0.416,0.8443331162612896,1.0,154/694,20.49%,FOXP2;PLAGL1;EGFR;SIX1;KLF12;HOXA5;C1D;ZNF423;FOXD1;NFIB;TCF7L2;RARB;COLEC11;GLI2;PRDM5;CUX1;HDAC4;TOPORS;RXRA;MEOX2;STAT3;TCF7L1;ATF4;TRIM28;MCMDC2;MPG;NR2F1;CHD3;TCFL5;PHF1;FOXC2;PRKDC;SAFB;SMAD4;NFE2L2;HMGB1;EZH1;E2F3;PBX1;TSHZ2;MEIS3;TBX21;THRAP3;SOX9;HUWE1;MAEL;MCM2;CENPC;IKZF3;MBD6;FOXJ3;ERCC5;ESRRB;ZNF76;HMGN1;FOXL1;RFX2;SLTM;PSIP1;RBBP8;ERCC4;RAD1;RORA;OGG1;ILF3;WRN;FOXA1;CSRNP1;SREBF1;EHF;ABL1;ZIC4;RBM6;SPTY2D1;RFX5;POU6F1;WDR48;TDG;RBM5;TERT;KDM5B;AIFM1;SFPQ;SDE2;FUBP1;TAF6;PMS2;CCDC25;TDP1;ERCC3;RAD50;LONP1;KHDRBS1;CDC45;HSPD1;LIG4;PCBP2;KMT2D;MEF2A;ERCC2;SUPV3L1;TRIM26;ERF;DEDD;MSH4;DCLRE1B;RNF11;ZNF148;VDR;SNAPC4;XRN1;MBD1;GRHL1;FOXO3;NKX6-2;NFE2;ZFPL1;CREBBP;MCM4;TSN;RC3H2;POLG2;PRDM2;NFYA;SMARCAD1;DNTTIP1;MEN1;HDGFL2;HMGA1;CDT1;E2F1;RYBP;ZMYND11;ZBTB32;ZMYM3;CHD8;RAD51;HOXB2;MLXIPL;SAFB2;QRICH1;GTF3C1;XRCC6;IRF3;GTF3C4;CBFB;TCF3;APLP2;ATF6;TWNK;MAX;BPTF;CALR;FANCG
prerank,nuclear receptor coactivator activity (GO:0030374),0.39121086858651594,1.0218857797633227,0.4662084765177549,0.8423425917894739,1.0,18/52,19.17%,FGF2;ZMIZ1;DCAF6;CCAR2;THRAP3;MED13;SRA1;ENY2;CARM1;SFR1;ZMIZ2;SLC30A9;MED14;HMGA1;MED12;CNOT9;CCDC62;BRD8
prerank,ligand-gated anion channel activity (GO:0099095),-0.36284707237362246,-1.0199559997222047,0.4016393442622951,0.7737148345188128,1.0,7/17,14.72%,GLRA2;GABRB1;GABRB3;GABRB2;GABRA5;GLRA1;CFTR
prerank,retinoid X receptor binding (GO:0046965),0.4807422335474992,1.016781026610067,0.46582984658298465,0.8533507317869374,1.0,5/11,17.76%,NRIP1;NSD1;MED25;VDR;HMGA1
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.4018027898855773,1.0162792442126907,0.43734939759036146,0.8518824127446721,1.0,11/35,27.91%,FTO;MTFMT;PTRH2;ALKBH1;TYW3;ELAC2;DUS1L;DUS3L;TARS2;PUS10;DTWD1
prerank,chemokine receptor binding (GO:0042379),0.3981868062413225,1.0143975365172042,0.44945188794153473,0.8539005292313088,1.0,4/35,9.83%,CCL13;CCL15;CXCL16;ITCH
prerank,transcription cis-regulatory region binding (GO:0000976),0.33834767787773495,1.0137748538048406,0.477,0.8527014083145777,1.0,82/406,20.21%,PLAGL1;BNC2;SIX1;FOXP1;TCF7L2;TWIST2;VSX1;SMAD6;PRDM5;DMTF1;GLIS2;TWIST1;DEAF1;LHX9;CUX1;HDAC4;RXRA;STAT3;ATF4;CHD3;FOXC2;ZNF25;RXRB;NFX1;NFXL1;PER3;SMAD4;NFE2L2;HMGB1;E2F3;PBX1;TBX21;SOX9;PURG;RARA;ESRRB;TFE3;FOXK1;CARM1;HNRNPL;RORA;FOXA1;ZFP90;SREBF1;FOXM1;AGO1;RFX5;SFPQ;LONP1;HDAC1;AGO2;MEF2D;ARID4B;KMT2D;NPAS1;MEF2A;RUNX1;ZBTB9;TFDP1;PER1;GRHL1;FOXO3;FOXN3;NFE2;RBL2;PRDM2;NFYA;NR3C1;RFXANK;E4F1;MEN1;HMGA1;E2F1;SUV39H2;ATF2;KLF10;FOSL2;XRCC6;VEZF1;TCF3;ATF6;MAX
prerank,fibroblast growth factor receptor binding (GO:0005104),0.4359593839023129,1.0136003776043463,0.45057766367137353,0.8503701942450911,1.0,2/21,2.08%,FGF2;FGF17
prerank,high voltage-gated calcium channel activity (GO:0008331),0.5079839390838503,1.0101111992948246,0.47150997150997154,0.856780490861946,1.0,1/10,0.48%,CACNA1C
prerank,nucleosomal DNA binding (GO:0031492),0.4249476020585423,1.009382347414431,0.46064516129032257,0.8559601751000527,1.0,12/21,32.03%,SMARCC2;RCC1;HDAC1;HNRNPC;CHD4;SMARCA4;HDAC2;H3-3A;SMARCD2;SMARCC1;MBD3;GATAD2B
prerank,DNA polymerase activity (GO:0034061),0.4275933507487452,1.0093183278640803,0.46573604060913704,0.8532987767769683,1.0,8/22,26.26%,REV3L;POLE2;TERT;POLB;REV1;PRIMPOL;POLD1;POLG
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.4395562856196083,1.005882995610725,0.46965699208443273,0.8594180807978532,1.0,4/18,21.84%,AKR1C1;DHRS9;HSD17B8;HSD3B7
prerank,growth factor receptor binding (GO:0070851),0.35662388436561865,1.004793799364866,0.49581589958158995,0.8595402949183056,1.0,10/95,8.79%,PGF;VEGFA;FGF2;FGF17;SHC1;GLMN;SNX2;AGR2;ARF4;SNX1
prerank,potassium channel activity (GO:0005267),0.3642515279284319,1.0045319406546493,0.48720682302771856,0.8573843425571979,1.0,8/89,9.14%,KCNK5;GRIK4;KCNB1;HCN4;KCNN1;KCNE5;KCND1;KCNK6
prerank,sterol binding (GO:0032934),-0.2637445091381932,-1.0029496270967637,0.49019607843137253,0.8079613964320176,1.0,11/56,6.96%,OSBPL8;APOD;SIDT1;PTCH1;PROM1;ABCG1;GRAMD1B;NR1H3;OSBPL10;INSIG2;STARD4
prerank,exoribonuclease activity (GO:0004532),-0.3865056193136345,-1.000093583297828,0.46204620462046203,0.8056103483117517,1.0,5/12,18.55%,EXOSC8;ZC3H12A;EXOSC1;EXOSC9;EXOSC10
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.42444382186719515,0.9996743257161355,0.48280254777070064,0.8676288539518408,1.0,8/24,24.13%,CAMKK1;CAMK2D;PHKA1;EEF2K;CAMK4;MKNK2;CAMK1;PHKA2
prerank,ubiquitin-protein transferase activity (GO:0004842),0.33331982487221423,0.9989364351293911,0.515,0.8666608633025633,1.0,106/346,26.17%,WWP1;RNF144A;SH3RF3;NEDD4;FBXO10;FBXW8;TOPORS;COP1;UBE2B;TRIM28;UBR4;RNF182;DTX3;LRSAM1;UBE2R2;ERCC8;NFX1;UBE3C;RNF115;TRIM41;HUWE1;TRIM27;SYVN1;CBL;RBBP6;WWP2;SHARPIN;ITCH;CUL4A;FBXO25;RNF114;UBR5;RNF25;UBE2C;FBXO22;RNF14;FBXO3;RNF2;ANAPC4;MYLIP;TRAF3;CUL1;RNF38;DTX2;LTN1;RNF103-CHMP3;TRIM26;FBXL14;RNF11;RING1;UBE2L6;FBXO17;STUB1;RNF214;TRAF3IP2;RNF121;RC3H2;BIRC6;TRIM13;VPS11;GID4;TRIM6;HECTD1;UHRF2;RNF7;FBXW2;UBR2;RNF141;MYCBP2;NEURL1B;NEURL3;UBE2G2;RMND5B;TRAIP;TRIM47;SMURF2;TRIM43;MUL1;SH3RF1;RNF4;KCTD13;BIRC3;AREL1;TTC3;RNF20;RNF216;ZFP91;RNF146;FBXO11;UBE2Z;TAF1;FBXO9;RNF122;AMFR;IRF2BPL;RCHY1;RNF138;RNFT1;XIAP;KCMF1;UBE2W;UBR3;RNF111;SHPRH;RNF126;RNF166
prerank,hormone receptor binding (GO:0051427),0.4632618522978078,0.9989277649533124,0.4896551724137931,0.8638694212182497,1.0,4/14,25.21%,SOCS2;VIP;JAK1;TYK2
prerank,semaphorin receptor activity (GO:0017154),0.4772871314685356,0.9963108535349471,0.49379310344827587,0.8680660832972406,1.0,1/11,0.51%,PLXNA4
prerank,phosphatidylcholine transporter activity (GO:0008525),0.44122835253375586,0.9961413221681299,0.4853963838664812,0.8657457788356496,1.0,6/17,13.71%,PITPNC1;PITPNA;PITPNM1;ATP8B2;PCTP;ABCA1
prerank,pseudouridine synthase activity (GO:0009982),0.4696014101300435,0.9944475228864366,0.4896836313617607,0.8671944570764984,1.0,8/13,34.70%,RPUSD1;PUS3;TRUB1;PUS1;PUS10;DKC1;PUS7;PUS7L
prerank,basic amino acid transmembrane transporter activity (GO:0015174),-0.36834278276116894,-0.9938225957100049,0.48031496062992124,0.8121650227725679,1.0,6/13,21.75%,SLC38A5;SLC7A1;SLC38A7;SLC25A29;SLC3A1;SLC7A3
prerank,endopeptidase regulator activity (GO:0061135),-0.27504281425434923,-0.9919720141910421,0.4305555555555556,0.8068975481866086,1.0,8/40,12.01%,ITIH2;TFPI;PROS1;SERPIND1;PSME3;PSME1;A2M;SPINT2
prerank,ubiquitin protein ligase activity (GO:0061630),0.3338371655582133,0.9919687140644176,0.522567703109328,0.8706390711468781,1.0,70/228,26.17%,WWP1;RNF144A;SH3RF3;NEDD4;TOPORS;COP1;UBR4;DTX3;LRSAM1;NFX1;UBE3C;RNF115;TRIM41;HUWE1;TRIM27;SYVN1;CBL;RBBP6;WWP2;ITCH;RNF114;UBR5;RNF25;RNF14;RNF2;MYLIP;RNF38;DTX2;LTN1;TRIM26;RNF11;RING1;FBXO17;STUB1;TRAF3IP2;RNF121;RC3H2;TRIM13;VPS11;UBE4A;GID4;TRIM6;HECTD1;UHRF2;RNF7;UBR2;MYCBP2;NEURL1B;NEURL3;UBOX5;SMURF2;TRIM43;MUL1;SH3RF1;BIRC3;AREL1;RNF216;RNF122;AMFR;IRF2BPL;RCHY1;RNF138;RNFT1;XIAP;KCMF1;UBR3;RNF111;SHPRH;RNF126;RNF166
prerank,platelet-derived growth factor receptor binding (GO:0005161),-0.38922773300316804,-0.9907062344723213,0.4696969696969697,0.8005827794527491,1.0,5/13,8.05%,IL1R1;PDGFD;PDGFRB;PDGFRA;PDGFC
prerank,general transcription initiation factor binding (GO:0140296),0.40868946866688427,0.9906069732078447,0.48375,0.8712633328289054,1.0,8/25,25.78%,ESR1;TAF13;PSMC5;THAP7;YEATS2;TBP;TAF1;PSMC1
prerank,single-stranded DNA binding (GO:0003697),0.35010694532699765,0.9891872432500611,0.5246589716684156,0.8719432349394117,1.0,43/93,32.97%,MCMDC2;HMGB1;MCM2;ERCC5;RBBP8;ERCC4;WDR48;FUBP1;PMS2;TDP1;LONP1;CDC45;HSPD1;PCBP2;MCM4;RAD51;TWNK;CRY2;HNRNPA1;TOP1;NUP35;HNRNPU;TOP3A;RNF138;RTF1;SMC6;POLR2H;MCM7;FBH1;SWSAP1;IGHMBP2;HMCES;DDX11;RAD52;CTC1;SSBP1;TDP2;MSH2;BLM;ERCC1;RAD23B;RPA3;PURA
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.39311300742761185,0.9881056525023489,0.4963592233009709,0.8719244584441643,1.0,14/31,31.49%,UBE2B;UBE2R2;UBE2C;UBE2L6;BIRC6;UBE2G2;UBE2Z;TAF1;UBE2W;UBE2Q2;UBE2H;UBE2S;UBE2A;UBE2N
prerank,chemokine binding (GO:0019956),0.4000981491258432,0.987284638404742,0.4943253467843632,0.8712947006692947,1.0,7/30,21.41%,FGF2;HMGB1;ACKR4;ITGAV;CXCR4;PLP2;ACKR3
prerank,5'-nucleotidase activity (GO:0008253),0.46488869908176655,0.9856577966184384,0.5104311543810849,0.8728103434478053,1.0,5/13,22.70%,NT5DC3;NT5C3B;ACP3;NT5C;NT5DC1
prerank,Notch binding (GO:0005112),0.41807751173131397,0.9856211366702584,0.4980289093298292,0.8701709972848313,1.0,3/22,6.53%,CCN3;NCOR2;JAG1
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.33175637282494747,0.9851093559013457,0.5476429287863591,0.8687990559075885,1.0,70/232,26.17%,WWP1;RNF144A;SH3RF3;NEDD4;TOPORS;COP1;UBR4;DTX3;LRSAM1;NFX1;UBE3C;RNF115;TRIM41;HUWE1;TRIM27;SYVN1;CBL;RBBP6;WWP2;ITCH;RNF114;UBR5;RNF25;RNF14;RNF2;MYLIP;RNF38;DTX2;LTN1;TRIM26;PIAS4;RNF11;RING1;FBXO17;STUB1;TRAF3IP2;RNF121;RC3H2;UFL1;TRIM13;VPS11;GID4;TRIM6;HECTD1;UHRF2;RNF7;UBR2;MYCBP2;NEURL1B;NEURL3;SMURF2;TRIM43;MUL1;SH3RF1;BIRC3;AREL1;RNF216;RNF122;AMFR;IRF2BPL;RCHY1;RNF138;RNFT1;XIAP;KCMF1;UBR3;RNF111;SHPRH;RNF126;RNF166
prerank,phospholipase activator activity (GO:0016004),-0.39927358180058226,-0.9833350494167445,0.45652173913043476,0.8102675410725968,1.0,1/10,0.73%,ARHGAP6
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.37166183772589395,0.9813017092387927,0.518058690744921,0.8754838933099285,1.0,15/49,21.59%,VCP;FAAP20;SHARPIN;TAB2;UBQLN1;SQSTM1;HDAC6;ATRIP;UBL7;ZFAND2B;IKBKE;ZRANB1;BRCC3;OPTN;PSMD4
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.46621398604719394,0.9802969557308266,0.5007112375533428,0.8752518643519152,1.0,5/12,22.07%,B3GNT7;B3GNT9;B4GAT1;B3GNT6;B3GNT2
prerank,phosphatidylinositol binding (GO:0035091),0.3459581757952641,0.9772116064008598,0.5323435843054083,0.8800821212908804,1.0,31/91,23.50%,TNFAIP8L3;PITPNC1;SNX2;PITPNA;PITPNM1;BCAS3;MYO1E;GPAA1;GAP43;FCHO2;EEA1;SNX24;SNX1;SNX9;SNAP91;MITD1;SCIN;HIP1;SNX13;DENND1B;C2CD2L;ZFYVE16;AIDA;APPL2;APPL1;SNX11;RUBCN;DENND1A;MTM1;SNX4;DPEP1
prerank,sterol transfer activity (GO:0120015),-0.34701789116476234,-0.9755746314246616,0.5018181818181818,0.820971045847716,1.0,4/17,6.96%,PLTP;ABCG1;GRAMD1B;STARD4
prerank,potassium ion leak channel activity (GO:0022841),0.44674969763346617,0.9750290935804828,0.5085865257595773,0.8827411672906202,1.0,1/15,0.40%,KCNK5
prerank,four-way junction DNA binding (GO:0000400),0.42931751160465276,0.9728051046949759,0.5296442687747036,0.8853412271957077,1.0,8/17,31.69%,HMGB1;WRN;ABL1;MEN1;XRCC3;YY1;MSH2;BLM
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),-0.3903942580900541,-0.9707489246028571,0.4870848708487085,0.823782613796956,1.0,4/11,18.42%,KCND3;KCNJ3;KCNJ8;KCNQ1
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.3602073463052969,0.9694351062890784,0.5359179019384265,0.89054754899759,1.0,7/55,8.21%,PKD1;SLC24A3;SEC61A1;TRPV3;ANXA2;MCU;TRPM7
prerank,phosphoric diester hydrolase activity (GO:0008081),0.38307552153259267,0.9672925073449412,0.5362997658079626,0.8929928673771248,1.0,9/35,16.32%,PLCE1;PDE11A;SMPD4;SMPDL3A;PDIA3;PLCXD2;ENPP6;MPPED2;GDPD3
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.3428693923392242,0.9646153556136025,0.5685654008438819,0.8967670168347003,1.0,29/100,22.42%,CYTH3;ARAP1;PLEKHA4;PLA2G4A;GAB2;GAP43;GBF1;WIPI2;LAPTM4B;SNX24;OGT;DAPP1;SH3PXD2B;ARFIP2;ZFYVE19;OSBP;BBS5;IQGAP1;HIP1;SNX13;GOLPH3;DENND1B;AKT1;ZFYVE16;MAPKAP1;SNX11;RUFY4;RUBCN;DENND1A
prerank,O-methyltransferase activity (GO:0008171),0.47634636384196294,0.9618414193315412,0.5608695652173913,0.9008335511126853,1.0,1/10,2.38%,LRTOMT
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.3763710425847625,0.9616930583895329,0.5142517814726841,0.8984188784623508,1.0,15/34,31.49%,UBE2B;UBE2R2;UBE2C;UBE2L6;BIRC6;UBE2G2;UBE2Z;TAF1;UBE2W;UFC1;UBE2Q2;UBE2H;UBE2S;UBE2A;UBE2N
prerank,mannosyltransferase activity (GO:0000030),-0.31942663761095996,-0.9612663251402099,0.49537037037037035,0.8385668975278442,1.0,2/21,1.25%,TMTC2;TMTC4
prerank,aminopeptidase activity (GO:0004177),0.39753178525843663,0.960010605393631,0.5502450980392157,0.8998075475479063,1.0,10/26,24.45%,MMP14;XPNPEP1;MMP16;LNPEP;LAP3;NPEPPS;LVRN;RNPEPL1;METAP1D;METAP2
prerank,anion transmembrane transporter activity (GO:0008509),-0.38417048620603306,-0.9590304160115566,0.5068027210884354,0.8349050616943495,1.0,3/12,4.15%,SLCO2B1;SLC22A6;SLC39A8
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),0.4631253215358126,0.9589235849834146,0.5381294964028777,0.8995804807303375,1.0,8/10,26.40%,EHMT1;ASH1L;SETD5;SETDB1;SUV39H2;SUV39H1;SETDB2;EHMT2
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.4031561989307019,0.9574546126774423,0.5303225806451612,0.9004735668122311,1.0,7/24,22.66%,AK5;AK3;IP6K1;DTYMK;AK1;NME3;PPIP5K1
prerank,5'-3' RNA polymerase activity (GO:0034062),0.39905736446140194,0.9558438833065239,0.5468164794007491,0.9014234214582032,1.0,11/27,22.06%,POLR3H;TERT;CRCP;POLR2F;MED21;POLR3K;TENT2;MED20;POLR1D;POLR1C;POLR2B
prerank,N-acetyltransferase activity (GO:0008080),0.42120068112112374,0.9550371418126157,0.538163001293661,0.9006448879330551,1.0,3/19,9.48%,NAT1;ATAT1;SAT2
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.3294407589780157,0.9542131006853477,0.5995934959349594,0.8997680665284458,1.0,36/147,17.20%,PLCE1;ARHGEF28;CYTH3;TIAM1;FARP1;DOCK4;RCC1L;ANKRD27;VAV2;FGD6;RABGEF1;RAB3GAP1;DENND6A;EPS8L1;LAMTOR1;RASGEF1B;RIC1;BCR;DOCK5;MON1A;KALRN;RGP1;MADD;RCC1;IQSEC2;GAPVD1;WDR41;NUCB1;PREB;HPS4;FARP2;AKAP13;SOS1;EEF1B2;DIS3;NGEF
prerank,leucine zipper domain binding (GO:0043522),0.4740752126991489,0.9510189643942304,0.5409153952843273,0.904670105849279,1.0,4/10,17.86%,ATF4;ERC1;AATF;DAPK3
prerank,transaminase activity (GO:0008483),0.4610419441903914,0.9509211347291296,0.5425383542538355,0.9022165868431062,1.0,3/11,21.05%,AGXT2;PSAT1;BCAT1
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.4424884115705006,0.9479186825337856,0.5449664429530201,0.906720925758992,1.0,7/14,30.83%,RPP40;ELAC2;RPP14;TSEN34;RPP21;POP5;PRORP
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",-0.39443554525804503,-0.9473665271419068,0.5151515151515151,0.8556749397234898,1.0,3/10,10.17%,ADARB2;LACC1;GDA
prerank,antiporter activity (GO:0015297),0.408047776573922,0.9461616689846696,0.5544303797468354,0.9082545865475585,1.0,7/20,25.25%,CLCN4;SLC35E1;TMEM241;SLC35C2;SLC35E2B;SLC35E2A;SLC25A11
prerank,protein phosphatase 1 binding (GO:0008157),0.4111809542538223,0.94469172267408,0.5710627400768246,0.9088229604910626,1.0,4/21,11.40%,PPP1R3C;PPP1R9B;PPP1R3F;SHOC2
prerank,cadherin binding (GO:0045296),0.3166990761087721,0.9407834929828001,0.675,0.9152763449429083,1.0,64/315,15.79%,EGFR;CDH11;CTNND2;MPP7;FXYD5;FMNL2;CTTN;EHD1;RDX;AHNAK;PDXDC1;STX5;SCYL1;LIMA1;CSNK1D;HDLBP;GCN1;SNX2;ANXA2;ERC1;BAG3;ARGLU1;EIF4G2;ATXN2L;ACVR1;EPS8L1;ABI1;KLC2;GIPC1;JUP;TES;NDRG1;PAK4;CBL;DLG1;SNX1;PKN2;PAK2;ANXA1;ATIC;BZW1;ARFIP2;CKAP5;ZC3H15;SNX9;HSPA5;USO1;EZR;EEF1G;PARVA;DHX29;GAPVD1;ADD1;DCHS1;RAB11B;MPRIP;YWHAE;SND1;HNRNPK;FLNB;TBC1D10A;LRRC59;IQGAP1;UBAP2
prerank,Tat protein binding (GO:0030957),0.4700296876216741,0.9398800294884692,0.5663716814159292,0.9146426051063087,1.0,4/10,25.18%,MDFIC;DNAJA1;SMARCA4;CTDP1
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),-0.3881229493952464,-0.9395627895707196,0.540625,0.8659548262412514,1.0,6/10,17.63%,CXADR;CD200;PKP2;SIRPA;DSP;CD47
prerank,sequence-specific mRNA binding (GO:1990825),0.4711976050375832,0.9391281553376303,0.5599415204678363,0.9137368073895142,1.0,6/10,34.60%,SSB;ETF1;SHFL;RBM24;DHFR;DHX9
prerank,leak channel activity (GO:0022840),0.41546296270583755,0.9381591209381679,0.5637755102040817,0.9132229265531683,1.0,1/18,0.40%,KCNK5
prerank,telomerase RNA binding (GO:0070034),0.4039469852575251,0.9369204471635484,0.5643693107932379,0.9132946032339394,1.0,8/22,26.90%,TENT4B;SMG6;TERT;HNRNPC;XRN1;SNRPB;HNRNPU;DKC1
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.3987662647716877,0.9365532429540391,0.5549805950840879,0.9114950428172929,1.0,7/21,26.26%,REV3L;POLE2;POLB;REV1;PRIMPOL;POLD1;POLG
prerank,kinase activity (GO:0016301),0.3263356366543577,0.93476137545943,0.6024844720496895,0.9127865136040985,1.0,31/109,20.13%,PAPSS2;MAPK15;PIK3C2B;NADK;SCYL3;CSNK2A1;SHPK;STK39;HYKK;TRRAP;FCSK;DGKQ;ETNK1;PKN2;PANK4;ABL1;IRAK1;DCAKD;IP6K1;PIK3CB;ADPGK;CKB;CHKB;COQ8B;PI4KB;PGK1;BCKDK;AKT1;RFK;CDK5;SEPHS2
prerank,glutathione transferase activity (GO:0004364),0.39596685301847223,0.9301446789062666,0.5746835443037974,0.9205510832260558,1.0,4/23,16.01%,GSTT1;GSTM5;GSTZ1;PTGES
prerank,peptide hormone receptor binding (GO:0051428),0.4483940861761326,0.930034255565081,0.5465753424657535,0.9181646521315574,1.0,2/11,15.57%,VIP;PSMC5
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",0.3980995784521039,0.9297881805148988,0.5682704811443433,0.916076170779938,1.0,4/21,4.85%,PDE11A;PDE6C;PDE3A;PDE6A
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.45134016762568113,0.9296779841809701,0.5722460658082976,0.9136795961384736,1.0,6/11,31.14%,AKR1C1;AKR1A1;AKR1B10;RDH14;RDH13;ALDH3A1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.4572609378335572,0.9295109679936603,0.5797950219619327,0.9114421856667926,1.0,4/10,27.45%,DPYSL3;CAD;DPEP1;OPLAH
prerank,ATP binding (GO:0005524),0.3139350975403802,0.9285702734032758,0.6966966966966966,0.9110121012591923,1.0,64/266,18.96%,PRPS2;ABCD3;N4BP2;MARK1;ACVR1B;HSPA2;SMC4;MAP3K5;TNK1;ACVR1;ERN2;TLK1;ABCF1;IRAK3;RPS6KA4;AK6;AKT2;HSPA14;PIP4K2B;PEX1;ABL1;NVL;MAP4K5;TDG;ABCE1;ABCB8;BMPR1A;HSPA5;DARS2;LONP1;UHMK1;TGFBR1;EIF4G1;LIG4;ABCA1;PI4K2A;DMPK;MARK4;WNK1;SRR;ABCB6;SRPK1;CLP1;TBCK;LATS2;HACL1;CDC42BPB;TLK2;IDE;HASPIN;YARS2;PGK1;MKNK2;SIK2;PRKAG1;DAPK3;BCKDK;CAD;PEX6;MAST2;AKT1;CHD8;RAD51;SARS2
prerank,vinculin binding (GO:0017166),-0.36109020412616766,-0.9284757384618036,0.521311475409836,0.8853024571240575,1.0,4/11,5.16%,UTRN;DAG1;CORO2B;SYNM
prerank,thyroid hormone receptor binding (GO:0046966),0.3782448095569468,0.9282174786345952,0.5760598503740648,0.9092179090334842,1.0,9/28,25.92%,JMJD1C;THRAP3;NSD1;MED13;MED12;BRD8;TRIP6;NCOR1;MED24
prerank,adenylate cyclase binding (GO:0008179),-0.3778334803204569,-0.9256462469481379,0.5523465703971119,0.8831065148557502,1.0,3/10,5.06%,ADCY5;CAP2;AKAP6
prerank,hexosyltransferase activity (GO:0016758),0.32562965737538985,0.9245819255646778,0.627471383975026,0.91465801550535,1.0,32/101,29.49%,EXT1;CHPF2;POGLUT3;B3GNT7;POGLUT1;B4GALT1;B4GALT5;OGT;MGAT4B;FUT4;HEXA;B3GNT9;B4GAT1;B3GNT6;ALG1;TMTC1;EXT2;GCNT7;B4GALNT3;B3GNT2;PIGV;DPY19L2;B4GALT7;POMT1;ALG12;RFNG;PIGB;B3GAT3;ALG9;DPY19L4;B3GALNT2;HAS3
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),0.4420764138647073,0.9242158994887196,0.5643153526970954,0.9129300825587158,1.0,3/12,12.37%,PIK3C2B;ATM;PIK3CB
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.39578217560770107,0.9234452762925583,0.5674300254452926,0.9119928489073058,1.0,7/22,20.95%,FAAP20;TAB2;SQSTM1;ATRIP;IKBKE;ZRANB1;OPTN
prerank,protein kinase regulator activity (GO:0019887),0.3258413043610364,0.9231161406546223,0.6369359916054564,0.9101774349458068,1.0,33/95,27.18%,FGF13;STRADA;CCNL2;KIDINS220;CCNL1;GMFB;MADD;CCNT2;PARVA;WNK1;CCNG2;CCNE2;HEXIM1;GSKIP;CDKN1C;PRKAG1;ELP4;DUSP19;PRKAR2A;ELP3;RPTOR;TAOK3;SMCR8;YWHAB;MAPK8IP1;QARS1;DAXX;CCNC;SOCS1;NCK1;WNT11;SH3BP5;CNPPD1
prerank,amino acid binding (GO:0016597),0.3715360038718471,0.9226115651885322,0.5867158671586716,0.9087645852844345,1.0,10/31,20.40%,GCLC;GRIN3A;DDAH1;CASTOR2;SRR;SHMT2;GNMT;CAD;SHMT1;GLRB
prerank,nucleotidyltransferase activity (GO:0016779),0.4050358896991289,0.9220979771618774,0.5675324675324676,0.9072774812005382,1.0,6/19,21.06%,PAPSS2;TENT4B;TERT;TUT7;REV1;TENT2
prerank,endopeptidase inhibitor activity (GO:0004866),0.3260995531540786,0.9219200266548216,0.616118769883351,0.9052336704609413,1.0,16/82,19.33%,SERPINH1;TIMP2;TIMP3;RARRES1;ANXA2;CARD16;SERPINF1;CST3;SERPINB9;SERPINE2;CRB2;RENBP;BIRC6;SERPING1;CAST;UCHL5
prerank,tau protein binding (GO:0048156),-0.2574334592290895,-0.9211575624606625,0.60431654676259,0.884799792045461,1.0,4/40,2.53%,ROCK2;APOE;MAP2;PICALM
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.36684029119821226,0.9199322301552032,0.5961768219832736,0.9070387003808723,1.0,7/33,17.07%,ERI3;REXO2;DIS3L2;XRN1;EXOSC4;CNOT8;DIS3
prerank,CCR chemokine receptor binding (GO:0048020),0.36814115110826484,0.9192499305411503,0.558968058968059,0.9060490486843036,1.0,3/28,12.09%,CCL13;CCL15;DEFB1
prerank,voltage-gated ion channel activity (GO:0005244),-0.33635862124886834,-0.9175931827904333,0.5886792452830188,0.8844727735238762,1.0,3/14,8.49%,CACNA1E;KCND2;ANO6
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),0.3863372978941892,0.9173525846114485,0.570694087403599,0.9076984650888726,1.0,4/23,4.85%,PDE11A;PDE6C;PDE3A;PDE6A
prerank,transmitter-gated ion channel activity (GO:0022824),0.369885706060469,0.9172583926565244,0.5904059040590406,0.9053870742204131,1.0,2/29,5.17%,GRIK4;GABRA3
prerank,phosphatidylglycerol binding (GO:1901611),0.4240034775432497,0.911415423819076,0.5923836389280677,0.9152100336950454,1.0,5/13,23.38%,PITPNC1;PITPNA;GSDME;UQCC3;STOML2
prerank,snRNA binding (GO:0017069),0.35481675083691866,0.9105187729620229,0.6048667439165701,0.9146142756597198,1.0,15/42,29.40%,SNRNP70;CCNT2;LSM2;HEXIM1;SNRPA;RBM22;NCBP2;LARP7;SNRPB2;HNRNPU;SNRNP35;DDX39B;TOE1;CDK9;MEPCE
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.3623368552961733,0.9102858599989535,0.6112412177985949,0.9126268868858451,1.0,6/35,14.24%,PKDCC;CLK1;TNK1;ABL1;SRMS;FRK
prerank,phosphatase inhibitor activity (GO:0019212),0.39768655700651584,0.9102473821304079,0.5745784695201037,0.9102150541032205,1.0,11/20,27.66%,PPP1R9B;URI1;CABIN1;ARPP19;STYX;SAG;BOD1L1;LMTK2;ANP32E;MGAT5;PPME1
prerank,adenyl ribonucleotide binding (GO:0032559),0.30633792490347656,0.9080232131869053,0.7447447447447447,0.9122152353216252,1.0,67/291,18.96%,PRPS2;ME1;ABCD3;N4BP2;GCLC;MARK1;ACVR1B;HSPA2;SMC4;MAP3K5;TNK1;ACVR1;ERN2;TLK1;ABCF1;IRAK3;RPS6KA4;AK6;AKT2;HSPA14;PIP4K2B;PEX1;ABL1;NVL;MAP4K5;TDG;ABCE1;ABCB8;BMPR1A;HSPA5;DARS2;LONP1;UHMK1;TGFBR1;EIF4G1;LIG4;ABCA1;PI4K2A;DMPK;MARK4;WNK1;SRR;ABCB6;SRPK1;CLP1;TBCK;LATS2;HACL1;CDC42BPB;TLK2;IDE;MPPED2;HASPIN;YARS2;PGK1;MKNK2;SIK2;PRKAG1;DAPK3;BCKDK;CAD;PEX6;MAST2;AKT1;CHD8;RAD51;SARS2
prerank,ATPase activator activity (GO:0001671),0.3935887671100897,0.9065237184533773,0.5947712418300654,0.9128608792231092,1.0,2/20,5.11%,ATP1B1;DNAJA2
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.36995974445482765,0.9056776117137385,0.6163366336633663,0.9120410783661561,1.0,14/29,33.67%,ACER3;GAA;GALC;HEXD;GANAB;PARG;GUSB;ADPRS;GANC;CTBS;MGAM;HPSE;GBA2;HYAL3
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.35954754372204534,0.9047534854570349,0.5913461538461539,0.911521510278794,1.0,6/34,9.18%,CYTH3;ARAP1;GAB2;GBF1;OGT;DAPP1
prerank,kinesin binding (GO:0019894),0.37199195459554524,0.9040938318171294,0.6177558569667078,0.9103197923084647,1.0,12/27,29.25%,KLC2;PLEKHM2;IFT88;SPAG9;KIF1B;ARHGEF10;MAPK8IP3;FAM83D;MAPK8IP1;NEK6;TTBK2;KIFAP3
prerank,SUMO binding (GO:0032183),0.4236001479001517,0.9024986083965814,0.5912806539509536,0.9111553978363218,1.0,8/13,35.85%,TDG;USPL1;RNF4;SIMC1;RNF111;HERC2;USP25;CBX4
prerank,endopeptidase activator activity (GO:0061133),-0.37054776432511716,-0.9017621133929784,0.5876288659793815,0.9149362108867721,1.0,7/10,29.94%,PSME3;PSME1;APH1B;NLRC4;PSME2;APH1A;PSENEN
prerank,carboxy-lyase activity (GO:0016831),0.3640322987948899,0.9005249783364307,0.5973072215422277,0.9126757047218701,1.0,5/23,22.16%,GGCX;CSAD;AZIN1;ACOD1;ECHDC1
prerank,ephrin receptor activity (GO:0005003),0.39569726669385274,0.899149500169617,0.5919463087248322,0.9103828213249847,1.0,3/17,5.82%,EPHB2;EPHB3;EPHB6
prerank,transmembrane-ephrin receptor activity (GO:0005005),0.39569726669385274,0.899149500169617,0.5919463087248322,0.9103828213249847,1.0,3/17,5.82%,EPHB2;EPHB3;EPHB6
prerank,nucleoside-diphosphatase activity (GO:0017110),0.42891501353047284,0.8968613050731188,0.6046831955922864,0.9125014356749622,1.0,6/12,27.74%,ENTPD2;ENTPD6;ENTPD7;ENTPD5;NUDT18;CANT1
prerank,ATPase regulator activity (GO:0060590),0.3532370960134944,0.8947692953522163,0.636471990464839,0.9142122094591515,1.0,15/38,31.19%,ATP1B1;BAG3;DNAJA2;SIL1;GRPEL1;DNAJA1;DNAJC24;DNAJC1;KATNB1;BAG1;TOR1AIP1;TOR1AIP2;DNAJB1;GRPEL2;HSPH1
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.3989018864185361,0.8938281394885592,0.6351531291611185,0.9136797508528179,1.0,4/18,8.51%,SOCS4;SOCS7;SOCS6;SOCS2
prerank,protein tyrosine kinase activity (GO:0004713),0.31423738497185866,0.8919850424934012,0.6915005246589717,0.9147646405843868,1.0,16/108,10.59%,EGFR;PKDCC;DDR2;CLK1;NTRK3;NTRK1;EPHB2;SCYL1;TNK1;EPHB3;EPHB6;FGFR1;ROR1;FGFR2;MUSK;ABL1
prerank,sulfotransferase activity (GO:0008146),0.35787824455393347,0.8902299330825482,0.6114494518879415,0.9158670170208283,1.0,3/33,2.94%,SULT1C2;SULT1C4;CHST11
prerank,delayed rectifier potassium channel activity (GO:0005251),0.3558506469055435,0.8897168102948616,0.6313868613138686,0.914433835129368,1.0,3/32,12.85%,KCNB1;KCNE5;KCNG3
prerank,estrogen receptor binding (GO:0030331),0.35435455505045826,0.8889093434137999,0.6391625615763546,0.9136581028428458,1.0,8/32,18.79%,ESR1;NRIP1;NSD1;DCAF13;MMS19;DNAAF4;LCOR;CCDC62
prerank,metallocarboxypeptidase activity (GO:0004181),-0.2786380598658916,-0.8842798291737144,0.6384976525821596,0.9479819619602984,1.0,3/26,3.51%,AEBP1;CPM;AGBL4
prerank,death receptor activity (GO:0005035),-0.3622120299796142,-0.8840766464756006,0.5980707395498392,0.9387302038062408,1.0,5/11,18.11%,TNFRSF19;FAS;TNFRSF1A;TNFRSF11A;TNFRSF25
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),-0.3535345240388007,-0.8834817337495324,0.6007194244604317,0.9306924743418572,1.0,1/11,4.13%,NUDT4
prerank,cytokine receptor binding (GO:0005126),0.3170078177387517,0.883082868812361,0.669831223628692,0.9225524920232873,1.0,5/83,4.20%,PGF;VEGFA;INHBC;SPRED2;TGFB2
prerank,pyridoxal phosphate binding (GO:0030170),0.38102379843189754,0.8823563401019664,0.6308100929614874,0.921622314473465,1.0,5/20,19.03%,PYGB;SRR;SHMT2;SHMT1;PSAT1
prerank,protein kinase activator activity (GO:0030295),0.3302584748426927,0.8806324147539737,0.6662908680947013,0.9224922070005241,1.0,19/60,26.38%,GAS6;FGF13;STRADA;CALM2;ABI1;PAK2;MADD;WNK1;IQGAP1;CALM3;DBF4;DUSP19;FAM20A;RPTOR;STK3;DAXX;TAOK1;IGF2;WNT11
prerank,phosphatidic acid binding (GO:0070300),0.38276153959083,0.8785433842352608,0.6319261213720316,0.9239654891070078,1.0,3/19,4.74%,PITPNC1;MARK1;PITPNM1
prerank,titin binding (GO:0031432),0.4064231097823797,0.8756062700607137,0.6226685796269728,0.9269570795124745,1.0,2/13,5.06%,CAMK2D;CALM2
prerank,adenyl nucleotide binding (GO:0030554),0.41491624890404355,0.8742983355738351,0.6411682892906815,0.9246656805258751,1.0,6/11,31.19%,BAG3;SIL1;GRPEL1;BAG1;GRPEL2;HSPH1
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.41491624890404355,0.8742983355738351,0.6411682892906815,0.9246656805258751,1.0,6/11,31.19%,BAG3;SIL1;GRPEL1;BAG1;GRPEL2;HSPH1
prerank,deoxyribonuclease activity (GO:0004536),0.40999802625463233,0.8740209075918189,0.6443812233285917,0.9228368004150492,1.0,8/14,36.01%,ERCC5;ERCC4;DFFB;ZRANB3;DNASE1L2;MBD4;MRE11;APLF
prerank,carboxylic ester hydrolase activity (GO:0052689),0.311042185645957,0.8736709293554141,0.7100213219616205,0.9210622150633104,1.0,13/85,18.90%,MGLL;PLA2G4F;PLA2G4A;CEL;ABHD6;PTRH2;PAFAH1B2;PLA2G12A;PNPLA3;GDPD3;PLA2G15;PNPLA7;PAFAH1B3
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.40908240271518903,0.8735715083418045,0.6422764227642277,0.9189324491691362,1.0,9/14,33.90%,MTMR11;SYNJ1;MTMR10;MTMR1;MTM1;MTMR2;MTMR12;MTMR9;MTMR4
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.37139793073436284,0.8708574752603172,0.6418663303909206,0.9214709522575377,1.0,3/21,8.43%,DRD1;CHRNB2;CHRNA5
prerank,protein tyrosine phosphatase activity (GO:0004725),0.3161956038114805,0.8696865442065519,0.6771058315334774,0.9213139270317064,1.0,14/71,14.36%,EYA2;UBASH3B;PTPN3;PTPRS;PTPRF;PTP4A2;DUSP11;PTPRU;CDC14A;PTPN18;CDC25B;PTPDC1;PTPN2;DUSP18
prerank,motor activity (GO:0003774),-0.22420937481353098,-0.8689459612597195,0.7032967032967034,0.9563398797129944,1.0,20/60,17.89%,STARD9;DYNC1I1;MYO6;KIF3C;MYL6;MYH9;KIF18A;KIFC3;KIF26A;KIFC2;KIF1A;KIF1C;KIF11;KIF5B;KIF26B;KIF15;KIF21B;DNAH3;GPR88;KIF27
prerank,cytokine receptor activity (GO:0004896),0.30933538907943664,0.8685482230747414,0.6865671641791045,0.921165117332495,1.0,8/83,8.47%,CMKLR1;F3;GHR;CNTFR;MPL;IL12RB2;IFNLR1;ACKR4
prerank,GTPase activator activity (GO:0005096),0.29355775948507096,0.8678062038108529,0.8485456369107321,0.9202441686494878,1.0,74/313,17.28%,SGSM2;PLCE1;SRGAP2;ARHGEF28;CYTH3;ARFGAP1;ARFGAP3;ASAP3;TIAM1;ARAP1;FARP1;NPRL3;DOCK4;RCC1L;ANKRD27;VAV2;TBC1D8B;TBC1D2B;SIPA1L1;SEC23A;FGD6;ARHGAP17;RABGEF1;RAB3GAP1;DENND6A;EPS8L1;CDC42EP2;LAMTOR1;RASGEF1B;RIC1;ARFGAP2;BCR;DOCK5;LLGL1;MON1A;PGAM5;ADAP1;KALRN;RGPD1;RGP1;MADD;RCC1;ARHGAP20;EVI5L;ARHGAP8;IQSEC2;NRP1;STXBP5;TBC1D9B;ARHGAP44;OCRL;GAPVD1;TBC1D25;WDR41;NUCB1;PREB;RANBP2;HPS4;TBCK;FARP2;TBC1D10A;SIPA1L3;AKAP13;SOS1;ARRB1;IQGAP1;TBC1D17;TAGAP;TBCD;EEF1B2;NF1;DIS3;NGEF;FLCN
prerank,rRNA binding (GO:0019843),0.33201631879173416,0.8666979679160718,0.674364896073903,0.9199830113366223,1.0,15/42,29.73%,RCC1L;RRS1;EMG1;PPAN;PTCD3;CAVIN1;CIRBP;SBDS;GTF3A;MRPS18A;RPS9;NOP53;MRPL11;RPF2;ERI1
prerank,epidermal growth factor receptor binding (GO:0005154),0.3614589549676272,0.8660875381875689,0.6317733990147784,0.9188386490797429,1.0,9/25,23.27%,SHC1;SNX2;AGR2;ARF4;SNX1;HIP1;CNOT9;ATXN2;SNX4
prerank,1-phosphatidylinositol binding (GO:0005545),-0.312038152091486,-0.8659769637514072,0.6533864541832669,0.9536879440826109,1.0,5/15,11.88%,EPB41;PICALM;ZFYVE9;SESTD1;SCARB1
prerank,actinin binding (GO:0042805),0.3693417971343009,0.8658497596666648,0.6452020202020202,0.9169720767217291,1.0,4/21,15.52%,CACNA1C;RARA;CSRP3;PKD2L1
prerank,cAMP response element binding (GO:0035497),-0.3556439660827832,-0.8658452232887797,0.6233333333333333,0.9447119053807089,1.0,1/10,0.38%,CREB5
prerank,calcium-activated potassium channel activity (GO:0015269),0.4187988320609827,0.8643315156197078,0.624103299856528,0.917295504222953,1.0,3/11,16.57%,KCNN1;PKD2L1;KCNN4
prerank,triglyceride lipase activity (GO:0004806),0.3819992266623792,0.8641390300430859,0.6489637305699482,0.9153371270097942,1.0,4/20,20.83%,CEL;PNPLA3;PLA2G15;DAGLB
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.358782817170589,0.8632828742765895,0.6695652173913044,0.9146509915156168,1.0,13/27,29.94%,POLR3H;CRCP;POLR2F;MED21;POLR3K;MED20;POLR1D;POLR1C;POLR2B;PRIMPOL;PRIM1;POLR2I;POLR2L
prerank,CoA hydrolase activity (GO:0016289),0.3925486433155069,0.8632451167439676,0.6688918558077437,0.912451544115454,1.0,5/16,27.11%,ACOT11;ACOT13;ABCD1;ACOT8;HIBCH
prerank,galactosyltransferase activity (GO:0008378),0.43210920776934747,0.8616426978981687,0.6714082503556188,0.9130249743866345,1.0,4/11,23.30%,B4GALT1;B4GALT5;B3GNT6;B4GALT7
prerank,acyl-CoA hydrolase activity (GO:0047617),0.3879551542414543,0.861532733766208,0.6568364611260054,0.9109755233653959,1.0,4/17,24.67%,ACOT11;ACOT13;ABCD1;ACOT8
prerank,GDP binding (GO:0019003),0.31384382895223323,0.8596380620138521,0.6987951807228916,0.9119448192112268,1.0,22/63,32.21%,MRAS;RAB2A;RAB21;RAB8A;RAB11B;RAB3B;RASL12;RAB5B;RHEB;RAB4A;RAB18;NRAS;KRAS;RAB5A;DIRAS1;RALA;RAB5C;MIEF1;RAB27B;RAP2C;ARL3;RAB12
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.340826423417478,0.8596255455684326,0.6862275449101797,0.9097397878092035,1.0,11/34,26.36%,STRADA;CALM2;CCNT2;IQGAP1;CALM3;DBF4;CKS1B;FAM20A;STK3;TAOK1;IGF2
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.3530534600721267,-0.8577739562276743,0.6234177215189873,0.9537729628727782,1.0,3/10,8.91%,DPP4;DPP10;DPP6
prerank,peptidase inhibitor activity (GO:0030414),0.3347135976875093,0.8538495383885816,0.6754176610978521,0.9176783876127061,1.0,8/33,24.22%,GPC3;TIMP2;CST3;RENBP;CAST;UCHL5;SIMC1;USP14
prerank,voltage-gated chloride channel activity (GO:0005247),-0.3487656197455038,-0.8538194680415901,0.6410256410256411,0.9532286184182991,1.0,2/10,8.49%,ANO1;ANO6
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.41947062153370973,0.8526297909152285,0.6671309192200557,0.9175793291778724,1.0,2/11,15.19%,SLC25A25;SLC35B3
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.3582257172353276,0.8521416016687654,0.6637717121588089,0.9161758401613745,1.0,4/23,9.26%,PLEKHA4;GBF1;WIPI2;SH3PXD2B
prerank,glycine binding (GO:0016594),0.41014552252966713,0.8508671502774414,0.6609686609686609,0.9160904088678739,1.0,4/11,20.40%,GRIN3A;SRR;GNMT;GLRB
prerank,lipase activity (GO:0016298),0.33028253695551135,0.8503782707678256,0.7072330654420207,0.9147210122099787,1.0,8/43,22.64%,MGLL;CEL;ABHD6;PNPLA3;PLA2G15;SEC23IP;DAGLB;ABHD12
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.33260280875528986,0.8502040121354156,0.6917562724014337,0.912837157193477,1.0,5/38,13.24%,SERPINH1;ANXA2;SERPINF1;SERPINB9;SERPINE2
prerank,metalloexopeptidase activity (GO:0008235),0.31999666883195893,0.8474592437823303,0.713961407491487,0.9152695270834672,1.0,18/51,24.74%,CPZ;CPQ;MMP14;XPNPEP1;AGBL5;AGBL3;MMP16;LNPEP;CPXM2;LAP3;NPEPPS;LVRN;CPB2;RNPEPL1;METAP1D;DPEP1;METAP2;VASH1
prerank,phosphatase activator activity (GO:0019211),0.3955707116520289,0.847421927969877,0.6577181208053692,0.9131317419637689,1.0,4/14,16.85%,CALM2;GTF2F1;PPP2R5C;CALM3
prerank,ribonuclease P RNA binding (GO:0033204),0.42549821986294495,0.8466984192706788,0.6779661016949152,0.9121210833784413,1.0,4/10,27.07%,RPP40;RPP14;RPP21;POP5
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.3116470146688513,0.845924096405382,0.7297592997811816,0.9112817904444422,1.0,24/69,27.39%,PLA2G4A;SOAT1;LPCAT4;LPCAT3;KAT6B;ZDHHC16;NAA16;HHAT;GLYAT;ZDHHC13;CREBBP;PLA2G15;LIPT1;ZDHHC20;ELP3;MCAT;KAT8;ZDHHC9;KAT2B;NMT1;CERS3;NAA15;ESCO1;SOAT2
prerank,GABA receptor binding (GO:0050811),-0.3368258229737132,-0.8451341250111503,0.6666666666666666,0.9637206403560865,1.0,4/11,16.55%,TRAK2;TRAK1;GABARAP;GABARAPL1
prerank,GTPase regulator activity (GO:0030695),0.2872075824113428,0.8431117014458326,0.8329979879275654,0.9138187773622654,1.0,46/212,16.39%,SLIT2;SGSM2;SRGAP2;ARFGAP1;ARFGAP3;ASAP3;ARAP1;NPRL3;TBC1D8B;GDI1;TBC1D2B;SIPA1L1;SEC23A;IPO5;ARHGAP17;RAB3GAP1;CDC42EP2;ARFGAP2;BCR;LLGL1;GPS1;PDE6D;PGAM5;ADAP1;RGPD1;ARHGAP20;EVI5L;ARHGAP8;NRP1;STXBP5;TBC1D9B;ARHGAP44;OCRL;TBC1D25;ARL2;PREB;RANBP2;TBCK;TBC1D10A;SIPA1L3;SOS1;ARRB1;IQGAP1;TBC1D17;TAGAP;TBCD
prerank,ribonuclease P activity (GO:0004526),0.4135086901853974,0.8430976547402589,0.6795048143053645,0.9116720076158656,1.0,5/11,30.83%,RPP40;RPP14;RPP21;POP5;PRORP
prerank,channel activity (GO:0015267),-0.2421411312431247,-0.8411911251768887,0.7482993197278912,0.9633025664303242,1.0,10/41,17.79%,BCL2;AQP11;TRPV2;CHRNB1;KCNK3;MCUB;TMEM120B;TRPV4;SLC14A1;TRPA1
prerank,muscle alpha-actinin binding (GO:0051371),0.38103478755351317,0.8399540013165631,0.6826265389876881,0.9146060124660522,1.0,3/15,15.52%,PDLIM7;PALLD;PKD2L1
prerank,ephrin receptor binding (GO:0046875),0.3578201600441913,0.8384077499394641,0.6961538461538461,0.915014272636347,1.0,7/21,19.61%,EFNA5;SHC1;CBL;ABL1;EFNA1;CRK;ANKS1B
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.4056574920315592,0.8375663330234109,0.6837725381414702,0.9142290470493167,1.0,2/12,6.77%,TENT4B;TENT5A
prerank,water transmembrane transporter activity (GO:0005372),0.4101472371212635,0.8368575765085655,0.6902017291066282,0.9131607236060848,1.0,1/11,5.65%,SLC4A11
prerank,snoRNA binding (GO:0030515),0.338425152379427,0.836063994901283,0.7045177045177046,0.9122866076026623,1.0,10/30,31.71%,TSR1;PRKDC;WDR3;BYSL;NOP56;TBL3;NOP58;DKC1;NOP10;NOP14
prerank,protein kinase A catalytic subunit binding (GO:0034236),-0.3133221912186492,-0.8343164946119084,0.6875,0.9685744892094202,1.0,3/13,6.41%,RYR2;PRKAR2B;PRKAR1B
prerank,double-stranded RNA binding (GO:0003725),0.3054520067186197,0.8343068870594993,0.7395498392282959,0.9130279550698083,1.0,12/70,14.08%,STRBP;SIDT2;MBNL1;PRKRA;ILF3;AGO1;DGCR8;EIF4A1;AGO2;HSPD1;SUPV3L1;CLTC
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.339293104503153,0.8327327196364759,0.713216957605985,0.9134603980607781,1.0,2/29,3.42%,CIT;SPRED2
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.3889035968098519,0.8325150747688462,0.6898395721925134,0.9116476833082842,1.0,4/13,17.91%,LPCAT1;GPAT4;PNPLA3;AGPAT5
prerank,AMP binding (GO:0016208),-0.33019808015825686,-0.8308627591823888,0.6877192982456141,0.9663538441406503,1.0,3/11,8.80%,PRKAG2;ACSS2;PRKAG3
prerank,SH2 domain binding (GO:0042169),0.33893809083135246,0.8304981818272631,0.6955475330926595,0.9127945374748105,1.0,5/31,14.33%,IRS1;SH3PXD2B;ABL1;KHDRBS1;SQSTM1
prerank,WW domain binding (GO:0050699),0.3429499878033571,0.8268877573208144,0.7194066749072929,0.9164470835098434,1.0,5/26,18.25%,PMEPA1;SCNN1A;NFE2;PRRG4;KIF20B
prerank,death domain binding (GO:0070513),-0.329056882301985,-0.8245512047770479,0.6525974025974026,0.9708791124312303,1.0,3/11,8.65%,BCL2;BCL2L1;DAPL1
prerank,peptide N-acetyltransferase activity (GO:0034212),0.4080050543373336,0.8221945779058366,0.6802919708029197,0.921554934763809,1.0,5/10,33.33%,NAA60;NAA16;NAA15;NAA25;NAA20
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.36982313287255497,0.8189336648144687,0.6906005221932114,0.9245053109777869,1.0,10/16,33.90%,MTMR11;SYNJ1;MTMR10;MTMR1;MTM1;SACM1L;MTMR2;MTMR12;MTMR9;MTMR4
prerank,monocarboxylic acid binding (GO:0033293),0.3594514530012796,0.8161030167268163,0.6998689384010485,0.9267649092062635,1.0,3/18,8.81%,RXRA;RARA;AKR1C1
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.2937341210714156,0.81555935111918,0.7750533049040512,0.9254392466596645,1.0,8/73,13.11%,GALR1;NPR3;FSHR;EDNRA;FPR3;GLP1R;F2R;MC4R
prerank,endodeoxyribonuclease activity (GO:0004520),0.3537044692310861,0.8153018174518718,0.7127937336814621,0.9237115757228088,1.0,11/20,36.82%,ERCC5;RBBP8;ERCC4;RAD50;ENDOV;ZRANB3;MBD4;ERCC1;MRE11;APLF;EXOG
prerank,UDP-galactosyltransferase activity (GO:0035250),0.40546376377268867,0.8125882391463807,0.7062146892655368,0.9257213210301897,1.0,2/10,9.01%,B4GALT1;B4GALT5
prerank,RNA stem-loop binding (GO:0035613),-0.3080460826874516,-0.8123710779712197,0.6690391459074733,0.9858180314429362,1.0,3/12,9.59%,MYH10;DDX3X;ZC3H12A
prerank,kinase activator activity (GO:0019209),0.32503765869770207,0.8105089690914902,0.7210965435041716,0.9266670943033153,1.0,8/30,26.38%,FGF13;STRADA;MADD;WNK1;DUSP19;RPTOR;DAXX;WNT11
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.3466790321403759,0.8078380811721876,0.7367088607594937,0.9286632265058153,1.0,2/23,3.20%,PLCE1;EDNRA
prerank,voltage-gated cation channel activity (GO:0022843),0.2884182369186111,0.8076286934086301,0.8111814345991561,0.9268299757695676,1.0,11/97,12.85%,CACNA1C;KCNB1;GRIN3A;HCN4;CACHD1;KCNE5;KCND1;CATSPER3;ITGAV;CACNA2D2;KCNG3
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.29432452044535334,0.8048752047332812,0.786096256684492,0.9288791207762862,1.0,15/74,16.06%,PAPSS2;PIK3C2B;NADK;SHPK;HYKK;FCSK;DGKQ;ETNK1;PANK4;DCAKD;PIK3CB;ADPGK;CLP1;CHKB;PI4KB
prerank,U6 snRNA binding (GO:0017070),0.3726320764805855,0.804248382917714,0.7164179104477612,0.9277008504781545,1.0,5/14,25.11%,METTL16;LSM2;RBM22;LARP7;DDX39B
prerank,cyclin-dependent protein kinase activity (GO:0097472),-0.26306705792065627,-0.8039750082193194,0.782051282051282,0.9843672754257359,1.0,5/21,10.51%,CDK6;CDK14;CDK19;CDK15;CDK8
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),-0.26306705792065627,-0.8039750082193194,0.782051282051282,0.9843672754257359,1.0,5/21,10.51%,CDK6;CDK14;CDK19;CDK15;CDK8
prerank,alpha-tubulin binding (GO:0043014),0.3243625256950929,0.8038608665124962,0.7442977190876351,0.9262438536721161,1.0,10/31,27.26%,TBCE;BEX4;SPAST;TRAPPC14;HDAC6;DIP2B;SETD2;TAOK1;DNAL1;EFHC1
prerank,phospholipase binding (GO:0043274),-0.3061544232642655,-0.8022669544021961,0.7357142857142858,0.9787212432075567,1.0,1/13,0.73%,ARHGAP6
prerank,ubiquitin conjugating enzyme binding (GO:0031624),0.3275578687516427,0.8014053064840111,0.7543640897755611,0.9278775480100578,1.0,4/27,12.60%,RNF144A;DCUN1D5;RNF14;DCUN1D2
prerank,active ion transmembrane transporter activity (GO:0022853),0.31581539094414934,0.799991943651024,0.7502903600464577,0.9278250268660826,1.0,3/37,5.65%,SLCO3A1;SLCO2A1;SLC4A11
prerank,single-stranded DNA helicase activity (GO:0017116),0.34335521582163037,0.7986790611315097,0.7159235668789808,0.9277264541299062,1.0,2/19,7.92%,HELB;MCM2
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.3803012672044098,0.797351407946084,0.7250673854447439,0.9276371182635136,1.0,2/13,8.19%,GDI1;GDI2
prerank,steroid hydroxylase activity (GO:0008395),-0.27810081789546376,-0.7948965217839148,0.7450980392156863,0.9836549883672667,1.0,2/16,5.32%,CYP7B1;CYP27A1
prerank,MAP-kinase scaffold activity (GO:0005078),0.3852503009000837,0.792652966613891,0.7438356164383562,0.9321913301937482,1.0,7/11,25.15%,AKAP13;IQGAP1;SPAG9;DUSP19;SH3RF1;MAPK8IP3;MAPK8IP1
prerank,PDZ domain binding (GO:0030165),0.2898068321269913,0.7908405206078709,0.801980198019802,0.9326507738225441,1.0,9/61,9.50%,CIT;CRIM1;DOCK4;SLC26A6;ERC1;KIDINS220;FZD7;DLG4;NSF
prerank,actin binding (GO:0003779),0.27343275907053055,0.7906283814760724,0.8767676767676768,0.9308755449856717,1.0,26/170,13.38%,MICAL2;FXYD5;MAP1B;GSN;P4HB;PRKCE;RDX;PDLIM7;LIMA1;COBL;TNNT3;ADCY8;SPATA32;DMD;EPS8L1;PFN2;SLC6A2;GIPC1;ABL1;TLNRD1;EZR;BCL7B;CAP1;PARVA;ADD1;PFN4
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),-0.25100300871162634,-0.7868734432388262,0.8333333333333334,0.9891476731653108,1.0,5/24,9.79%,OSBPL8;PLEKHA5;CERT1;SESTD1;LANCL2
prerank,neuropeptide hormone activity (GO:0005184),0.33349323988273427,0.7864660020030988,0.7252195734002509,0.9348953841783164,1.0,7/22,33.66%,VIP;AGRP;PENK;NMB;SPX;HCRT;NPFF
prerank,peptidoglycan binding (GO:0042834),0.3818579072972096,0.786290279118593,0.7398255813953488,0.9330991137824886,1.0,1/10,4.60%,RNASE7
prerank,phosphatase activity (GO:0016791),0.2829523851466702,0.7853197054777754,0.8276231263383298,0.9324196974354956,1.0,8/73,8.39%,ALPL;PLPP3;PPP1CC;PLPP5;DUSP11;PLPP1;PGAM5;NANP
prerank,tau-protein kinase activity (GO:0050321),0.3360256032750973,0.7824358676731956,0.7683397683397684,0.9343698605380967,1.0,7/20,28.21%,MARK1;MARK4;CDK5;ROCK1;TAOK2;TAOK1;TTBK2
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.3680791424843902,0.7819180134376184,0.7547945205479452,0.9330446117671416,1.0,4/14,26.01%,DHRS9;AKR1A1;DHRS3;RDH10
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.3379945941345228,0.7817592216992244,0.7319587628865979,0.9311991249084423,1.0,8/21,24.92%,PRRC1;EZR;AKAP9;GSKIP;AKAP8;PRKACA;ARFGEF2;ACBD3
prerank,purinergic nucleotide receptor activity (GO:0001614),-0.2844683665280071,-0.7812697609689122,0.7647058823529411,0.990427473930352,1.0,11/15,42.17%,P2RY14;GPR34;P2RY1;P2RX7;P2RX5;P2RX3;GPR171;P2RX1;GPR87;P2RY13;P2RX6
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),-0.20291217793068284,-0.7801286239395959,0.9042553191489362,0.9839539815671043,1.0,17/57,24.70%,COX8A;NDUFC2;COX4I1;UQCR11;COX10;NDUFA13;NDUFB2;NDUFB7;COX5B;UQCRC1;NDUFS1;NDUFA4L2;NDUFA8;UQCRQ;NDUFS6;NDUFA4;CYB561D2
prerank,exopeptidase activity (GO:0008238),-0.20566557701149885,-0.7789616773004218,0.8770491803278688,0.9773568214876254,1.0,9/50,12.56%,DPP4;DPP10;CPM;ENPEP;TRHDE;ACE;DPP6;ACE2;GGH
prerank,protein phosphatase regulator activity (GO:0019888),0.2945069916566252,0.7764505789185946,0.8064876957494407,0.9365057846330614,1.0,23/53,29.05%,PPP1R9B;CALM2;PPP6R1;PPP6R3;RCAN1;CABIN1;SHOC2;DMPK;PPP2R2D;ARPP19;PPP2R5C;CALM3;PPP6R2;SAG;RCAN3;PPP1R7;BOD1L1;LMTK2;MGAT5;PPP2R1A;PPME1;B3GAT3;PPP2R1B
prerank,ubiquitin-dependent protein binding (GO:0140036),0.38274502652770326,0.7737992935040512,0.7340116279069767,0.938080171360097,1.0,3/10,22.10%,FAAP20;IDE;DNAJC2
prerank,calcium activated cation channel activity (GO:0005227),0.33859341431279866,0.77324091164948,0.734640522875817,0.9368076427507922,1.0,4/17,16.57%,KCNN1;TRPM4;PKD2L1;KCNN4
prerank,carboxypeptidase activity (GO:0004180),-0.22384727909295,-0.771048750716958,0.8547486033519553,0.982432971157078,1.0,3/35,3.51%,AEBP1;CPM;AGBL4
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.3093158738112256,0.7709714300810595,0.7866831072749692,0.9377397999404279,1.0,6/34,17.07%,ERI3;REXO2;DIS3L2;EXOSC4;CNOT8;DIS3
prerank,microtubule motor activity (GO:0003777),-0.20802266995262228,-0.770643463329438,0.9130434782608695,0.9748374287503839,1.0,15/51,16.13%,STARD9;DYNC1I1;KIF3C;KIF18A;KIFC3;KIF26A;KIFC2;KIF1A;KIF1C;KIF11;KIF5B;KIF26B;KIF15;KIF21B;DNAH3
prerank,palmitoyltransferase activity (GO:0016409),-0.23273068858456147,-0.7705856441499175,0.8662790697674418,0.9668246905840454,1.0,13/28,28.06%,ZDHHC14;GLUL;ZDHHC18;ZDHHC3;ZDHHC2;ZDHHC23;ZDHHC12;ZDHHC21;ZDHHC7;ZDHHC6;GOLGA7B;ZDHHC24;ZDHHC22
prerank,poly(A)-specific ribonuclease activity (GO:0004535),-0.30204368887325517,-0.769404941721506,0.8026315789473685,0.9606710563451223,1.0,3/12,13.07%,CNOT1;NOCT;CNOT6L
prerank,NAD+ binding (GO:0070403),0.3619245254682554,0.7674206754210156,0.7647867950481431,0.9402993307601895,1.0,3/12,15.49%,SIRT5;SIRT2;CRYL1
prerank,beta-tubulin binding (GO:0048487),0.30860174302364274,0.7665848569305306,0.7946210268948656,0.9393430638235437,1.0,4/31,9.94%,FGF13;BCAS3;SMC3;SPAST
prerank,CXCR chemokine receptor binding (GO:0045236),0.3693824022898736,0.7642474326903671,0.7813884785819794,0.940427229250317,1.0,2/11,10.99%,ITCH;YARS1
prerank,protein heterodimerization activity (GO:0046982),0.26024035229753173,0.7638421664638033,0.9207317073170732,0.9389111988398917,1.0,28/178,14.26%,EXT1;KCNB1;ATP1B1;P4HB;SNX2;CD3E;ATF4;ADCY8;BHLHE40;IRAK3;SMC3;SNX1;CHUK;IRAK1;RCC1;BCL2L2;NEUROD2;AOC3;TENM1;MICU2;HEXA;ADD1;PAFAH1B2;NPAS1;MEF2A;YWHAE;NOLC1;MICU1
prerank,exonuclease activity (GO:0004527),0.2878708470081043,0.7598703038948341,0.8183856502242153,0.9421122361786445,1.0,9/46,16.07%,REV3L;REXO2;RAD1;WRN;REXO1;RAD50;DCLRE1B;EXOSC4;AEN
prerank,cardiolipin binding (GO:1901612),0.36889882859048506,0.7568387194582463,0.7641921397379913,0.9439345704626964,1.0,4/10,30.99%,GSDME;UQCC3;STOML2;PLEKHN1
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.3435296121142254,0.756680306077161,0.7906371911573472,0.9421449800325465,1.0,4/15,17.91%,LPCAT1;GPAT4;PNPLA3;AGPAT5
prerank,protein tyrosine kinase binding (GO:1990782),0.2776258032347551,0.7555662522977513,0.8483206933911159,0.9415667402360807,1.0,12/71,14.33%,GAS6;DOCK4;PRR7;SHC1;PITPNM1;ACVR1;NOX4;CBL;ANGPT4;KHDRBS1;PTPN2;SQSTM1
prerank,P-type ion transporter activity (GO:0015662),-0.2905113137012678,-0.7542879627134403,0.8006042296072508,0.976146386172757,1.0,2/12,8.72%,ATP2B1;ATP2A3
prerank,glucose transmembrane transporter activity (GO:0005355),0.3321459023251265,0.7476348221516456,0.7837116154873164,0.9494619549829892,1.0,3/17,17.10%,SLC5A2;SLC2A2;SLC2A10
prerank,neuropeptide receptor binding (GO:0071855),0.3473673294226517,0.7472394855467376,0.7771664374140302,0.9479481468650854,1.0,2/14,12.25%,SHANK1;AGRP
prerank,tubulin binding (GO:0015631),0.2535477509154889,0.7470696994357121,0.964,0.9461172093909119,1.0,67/295,22.75%,MAP7D3;FGF13;MAP1B;CFAP157;STMND1;KIF13A;TBCE;TTLL2;MID1;RAE1;TUBGCP3;BCAS3;DNM2;BLOC1S2;GPAA1;SYBU;ALMS1;NDRG1;BEX4;SMC3;AGBL5;TPGS1;SPAST;MTUS1;MACO1;EML3;CKAP5;CCDC66;GIT1;RAB11FIP5;RCC2;MID2;EZR;CHP1;TRAPPC14;MAPRE3;REEP3;MARK4;NDEL1;RMDN1;HDAC6;TBCD;VBP1;POLB;DIP2B;KIF20B;KATNA1;BIRC5;MAST2;KIF6;KIF1B;CDK5;DLGAP5;APPL1;DCTN1;CCDC61;STMN2;CLIP2;KIF21A;RITA1;CRIPT;SBDS;LRRK2;CDK5RAP2;SETD2;PEX14;CAPN6
prerank,nucleotide diphosphatase activity (GO:0004551),-0.27664740745219835,-0.7457432492286149,0.7832699619771863,0.9805663398118442,1.0,5/14,19.19%,ENPP1;NUDT4;CILP;NUDT12;CILP2
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.29148398369756345,-0.7450387910666171,0.8007246376811594,0.9740437183049545,1.0,4/12,13.23%,GABRB1;GABRB3;GABRB2;GABRA5
prerank,extracellular ligand-gated ion channel activity (GO:0005230),0.3671271647668201,0.7425105317891669,0.7801418439716312,0.9496118266223416,1.0,1/10,5.17%,GABRA3
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),0.34628457655145384,0.7411272689090305,0.7891816920943134,0.9492089264538052,1.0,4/13,15.88%,PIK3C2B;PIP4K2B;PIK3CB;PIP5K1A
prerank,phospholipase C activity (GO:0004629),0.31338214469982023,0.740374405227842,0.8045112781954887,0.9481688703729376,1.0,2/25,3.20%,PLCE1;EDNRA
prerank,GABA-A receptor activity (GO:0004890),-0.2529806324139763,-0.737104881199972,0.8418803418803419,0.9774518579628962,1.0,4/18,13.23%,GABRB1;GABRB3;GABRB2;GABRA5
prerank,microtubule binding (GO:0008017),0.25262644935843165,0.7370358581101303,0.959718026183283,0.9501510085687965,1.0,51/222,22.75%,MAP7D3;FGF13;MAP1B;CFAP157;KIF13A;MID1;RAE1;CLIP4;TUBGCP3;DNM2;SYBU;ALMS1;NDRG1;STIM1;TPGS1;SPAST;MTUS1;MACO1;EML3;CKAP5;CCDC66;RCC2;MID2;EZR;CHP1;MAPRE3;REEP3;MARK4;NDEL1;RMDN1;HDAC6;POLB;KIF20B;KATNA1;BIRC5;MAST2;KIF6;KIF1B;CDK5;DLGAP5;DCTN1;CCDC61;CLIP2;KIF21A;CRIPT;SBDS;LRRK2;CDK5RAP2;CAMSAP3;PEX14;CAPN6
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),-0.2889138836685652,-0.7357737417610889,0.832089552238806,0.9716403016023891,1.0,3/12,10.51%,CDK6;CDK19;CDK8
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.3289680539483894,0.7347898549387064,0.8063660477453581,0.9508277025081499,1.0,2/15,9.26%,PLA2G4A;SH3PXD2B
prerank,calcium:sodium antiporter activity (GO:0005432),0.3678241221461238,0.7344261990768118,0.7854077253218884,0.9493352670939026,1.0,1/10,1.39%,SLC24A3
prerank,mRNA 5'-UTR binding (GO:0048027),-0.23335688555080403,-0.7341156381088104,0.8541666666666666,0.9662753832425256,1.0,5/24,10.34%,RPS14;MYH10;DDX3X;RPL26;RPS7
prerank,ribosomal small subunit binding (GO:0043024),-0.25738090717072837,-0.728300429793595,0.859504132231405,0.9662651194622477,1.0,2/17,5.11%,CPEB2;DDX3X
prerank,syntaxin-1 binding (GO:0017075),0.3077241433374417,0.7271560015848887,0.8145363408521303,0.9558029981437893,1.0,4/22,12.59%,UNC13B;PRRT2;NSF;STXBP5
prerank,retinoic acid receptor binding (GO:0042974),0.3213218296422473,0.727131368261307,0.8130841121495327,0.9538343203841664,1.0,5/17,17.76%,NRIP1;NSD1;MED25;VDR;HMGA1
prerank,mRNA 3'-UTR binding (GO:0003730),0.2630762664301781,0.7260031298948402,0.8775510204081632,0.9531314983143829,1.0,28/79,29.94%,DDX5;YBX3;PABPC1;PUM1;CRYZ;HNRNPA2B1;ILF3;PCBP4;DAZAP1;AUH;RBM4;HNRNPC;EXOSC4;SECISBP2;CIRBP;FXR2;RNF20;HNRNPU;TP53;RBM24;PABPC4;RPL41;CCT5;FXR1;LARP1;PUM2;ZFP36L1;KHSRP
prerank,alanine transmembrane transporter activity (GO:0022858),0.3481360152330203,0.7217988343456245,0.8027586206896552,0.9559187805672789,1.0,4/12,23.41%,SLC38A3;SLC1A4;SLC3A2;SLC36A1
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.35404649794512977,0.7211166139476631,0.8245125348189415,0.9546597164167078,1.0,2/12,15.19%,SLC25A25;SLC35B3
prerank,histone acetyltransferase binding (GO:0035035),0.31086729811982017,0.721101729701616,0.8177083333333334,0.9527076352474111,1.0,7/21,24.29%,BCAS3;MEF2A;SIRT2;CITED2;KANSL1;GLI3;TP53
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.2857392676809987,0.7210012479141348,0.8518072289156626,0.9508468924849075,1.0,4/33,12.60%,RNF144A;DCUN1D5;RNF14;DCUN1D2
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.3329271168654352,0.7174164904622609,0.8016304347826086,0.9527401633802057,1.0,2/14,11.53%,NOX4;AIFM1
prerank,protein phosphatase 2A binding (GO:0051721),0.30362204763491596,0.7079620632362177,0.8557336621454994,0.9612451975410362,1.0,3/23,7.41%,GRIN3A;ADCY8;STRN4
prerank,pentosyltransferase activity (GO:0016763),0.2778396617752885,0.7054282951055241,0.8628370457209847,0.9620030216392209,1.0,7/36,16.21%,PARP3;SIRT5;QPRT;UPP2;TNKS2;SIRT2;PARP1
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",-0.25245152777333757,-0.6989074513226762,0.8622222222222222,0.9927437145658667,1.0,9/16,28.46%,CD38;MACROD2;SARM1;NEIL1;NEIL3;RPS3;OARD1;NEIL2;MACROD1
prerank,ATP hydrolysis activity (GO:0140603),0.26836572204788817,0.6981067905338992,0.8754406580493537,0.9679055908063235,1.0,10/41,23.28%,CHD1L;VCP;CHD3;MYO1E;ABCB6;VWA8;KIF20B;CLU;ABCD1;ABCB10
prerank,protein phosphatase activator activity (GO:0072542),0.3305010134131091,0.6980112195366399,0.8060522696011004,0.9660006477774735,1.0,3/13,16.85%,CALM2;PPP2R5C;CALM3
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.29242739303582416,0.6973407733761627,0.8691232528589581,0.9647937363055884,1.0,6/25,20.17%,PLEKHA4;GAB2;DAPP1;HIP1;AKT1;MAPKAP1
prerank,neuropeptide receptor activity (GO:0008188),0.2819773850182429,0.6960124272563858,0.8734793187347932,0.9642205243050943,1.0,1/29,1.83%,GALR1
prerank,hormone activity (GO:0005179),0.2579533693084063,0.6946272534988077,0.8971238938053098,0.9636916054648496,1.0,5/54,13.03%,INSL6;EDN3;VIP;AGRP;INHBA
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",-0.24182286362091282,-0.6946231827253242,0.8859315589353612,0.9897581760334573,1.0,1/16,1.69%,PIR
prerank,fatty acid synthase activity (GO:0004312),0.34463371501649165,0.6890526385788105,0.856093979441997,0.9674468458576254,1.0,4/10,27.15%,ELOVL5;CBR4;MCAT;ELOVL1
prerank,proton transmembrane transporter activity (GO:0015078),0.2671546588441035,0.6875671679417745,0.8807870370370371,0.966947382871803,1.0,5/39,13.39%,SLC4A11;SLC9A1;CLCN4;NNT;ATP6V1B2
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.3399242218320967,0.6861530942379356,0.861731843575419,0.96634465586268,1.0,4/10,23.23%,OTUD5;YOD1;DESI2;CYLD
prerank,amyloid-beta binding (GO:0001540),0.24699582683211882,0.6860176512996589,0.9237379162191193,0.9645430318054817,1.0,10/79,10.64%,LRP1;EPHB2;APBB3;LRPAP1;TGFB2;FZD5;IAPP;CST3;BACE1;COL25A1
prerank,FMN binding (GO:0010181),-0.26437765182191914,-0.6839043898258746,0.8850174216027874,0.993285547421955,1.0,7/11,33.41%,NOS3;NOS1;PNPO;NDOR1;NOS2;POR;HAO1
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.28102166027886044,0.6828894807354265,0.8767123287671232,0.9655243379572199,1.0,6/26,22.07%,CHPF2;B3GNT7;B3GNT9;B3GNT6;B4GALNT3;B3GNT2
prerank,translation elongation factor activity (GO:0003746),0.31559175563029385,0.6780424210270664,0.8418918918918918,0.9682964724016723,1.0,5/14,23.97%,EEF1B2;TUFM;EEFSEC;GTPBP2;EIF5A2
prerank,G protein-coupled receptor activity (GO:0004930),0.22917538757825223,0.677930990200119,0.9889669007021064,0.9664761381364986,1.0,9/239,2.76%,CMKLR1;PDGFRL;GPR27;GALR1;NPR3;GNRHR;DRD1;FSHR;ADGRL2
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.3296775937500618,0.674244945249811,0.8705234159779615,0.9680986387473298,1.0,5/11,27.37%,PPEF2;DUSP19;TCF3;STK38;MAP3K11
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.2555546343773393,0.6688430184252078,0.9124423963133641,0.9712435683082484,1.0,6/42,14.29%,CCNL2;CCNL1;CCNT2;CCNG2;CCNE2;HEXIM1
prerank,hexosaminidase activity (GO:0015929),-0.26363668733042733,-0.6673797878830061,0.8677966101694915,1.0,1.0,3/12,16.11%,CEMIP;CEMIP2;HYAL2
prerank,MAP kinase activity (GO:0004707),0.3047356294589784,0.665254786437428,0.8672199170124482,0.9727757077516713,1.0,3/14,11.43%,MAPK15;MAPK8;MAPK12
prerank,ion channel inhibitor activity (GO:0008200),0.2632557080160646,0.6649090475696424,0.9068100358422939,0.9711935600428232,1.0,3/35,5.06%,NEDD4;CAMK2D;CALM2
prerank,acetylcholine receptor activity (GO:0015464),0.28412083960871426,0.6644899510772275,0.8759305210918115,0.9696410899814806,1.0,2/22,8.43%,CHRNB2;CHRNA5
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",0.3237303517671869,0.66441166810502,0.8742857142857143,0.9678046351889402,1.0,8/11,34.34%,PIGF;PTDSS1;PTDSS2;SGMS2;PIGN;GNPTAB;PIGO;SAMD8
prerank,adenylyltransferase activity (GO:0070566),0.286011238631841,0.6616673280067769,0.8668373879641486,0.9683520564455784,1.0,9/21,33.10%,TENT4B;ABL1;NMNAT3;NMNAT2;TENT2;SELENOO;NMNAT1;PAPOLG;COASY
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.28813373492349537,0.6587164407494027,0.9057788944723618,0.9688856857715088,1.0,5/20,17.91%,LPCAT1;GPAT4;PNPLA3;PLA2G15;AGPAT5
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.27051034520585715,0.6556290760165696,0.9134615384615384,0.969661109528401,1.0,7/28,27.07%,AGO2;RPP40;ELAC2;RPP14;ENDOV;RPP21;POP5
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.32100031044277794,0.6530392623579317,0.8804500703234881,0.9699756441679974,1.0,1/10,6.00%,NOX4
prerank,single-stranded telomeric DNA binding (GO:0043047),0.31203262126673026,0.64917666023494,0.8733812949640288,0.9712819030743082,1.0,3/11,21.87%,HNRNPA2B1;RAD50;HNRNPA1
prerank,bHLH transcription factor binding (GO:0043425),0.28533006389513793,0.6476494499911565,0.8823529411764706,0.9707030155442428,1.0,5/19,19.78%,TWIST1;BHLHE40;MAP3K10;CREBBP;TCF3
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.28811266863202595,0.6470159057385119,0.8857509627727856,0.9693082298401736,1.0,6/18,25.23%,ANXA2;PAK4;ANXA1;CNN3;BAIAP2L1;S100A11
prerank,methyl-CpG binding (GO:0008327),-0.21420499677950988,-0.6448718103117994,0.9642857142857143,1.0,1.0,5/22,14.61%,MBD2;CXXC4;TET1;ERH;CXXC5
prerank,thioesterase binding (GO:0031996),-0.24972615149516536,-0.6438565399029917,0.922077922077922,1.0,1.0,4/11,22.57%,ADRA2A;CDC42;TRAF2;TRAF1
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.3059621851444065,0.642777196983398,0.8850415512465374,0.9708324305250657,1.0,4/12,24.96%,CASP1;BAD;RPS27L;BCL2L13
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.2378764155195965,0.6379048724206562,0.9464285714285714,0.9727658532293427,1.0,7/60,8.99%,PPP1CC;PPP1R3C;PHLPP2;CDC14A;PPM1H;PGAM5;PPM1M
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.29495467843391987,0.636102524934512,0.8937931034482759,0.9723432375729782,1.0,6/14,24.48%,ALDH1L2;MTHFD1;NOXRED1;MTHFR;PYCR1;CRYM
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.27714265512110653,0.6360580118605251,0.8924870466321243,0.9705082329222472,1.0,2/21,8.43%,CHRNB2;CHRNA5
prerank,glycerophospholipid flippase activity (GO:0140333),0.30377090991029,0.6259984747041727,0.8914616497829233,0.9759783394363075,1.0,2/11,9.19%,ATP8B2;ATP8A1
prerank,GABA receptor activity (GO:0016917),-0.2050783558801175,-0.6248196806324826,0.9759615384615384,1.0,1.0,4/21,13.23%,GABRB1;GABRB3;GABRB2;GABRA5
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.27793586286019284,0.6216287813975907,0.9057377049180327,0.9773098479089236,1.0,8/17,35.47%,AKR1C1;BDH2;SRD5A3;MECR;DECR2;TM7SF2;TECR;BLVRA
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.25565924160859965,0.6195865311162414,0.9290953545232273,0.9769063757671094,1.0,5/25,16.21%,PARP3;SIRT5;TNKS2;SIRT2;PARP1
prerank,protein phosphatase inhibitor activity (GO:0004864),0.25873181870751044,0.6190728053470235,0.9155107187894073,0.9753584691864694,1.0,10/26,29.27%,PPP1R9B;PPP1R8;CABIN1;ARPP19;SAG;BOD1L1;LMTK2;MGAT5;PPME1;PABIR1
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),-0.19108298951975342,-0.6175845367982679,0.9888888888888889,1.0,1.0,9/28,25.93%,STAT1;BABAM2;EDA;TRAP1;MYD88;TRAF2;TRAF1;FADD;FEM1B
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.2935182833263902,0.6161958992204812,0.9132791327913279,0.9755151881922272,1.0,8/12,36.40%,HDAC1;TBP;FOS;TAF1;H3-3A;RELA;RUVBL2;POU2F1
prerank,chloride channel regulator activity (GO:0017081),0.2826379201168563,0.6139214577015716,0.9171122994652406,0.9752041180701774,1.0,5/14,26.58%,WNK1;STX1A;SGK3;VTI1B;SGK1
prerank,MAP kinase kinase activity (GO:0004708),-0.23083316153480105,-0.6068950282296548,0.9256505576208178,1.0,1.0,2/15,6.05%,MAP2K6;PAK3
prerank,mitogen-activated protein kinase binding (GO:0051019),0.2444508638484903,0.600983762807034,0.9376528117359413,0.9815991526205995,1.0,4/29,10.59%,NBR1;CDK5RAP3;NFATC1;ABL1
prerank,MHC class I protein binding (GO:0042288),-0.2293157564344005,-0.5991130357261075,0.9537366548042705,1.0,1.0,13/13,77.09%,ATP5F1B;TAP1;CD8B;ATP5F1A;ABCB9;TUBB;PILRA;CD8A;TAPBP;TAP2;LILRB1;TUBB4B;DERL1
prerank,chloride channel inhibitor activity (GO:0019869),-0.23713782078423887,-0.5911236779233989,0.9366666666666666,1.0,1.0,3/10,14.72%,WNK2;WNK4;CFTR
prerank,ribosomal large subunit binding (GO:0043023),0.281048996527687,0.5890419092463094,0.9117221418234442,0.9868588463075079,1.0,4/11,24.95%,LTN1;EIF6;CPSF6;RBM3
prerank,microtubule plus-end binding (GO:0051010),0.2582626307161323,0.5875836740435104,0.9335071707953064,0.9858068464875166,1.0,5/20,20.75%,CLIP4;STIM1;MAPRE3;DCTN1;CLIP2
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.2882303580512109,0.5873426021608585,0.927038626609442,0.9840708515215726,1.0,3/10,25.58%,FAAP20;IDE;DAXX
prerank,peptidase activator activity (GO:0016504),0.2490565116887848,0.5807980280730943,0.9457755359394704,0.9858513606516003,1.0,4/22,16.38%,VCP;PCOLCE;TANK;PSMD14
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.2782117743958826,0.5735124940826765,0.9217638691322901,0.9878765707139168,1.0,2/11,22.12%,SLC25A47;SLC22A3
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),-0.16548166138366138,-0.5706327208425797,0.9863945578231292,0.9976455145478529,1.0,33/34,72.68%,NDUFC2;NDUFA13;NDUFB2;NDUFB7;NDUFS1;NDUFA8;NDUFS6;NDUFA4;NDUFA2;NDUFA12;NDUFC1;NDUFB4;NDUFV1;NDUFS5;NDUFB8;NDUFS4;NDUFA5;NDUFA3;NDUFS2;NDUFS8;NDUFB5;NDUFB3;NDUFS3;NDUFB10;NDUFA10;NDUFA9;NDUFV3;NDUFA6;NDUFV2;NDUFB9;NDUFA7;NDUFA1;NDUFB6
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),-0.16548166138366138,-0.5706327208425797,0.9863945578231292,0.9976455145478529,1.0,33/34,72.68%,NDUFC2;NDUFA13;NDUFB2;NDUFB7;NDUFS1;NDUFA8;NDUFS6;NDUFA4;NDUFA2;NDUFA12;NDUFC1;NDUFB4;NDUFV1;NDUFS5;NDUFB8;NDUFS4;NDUFA5;NDUFA3;NDUFS2;NDUFS8;NDUFB5;NDUFB3;NDUFS3;NDUFB10;NDUFA10;NDUFA9;NDUFV3;NDUFA6;NDUFV2;NDUFB9;NDUFA7;NDUFA1;NDUFB6
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",-0.2120527306967985,-0.5601644022041915,0.9772727272727273,0.9949058609868116,1.0,13/13,78.82%,DNA2;DNASE1L1;EXO1;FEN1;GEN1;DNASE1;DNASE1L3;DICER1;ZGRF1;FAN1;DNASE1L2;SLX4;ENDOV
prerank,voltage-gated anion channel activity (GO:0008308),0.25099589017133306,0.5530843429047779,0.9544846050870147,0.995067593949158,1.0,2/15,11.05%,CLCN4;VDAC2
prerank,C-C chemokine binding (GO:0019957),-0.18048428293532398,-0.5465560085426847,0.9956896551724138,0.9930354533091825,1.0,3/22,12.05%,CCR9;CX3CR1;ZFP36
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.26228728124097567,0.5453243333481153,0.9452247191011236,0.9963015195818583,1.0,1/11,8.40%,DDAH1
prerank,phosphate ion binding (GO:0042301),-0.22265625400311911,-0.5403835229557642,0.9654088050314465,0.9883565120520915,1.0,2/10,14.86%,PDE2A;ADSS1
prerank,microtubule minus-end binding (GO:0051011),0.25672173545679594,0.5401956635766618,0.9547945205479452,0.9963899986569377,1.0,1/13,5.07%,TUBGCP3
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),0.2480538787888548,0.5307486385979844,0.9728260869565217,0.9978866920738639,1.0,3/13,24.14%,GABRA3;GLRB;GABRE
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),-0.19782528554816137,-0.5173102530887053,0.9785714285714285,0.9879277697570319,1.0,6/11,27.12%,NEIL1;NEIL3;RPS3;HMGA2;NEIL2;APEX1
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.2504705509184606,0.5089228199397997,0.9683453237410072,1.0,1.0,7/10,41.89%,CASP1;CASP2;CASP6;CASP7;CASP8;CASP12;CFLAR
prerank,RNA methyltransferase activity (GO:0008173),0.21917052896256373,0.5043587967627436,0.9832689832689833,1.0,1.0,6/19,35.07%,TYW3;FBL;METTL8;MEPCE;TGS1;MRM2
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),0.22319541673348064,0.48156130805127345,0.986468200270636,1.0,1.0,4/14,24.96%,CASP1;BAD;RPS27L;BCL2L13
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.19587506969449717,0.47876031964649646,0.992583436341162,1.0,1.0,11/28,30.96%,SBK2;AKT1;MAP2K3;PRKACA;MAP2K7;LRRK2;RPS6KA2;RPS6KB1;SGK1;MAP2K4;MAP2K5
prerank,neuropeptide binding (GO:0042923),0.18546497558859587,0.43199029267536304,0.9893758300132802,1.0,1.0,4/18,31.90%,MC4R;NMUR1;GPR37;SSTR2
prerank,5'-3' exonuclease activity (GO:0008409),0.19419645331264518,0.4198692503097956,0.9919137466307277,1.0,1.0,7/14,36.82%,DCLRE1B;XRN1;DXO;CPSF3;FAN1;MRE11;EXOG
prerank,C-C chemokine receptor activity (GO:0016493),0.17652255311146797,0.41002020656516475,0.994750656167979,1.0,1.0,4/21,26.07%,ACKR4;CXCR4;ACKR3;CCRL2
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.20156184279426848,0.4090469642768925,0.9955621301775148,1.0,1.0,2/10,23.44%,HEXIM1;KAT2B
prerank,death receptor binding (GO:0005123),0.1797983327156088,0.39364503934130973,0.9960212201591512,1.0,1.0,3/15,26.25%,MADD;BID;RIPK1
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.17691608729436883,0.3667938951641857,0.9971910112359551,1.0,1.0,7/11,41.89%,CASP1;CASP2;CASP6;CASP7;CASP8;CASP12;CFLAR
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.17205102137758532,0.3495467164075247,0.9986013986013986,1.0,1.0,4/10,36.22%,DCLRE1B;POLD1;MGME1;TATDN1
prerank,MHC protein binding (GO:0042287),0.14226187878771265,0.3234500582617673,1.0,0.9999023795879334,1.0,5/20,34.30%,LAG3;DERL1;TUBB4B;LILRB1;TAP2
